papaverine has been researched along with Impotence in 655 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of our work is to evaluate the efficacy of intracavernous sodium nitroprusside (SNP) in management of erectile dysfunction (ED) in a clinical comparative study with papaverine/phentolamine in ED patients." | 9.11 | Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. ( Abdelsalam, W; Atteya, A; Elnashaar, A; Gadallah, A; Shamloul, R; Zohdy, W, 2005) |
| "To assess the levels of adrenomedullin (a vasodilatory peptide) in penile blood before and after injection with papaverine in impotent men, and in the internal spermatic vein in infertile patients with varicocele, comparing the results with levels in the brachial vein in the same patients." | 9.09 | The role of adrenomedullin in varicocele and impotence. ( Balbay, MD; Davarci, M; Ozbek, E; Soylu, A; Yurekli, M, 2000) |
| "Forty-two patients with erectile dysfunction (ED) were randomly assigned to receive SNP 300 micrograms or the control drugs (papaverine 30 mg + phentolamine 1 mg) intracavernously crosswise one week apart." | 9.09 | A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. ( Fu, Q; Jiang, YQ; Yao, DH, 2000) |
| "To suggest a new noninvasive method for penile Doppler ultrasound (PDU) evaluation of erectile dysfunction using oral sildenafil citrate as an erection induction agent." | 9.09 | Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction. ( Altinok, D; Baçar, H; Baçar, MM; Batislam, E; Yilmaz, E, 2001) |
| "This study was done to evaluate the effectiveness of transdermal nitroglycerin in the treatment of erectile dysfunction in males with spinal cord lesions as compared to the treatment with intracavernous injection of papaverine." | 9.08 | Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions. ( Kurien, T; Renganathan, R; Suranjan, B, 1997) |
| "Recently, nitric oxide was shown to be a mediator of penile erection in men and the nitric oxide donor linsidomine chlorhydrate (SIN-1) was introduced as a novel treatment option in patients with erectile dysfunction." | 9.07 | Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. ( Becker, AJ; Djamilian, MH; Jonas, U; Stief, CG; Truss, MC, 1994) |
| "In an attempt to determine whether penile pain associated with intracorporeal injections could be due to the acidity of the medication, we performed a randomized study comparing the incidence of penile pain following intracorporeal injections with or without the addition of sodium bicarbonate to the intracorporeal medications." | 9.07 | Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. ( Moriel, EZ; Rajfer, J, 1993) |
| "Intracavernosal injection of papaverine and phentolamine was used in 20 patients with impotence." | 9.06 | Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. ( Dinsmore, WW, 1990) |
| "The efficacy of prostaglandin E1 as a pharmacological treatment of erectile dysfunction (impotence) was compared with the standard treatment, papaverine, in a single blind, crossover trial." | 9.06 | Prostaglandin E1 therapy for impotence, comparison with papaverine. ( Earle, CM; Glatthaar, C; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1990) |
| "The efficacy of papaverine and phenoxybenzamine as a pharmacological treatment of impotence was compared in a double blind, crossover, placebo controlled trial." | 9.06 | Treatment of impotence by intrapenile injections of papaverine and phenoxybenzamine: a double blind, controlled trial. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1989) |
| "The efficacy of papaverine, and a combination of papaverine and phentolamine as a pharmacological treatment of impotence was compared in a double-blind, crossover trial." | 9.06 | Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, GS; Watters, GR; Wisniewski, ZS, 1989) |
| " Of 15 men with arteriogenic impotence who had failed prior intracavernous phentolamine and papaverine therapy 10 had adequate erections with prostaglandin E1." | 9.06 | Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. ( Lee, LM; Stevenson, RW; Szasz, G, 1989) |
| " The results of a pharmacological test using intracavernously applied mixture of papaverine and phentolamine were compared with the results of a multidisciplinary evaluation of erectile dysfunction." | 9.06 | [Open multicenter study of the differential diagnosis of erectile dysfunction with a papaverine-phentolamine combination (BY023)]. ( Altwein, JE; Baccouche, M; Bähren, W; Jecht, E; Jünemann, KP; Lühmann, R; Müller-Mattheis, V; Weiske, WH; Wetterauer, U; Zentgraf, M, 1988) |
| "To evaluate the efficacy and safety of intracavernous self-injection of phentolamine and papaverine for the treatment of impotence, 30 patients were enrolled in a prospective, randomized, double-blind, placebo-controlled cross-over study of papaverine and phentolamine versus normal saline." | 9.06 | Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. ( Bruskewitz, RC; Gasser, TC; Larsen, EH; Madsen, PO; Roach, RM, 1987) |
| "Intracorporeal administration of papaverine hydrochloride is frequently used in the diagnosis and treatment of impotence." | 8.78 | Risk factors for papaverine-induced priapism. ( Jarow, JP; Lomas, GM, 1992) |
| "To analyze the predictive factors causing ischemic priapism following penile doppler ultrasonography (PDU) with intracavernosal papaverine injection Materials and methods: Medical records of 467 patients who underwent PDU examination following intracavernosal papaverine injection for erectile dysfunction (ED) between 2009 and 2017 were retrospectively reviewed." | 7.96 | Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection. ( Erbin, A; Güler, Y, 2020) |
| "Papaverine hydrochloride (PaHCl) is an old, well-known drug with spasmolytic activity but it has therapeutic effect in erectile dysfunction, too." | 7.88 | Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction. ( Bajory, Z; Berkó, S; Budai-Szűcs, M; Csányi, E; Deák, G; Gácsi, A; Kovács, A; Pajor, L; Zsikó, S, 2018) |
| "To enhance the systemic transdermal delivery of papaverine for the treatment of erectile dysfunction, several factors that influence transdermal delivery of papaverine HCl were studied." | 7.78 | Systemic enhancement of papaverine transdermal gel for erectile dysfunction. ( El-Kamel, AH; Khalil, SA; Wen, MM, 2012) |
| "The aim of the study was to determine which vasoactive agent was more efficacious for erectile dysfunction (ED), intracavernosal papaverine or oral sildenafil, in paraplegic men within the first year after injury by using a penile color Doppler ultrasound as a quantitative imaging method and to determine the association between responses to these two vasoactive agents and factors such as neurological lesion level and lesion severity." | 7.77 | Efficacies of papaverine and sildenafil in the treatment of erectile dysfunction in early-stage paraplegic men. ( Comert, D; Gokkaya, NK; Gokkaya, S; Koseoglu, F; Yildiz, N, 2011) |
| "The autors recommend intravenous methylene blue for the treatment of priapism." | 7.72 | Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. ( Hübler, J; Könyves, K; Szántó, A, 2003) |
| "To determine the results of an auto-injection therapy with papaverine-phentolamine (using an auto-injection pen) prescribed by a GP or a urologist, in patients with erectile dysfunction." | 7.71 | [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology]. ( de Boer, BJ; Kleinjans, HA; Lycklama a Nijeholt, AA, 2001) |
| "The aim of this study was to evaluate the effectiveness of a progressive program for the treatment of erectile dysfunction in patients with cardiovascular disease in whom sildenafil citrate (Viagra) was not an option." | 7.71 | Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. ( Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J, 2002) |
| "The effectiveness and complications of intracorporeal phenylephrine without aspiration or irrigation as a treatment for priapism were assessed." | 7.69 | Intracorporeal phenylephrine in the treatment of priapism. ( Hosking, DH; Muruve, N, 1996) |
| "To compare the effectiveness of topically applied 2% minoxidil to that of intracorporeal injection therapy and vacuum constriction devices for the treatment of erectile dysfunction in the spinal cord injured (SCI) male." | 7.69 | Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury. ( Chancellor, MB; Freedman, MK; Panzer, DE; Rivas, DA; Staas, WE, 1994) |
| " A comparative study with intracavernous injection of prostaglandin E1 (PGE1) and papaverine was performed in 60 patients with impotence." | 7.68 | A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence. ( Chiang, CP; Huang, CH; Wang, CJ; Wu, CC, 1992) |
| "Thirty-three diabetic men were instructed in the use of phentolamine-papaverine injections for the treatment of erectile dysfunction over a two-year period." | 7.68 | Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. ( Bell, DS; Cutter, GR; Hayne, VB; Lloyd, LK, 1992) |
| "We report an unusual complication of papaverine injection therapy for impotence." | 7.68 | Intracorporeal needle breakage: an unusual complication of papaverine injection therapy for impotence. ( Beer, SJ; See, WA, 1992) |
| "Forty men with organic or psychogenic impotence, who were highly motivated for treatment, were offered instruction in the intracavernosal (I-C) self-injection of papaverine and regular ongoing supervision by the investigator." | 7.68 | Evaluation of I-C papaverine in patients with psychogenic and organic impotence. ( Cooper, AJ, 1991) |
| " Arteriogenic impotence falls within the first group and has been assessed with the papaverine test, simple Doppler and arteriography." | 7.68 | [Duplex ultrasound before and after intracavernous papaverine injection in the diagnosis of impotence]. ( Alonso Gorrea, M; Boronat Tormo, F; Jiménez Cruz, JF; Moreno Pardo, B; Pontones Moreno, JL; Vidal Moreno, JF, 1991) |
| "Most studies of duplex Doppler sonography for the assessment of erectile dysfunction involve determination of peak systolic velocities 5 min after intracavernosal injection of papaverine." | 7.68 | Color Doppler sonography in the evaluation of erectile dysfunction: patterns of temporal response to papaverine. ( Erickson, SJ; Fitzgerald, SW; Foley, WD; Lawson, TL; Lipchik, EO, 1991) |
| "Priapism occurred in ten patients undergoing treatment of depression with trazodone or impotence with papaverine." | 7.68 | Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. ( Bardin, ED; Krieger, JN, 1990) |
| "After evaluating approximately 500 patients to identify the cause of erectile dysfunction, I selected 60 patients to receive a therapeutic injection of the vasoactive drugs papaverine and phentolamine mesylate (Regitine) into the corpora cavernosa." | 7.67 | Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients. ( Nelson, RP, 1989) |
| "To determine the efficacy of the intracavernous administration of papaverine hydrochloride every 2 weeks to treat male impotence, we recruited 50 patients from a sexual dysfunction clinic." | 7.67 | Biweekly intracavernous administration of papaverine for erectile dysfunction. ( Davis, SS; Kaiser, FE; Korenman, SC; Mooradian, AD; Morley, JE; Viosca, SP, 1989) |
| " orally) for persistent penile erection and priapism resulting from injection of pharmacological agents, such as phentolamine, phenoxybenzamine and papavarine, into the penis for erectile impotence." | 7.67 | Treatment of persistent penile erection and priapism using terbutaline. ( Finnerty, DP; Rodriquez, AP; Shantha, TR, 1989) |
| "Forty milligrams papaverine HCl was intracavernously injected to 28 patients with erectile dysfunction for diagnosis and treatment in 14 cases in which it was injected a few times." | 7.67 | [Investigation of intracavernous injection of papaverine for erectile impotence]. ( Aoki, Y; Hamada, T; Hosokawa, H; Kawazoe, K; Ono, M; Takimoto, Y; Yasuoka, S, 1989) |
| "The present study evaluates both penile xenon-133 washout (XWT) and papaverine tests (PT) in the diagnosis of vasculogenic impotence." | 7.67 | Diagnosis of vasculogenic impotence: combination of penile xenon-133 washout and papaverine tests. ( Chang, LS; Kuo, JS; Lin, SN; Liu, RS; Yeh, SH; Yu, PC, 1989) |
| "Intracorporeal papaverine injections were performed for evaluation of penile erection on 120 patients with sexual impotence." | 7.67 | [Intracorporeal injection of papaverine for diagnosis of impotence: clinical evaluation of 120 patients]. ( Chiang, HS, 1989) |
| "In 5 out of 84 patients suffering from impotence a prolonged erection was observed after intracavernous papaverine injection." | 7.67 | [Priapism as a complication following diagnostic papaverine test]. ( Darewicz, J; Galek, L, 1989) |
| "Intracorporeal papaverine self-injection is a new therapy for erectile dysfunction." | 7.67 | Papaverine-induced fibrosis of the corpus cavernosum. ( Brawer, MK; Fuchs, ME, 1989) |
| "Ten patients with priapism after self-administered intracavernous papaverine injection for erectile impotence had to be treated as emergencies between September 1985 and February 1988." | 7.67 | [Papaverine-induced priapism. Experiences with a new urologic emergency]. ( Busch, R; Gonnermann, D; Klosterhalfen, H; Schneider, AW, 1989) |
| "We injected papaverine into the corpus cavernosum of 93 patients with impotence, and compared the results with findings from nocturnal penile tumescence monitoring, psychogenic erection monitoring after sexual stimulation, penile-brachial indexes, and dynamic cavernosography." | 7.67 | Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence? ( Imagawa, A; Kawanishi, Y, 1988) |
| "To evaluate the use of papaverine-induced erection as a diagnostic test in men with erectile dysfunction, 24 patients had papaverine injected into the corpus cavernosum." | 7.67 | The intracavernous injection of papaverine as a diagnostic procedure in patients with erectile dysfunction. ( Frimodt-Møller, C; Lyngdorf, P; Mouritsen, L, 1988) |
| "The diagnosis and treatment of male impotence have been radically modified by the introduction of intracavernous injections of papaverine." | 7.67 | Diagnosis of male impotence after intracavernous papaverine test. ( De Rose, AF; Giuliani, L; Pittaluga, P; Puppo, P, 1988) |
| "In 61 patients with erectile dysfunction a comparative study with intracavernous injection of prostaglandin E1 (PGE1), papaverine and a mixture of papaverine and phentolamine was performed." | 7.67 | [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction]. ( Porst, H, 1988) |
| "A second Doppler examination after intracavernous injection of papaverine provides more objective data in cases with questionable penile Doppler results and vascular impotence." | 7.67 | Papaverine--injection and Doppler-sonographic examination in the diagnosis of vascular erectile dysfunction. ( Weidner, W; Weiske, WH, 1987) |
| "We present our experience with the intracorporeal injection of papaverine and duplex sonography in the assessment of 47 patients with suspected vasculogenic impotence." | 7.67 | Experience with intracorporeal injection of papaverine and duplex ultrasound scanning for assessment of arteriogenic impotence. ( Collins, JP; Lewandowski, BJ, 1987) |
| "To determine whether intracavernous injection of papaverine can discriminate vascular versus psychogenic impotence 80 mg." | 7.67 | Is intracavernous injection of papaverine a reliable screening test for vascular impotence? ( Buvat, J; Buvat-Herbaut, M; Dehaene, JL; Lemaire, A, 1986) |
| " Studies have shown that sildenafil may not be effective in all patients, and has been associated with a variety of adverse effects and an adverse interaction with nitrates and inhibitors of cytochrome P450 enzymes." | 6.70 | Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd ( Castaneda, J; Castell, R; Hurley, D; Lammers, PI; Lipezker, M; Loehr, LA; Lowrey, F; Ponce de Leon, R; Rubio-Aurioles, E, 2002) |
| "Of 20 men with organic impotence 17 completed the trial and 13 of these patients had spinal cord injuries." | 6.68 | Papaverine topical gel for treatment of erectile dysfunction. ( el-Rashidy, R; Kim, ED; McVary, KT, 1995) |
| " Careful investigation of erectile disturbances and search for the appropriate papaverin dosage are therefore crucial." | 6.37 | [Diagnosis and therapy of erectile impotence with special reference to papaverine]. ( Schnyder von Wartensee, M; Studer, UE, 1986) |
| "Papaverine has the greatest deteriorating effect on PGE1." | 5.30 | Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. ( Andrisano, V; Bertaccini, A; Carparelli, F; Cavrini, V; Gotti, R; Martorana, G; Soli, M, 1998) |
| "Papaverine was injected into the base of one corpora cavernosum." | 5.29 | Management of impotence due to spinal cord injury using low dose papaverine. ( Chen, D; Lovell, L; Palmer, J; Rayner, S; Roth, EJ; Yarkony, GM, 1995) |
| "Most of the patients with venogenic impotence found the device to be of therapeutic benefit." | 5.29 | A modified papaverine test and the use of venous constriction in erectile dysfunction. ( Choa, RG; Lanigan, D; Roobottom, C, 1993) |
| "The nitroglycerin plasters were applied on the skin of the penile shaft and a positive response was obtained in 12 men." | 5.28 | Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured. ( Biering-Sørensen, F; Sønksen, J, 1992) |
| "The investigation of vascular impotence requires a simple, reliable and non-invasive method of estimating penile arterial supply." | 5.28 | Combined papaverine test and radionuclide penile blood flow in impotence: method and preliminary results. ( Cunningham, DA; Dave, S; Grech, P; Witherow, RO, 1992) |
| " Use of low dosage of papaverine is suggested as an additional mode of therapy in the management of psychogenic impotence." | 5.28 | Intracavernous papaverine in the management of psychogenic impotence. ( Bhutwala, A; Dhabuwala, CB; Kerkar, P; Kumar, A; Pierce, JM, 1990) |
| "Priapism is a recognized complication of intracavernous self-injection of vasoactive agents for the management of impotence." | 5.28 | Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. ( Lue, TF; Vapnek, J, 1989) |
| "Priapism was not encountered during self-injection but it did occur twice in 329 physician-administered injections." | 5.28 | Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, CB; Turner, LA, 1989) |
| "Fourteen patients with organic impotence received intracorporeal injections of papaverine and were then monitored by Rigiscan." | 5.27 | Utility of Rigiscan and papaverine in diagnosis of erectile impotence. ( Badlani, GH; Weinberg, JJ, 1988) |
| "We tested 50 patients complaining of impotence with intracavernous injection of 60 mg." | 5.27 | The erectile angle: objective criterion to evaluate the papaverine test in impotence. ( Delcour, C; Rondeux, C; Schulman, CC; Struyven, J; Wespes, E, 1987) |
| " A total of 400 patients with erectile dysfunction were evaluated before and after diagnostic intracavernous injection of a trimix solution (papaverine+phentolamine+PGE1) using color Doppler sonography." | 5.11 | The value of penile duplex in the prediction of intracavernous drug-induced priapism. ( Ghanem, HM; Kamel, II; Mousa, AA; Salem, A; Shamloul, R, 2004) |
| "The aim of our work is to evaluate the efficacy of intracavernous sodium nitroprusside (SNP) in management of erectile dysfunction (ED) in a clinical comparative study with papaverine/phentolamine in ED patients." | 5.11 | Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects. ( Abdelsalam, W; Atteya, A; Elnashaar, A; Gadallah, A; Shamloul, R; Zohdy, W, 2005) |
| "To assess the levels of adrenomedullin (a vasodilatory peptide) in penile blood before and after injection with papaverine in impotent men, and in the internal spermatic vein in infertile patients with varicocele, comparing the results with levels in the brachial vein in the same patients." | 5.09 | The role of adrenomedullin in varicocele and impotence. ( Balbay, MD; Davarci, M; Ozbek, E; Soylu, A; Yurekli, M, 2000) |
| "Forty-two patients with erectile dysfunction (ED) were randomly assigned to receive SNP 300 micrograms or the control drugs (papaverine 30 mg + phentolamine 1 mg) intracavernously crosswise one week apart." | 5.09 | A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. ( Fu, Q; Jiang, YQ; Yao, DH, 2000) |
| "To suggest a new noninvasive method for penile Doppler ultrasound (PDU) evaluation of erectile dysfunction using oral sildenafil citrate as an erection induction agent." | 5.09 | Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction. ( Altinok, D; Baçar, H; Baçar, MM; Batislam, E; Yilmaz, E, 2001) |
| "A study was designed to compare intracorporeal injections of papaverine plus phentolamine (2-drug solution) and papaverine plus phentolamine and prostaglandin E1 (3-drug solution) for the treatment for impotence." | 5.08 | Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. ( Goldwasser, B; Hanani, J; Shalhav, A; Shenfeld, O; Vardi, Y, 1995) |
| " All patients had presented with erectile dysfunction longer than 6 months in duration and had failed to respond to high doses of papaverine (60 mg." | 5.08 | Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. ( Bechara, A; Casabé, A; Chéliz, G; Fredotovich, N; Romano, S, 1996) |
| "This study was done to evaluate the effectiveness of transdermal nitroglycerin in the treatment of erectile dysfunction in males with spinal cord lesions as compared to the treatment with intracavernous injection of papaverine." | 5.08 | Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions. ( Kurien, T; Renganathan, R; Suranjan, B, 1997) |
| "A study comparing intracorporeal injection of prostaglandin E1 (one-drug solution) and papaverine plus prostaglandin E1 (2-drug solution) for treatment of impotence." | 5.08 | Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy. ( Zaher, TF, 1998) |
| "Transurethral alprostadil therapy is an effective therapeutic option for patients with erectile dysfunction and may even "rescue" some patients who have failed prior intracavernous injection therapy." | 5.08 | Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. ( Engel, JD; McVary, KT, 1998) |
| "Thirty-eight consecutive men with moderate to severe erectile dysfunction on the basis of history and examination and with minimal or no therapeutic response to intracavernosal alprostadil injection therapy were evaluated." | 5.08 | Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. ( Kaplan, SA; Kohn, IJ; Reis, RB; Shabsigh, R; Te, AE, 1998) |
| "Recently, nitric oxide was shown to be a mediator of penile erection in men and the nitric oxide donor linsidomine chlorhydrate (SIN-1) was introduced as a novel treatment option in patients with erectile dysfunction." | 5.07 | Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction. ( Becker, AJ; Djamilian, MH; Jonas, U; Stief, CG; Truss, MC, 1994) |
| "In an attempt to determine whether penile pain associated with intracorporeal injections could be due to the acidity of the medication, we performed a randomized study comparing the incidence of penile pain following intracorporeal injections with or without the addition of sodium bicarbonate to the intracorporeal medications." | 5.07 | Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. ( Moriel, EZ; Rajfer, J, 1993) |
| "In a double-blind, crossover designation penile intracavernous prostaglandin E1 and papaverine hydrochloride were compared in regard to effectiveness and safety in 52 patients investigated and treated for sexual erectile dysfunction." | 5.07 | Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients. ( Abdel-Aziz, AB; el Dakhli, MR; Fahmi, IM; Mahmoud, KZ, 1992) |
| "The intracorporeal injection of papaverine (ICP) is now a well recognized therapeutic option in the management of impotence." | 5.06 | Intracorporeal papaverine injection in androgen deprived men. ( Desai, KM; Gilbert, HW; Gillatt, DA; Gingell, JC, 1990) |
| "Intracavernosal injection of papaverine and phentolamine was used in 20 patients with impotence." | 5.06 | Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. ( Dinsmore, WW, 1990) |
| "The efficacy of prostaglandin E1 as a pharmacological treatment of erectile dysfunction (impotence) was compared with the standard treatment, papaverine, in a single blind, crossover trial." | 5.06 | Prostaglandin E1 therapy for impotence, comparison with papaverine. ( Earle, CM; Glatthaar, C; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1990) |
| "A total of 100 men with organic impotence underwent a trial of intracavernous drug-induced erections with a mixture of papaverine (25 mg." | 5.06 | Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. ( Cameron, JS; Duffy, LM; Lange, PH; Sidi, AA, 1986) |
| "A total of 66 spinal cord injury patients with erectile dysfunction entered a protocol of penile intracavernous pharmacotherapy with papaverine hydrochloride (30 mg." | 5.06 | Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury. ( Cameron, JS; Dykstra, DD; Lange, PH; Reinberg, Y; Sidi, AA, 1987) |
| "We tested the possibility of using intracavernous injections of the alpha-blocking agent moxisylyte (6-acetoxy-thymoxy-ethyl-dimethylamine) as treatment of erectile impotence." | 5.06 | Safety of intracavernous injections using an alpha-blocking agent. ( Buvat, J; Buvat-Herbaut, M; Lemaire, A; Marcolin, G, 1989) |
| "The efficacy of papaverine and phenoxybenzamine as a pharmacological treatment of impotence was compared in a double blind, crossover, placebo controlled trial." | 5.06 | Treatment of impotence by intrapenile injections of papaverine and phenoxybenzamine: a double blind, controlled trial. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1989) |
| "The efficacy of papaverine, and a combination of papaverine and phentolamine as a pharmacological treatment of impotence was compared in a double-blind, crossover trial." | 5.06 | Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, GS; Watters, GR; Wisniewski, ZS, 1989) |
| " Of 15 men with arteriogenic impotence who had failed prior intracavernous phentolamine and papaverine therapy 10 had adequate erections with prostaglandin E1." | 5.06 | Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. ( Lee, LM; Stevenson, RW; Szasz, G, 1989) |
| " The results of a pharmacological test using intracavernously applied mixture of papaverine and phentolamine were compared with the results of a multidisciplinary evaluation of erectile dysfunction." | 5.06 | [Open multicenter study of the differential diagnosis of erectile dysfunction with a papaverine-phentolamine combination (BY023)]. ( Altwein, JE; Baccouche, M; Bähren, W; Jecht, E; Jünemann, KP; Lühmann, R; Müller-Mattheis, V; Weiske, WH; Wetterauer, U; Zentgraf, M, 1988) |
| "To evaluate the efficacy and safety of intracavernous self-injection of phentolamine and papaverine for the treatment of impotence, 30 patients were enrolled in a prospective, randomized, double-blind, placebo-controlled cross-over study of papaverine and phentolamine versus normal saline." | 5.06 | Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. ( Bruskewitz, RC; Gasser, TC; Larsen, EH; Madsen, PO; Roach, RM, 1987) |
| " The literature search was restricted to articles published in English, French, and Spanish up to November 2014 using the key words alprostadil, papaverine, moxisylite, alpha-blocking agent, phentolamine, intracavernous injection, spinal cord injuries, paraplegia, quadriplegia, and erectile dysfunction." | 4.93 | Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis. ( Bonan, I; Chéhensse, C; Chochina, L; Damphousse, M; Giuliano, F; Manunta, A; Naudet, F, 2016) |
| "Despite the proven efficacy of oral therapy for erectile dysfunction (ED), some patients are unable to take these medications because of drug interactions (ie, sildenafil and nitroglycerin) or a lack of response." | 4.81 | Topical agents and erectile dysfunction: is there a place? ( McVary, KT; Yap, RL, 2002) |
| "Patients with psychogenic and neurogenic impotence responded to low dose therapy, whereas those with veno-occlusive impotence required the highest doses of PGE1 or papaverine + PGE1." | 4.79 | [Long-term results of the treatment with intracavernous injection of vasoactive drugs]. ( Benejan Gual, J; Cuesta Presedo, JM; Gil Martínez, P; Gonzalvo Ibarra, A; Ríoja Sanz, LA; Rodríguez Vela, L, 1996) |
| "Intracorporeal administration of papaverine hydrochloride is frequently used in the diagnosis and treatment of impotence." | 4.78 | Risk factors for papaverine-induced priapism. ( Jarow, JP; Lomas, GM, 1992) |
| "From the beginning of the eighties papaverine was well established as the drug of choice for diagnosis and management of vasculogenic impotence." | 4.78 | [Endocavernous drug infusions revisited]. ( Bellorofonte, C; Dell'Acqua, S; Ferri, PM; Ruoppolo, M; Tagliaferri, A; Tombolini, P; Yamak, R; Zaatar, C, 1991) |
| "Intracavernous administration of papaverine and phentolamine has become an essential and indispensible element in the diagnosis and treatment of erectile dysfunction." | 4.77 | How safe is the treatment of impotence with intracavernous autoinjection? ( Ludwig, G; Zentgraf, M; Ziegler, M, 1989) |
| "To analyze the predictive factors causing ischemic priapism following penile doppler ultrasonography (PDU) with intracavernosal papaverine injection Materials and methods: Medical records of 467 patients who underwent PDU examination following intracavernosal papaverine injection for erectile dysfunction (ED) between 2009 and 2017 were retrospectively reviewed." | 3.96 | Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection. ( Erbin, A; Güler, Y, 2020) |
| "Papaverine hydrochloride (PaHCl) is an old, well-known drug with spasmolytic activity but it has therapeutic effect in erectile dysfunction, too." | 3.88 | Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction. ( Bajory, Z; Berkó, S; Budai-Szűcs, M; Csányi, E; Deák, G; Gácsi, A; Kovács, A; Pajor, L; Zsikó, S, 2018) |
| "It is evident from the study that the transferosomes can be used as a carrier of papaverine hydrochloride for both diagnosis and treatment of the erectile dysfunction." | 3.81 | Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction. ( Abdelmohsen, HF; Ali, MF; Attia, SK; Salem, HF, 2015) |
| "Currently, severe erectile dysfunction can be treated by intracavernous injections of solutions containing three active ingredients: prostaglandin E1 (PGE1), papaverine and urapidil." | 3.79 | Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. ( Astier, A; Deffaux, C; Eychenne, N; Paul, M; Vieillard, V; Yiou, R, 2013) |
| "To enhance the systemic transdermal delivery of papaverine for the treatment of erectile dysfunction, several factors that influence transdermal delivery of papaverine HCl were studied." | 3.78 | Systemic enhancement of papaverine transdermal gel for erectile dysfunction. ( El-Kamel, AH; Khalil, SA; Wen, MM, 2012) |
| "The aim of the study was to determine which vasoactive agent was more efficacious for erectile dysfunction (ED), intracavernosal papaverine or oral sildenafil, in paraplegic men within the first year after injury by using a penile color Doppler ultrasound as a quantitative imaging method and to determine the association between responses to these two vasoactive agents and factors such as neurological lesion level and lesion severity." | 3.77 | Efficacies of papaverine and sildenafil in the treatment of erectile dysfunction in early-stage paraplegic men. ( Comert, D; Gokkaya, NK; Gokkaya, S; Koseoglu, F; Yildiz, N, 2011) |
| " We describe the procedure to establish the dosage for home use and discuss the implications of the low dosages relative to previous reports." | 3.77 | Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. ( Donatucci, CF; Kaula, N; Lue, TF; von Heyden, B, 1993) |
| " E1-PG dosage varied from 10 to 40 mcg based on diagnosis, and was readjusted in 6 of the 9 patients which in the initial tests had not obtained sufficient erection, therefore bringing about a final 91." | 3.77 | [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature]. ( Alvarez González, E; Chandeck Montesa, K; Chen Jiménez, J; Rodríguez Antolín, A; Tamayo, JC, 1992) |
| "Patients with organic and mixed impotence are best suited for injection treatment, but selected patients with psychogenic impotence also benefit from therapy." | 3.76 | Injection therapy for impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, C; Turner, L, 1988) |
| "To determine the ability of transanal pelvic plexus stimulation (TPPS) in inducing penile tumescence in patients with non-neurogenic erectile dysfunction (ED) and to compare the erection degree with papaverine-induced erection." | 3.74 | Effects of transanal pelvic plexus stimulation on penile erection: clinical implications. ( Agras, K; Gurdal, M; Kayigil, O; Okulu, E; Serefoglu, EC; Ucgul, Y, 2007) |
| "A total of 24 patients with erectile dysfunction underwent color Doppler ultrasound before and after intracavernous injection of 60 mg papaverine with genital and audiovisual sexual stimulation." | 3.73 | Effectiveness of vardenafil versus papaverine in penile Doppler ultrasonography. ( Ardicoglu, A; Bozgeyik, Z; Kocakoc, E; Orhan, I; Tuygun, UO, 2005) |
| "The autors recommend intravenous methylene blue for the treatment of priapism." | 3.72 | Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. ( Hübler, J; Könyves, K; Szántó, A, 2003) |
| "To determine the results of an auto-injection therapy with papaverine-phentolamine (using an auto-injection pen) prescribed by a GP or a urologist, in patients with erectile dysfunction." | 3.71 | [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology]. ( de Boer, BJ; Kleinjans, HA; Lycklama a Nijeholt, AA, 2001) |
| "Self-injection therapy with papaverine, phentolamine and prostaglandin E1 is effective and safe in the treatment of erectile dysfunction after radical prostatectomy." | 3.71 | Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study. ( Aguiar, W; Andrade, E; Claro, Jde A; de Aboim, JE; Maríngolo, M; Nardozza Júnior, A; Nogueira, M; Srougi, M, 2001) |
| "The aim of this study was to evaluate the effectiveness of a progressive program for the treatment of erectile dysfunction in patients with cardiovascular disease in whom sildenafil citrate (Viagra) was not an option." | 3.71 | Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. ( Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J, 2002) |
| "In vitro and in vivo studies were performed to determine the potential use of tamsulosin (TAM) versus phentolamine (PHE) for intracavernosal injection (ICI) therapy when mixed with papaverine (PAP) and/or prostagladin E1 (PGE1) or with vasoactive intestinal polypeptide (VIP) for the treatment of erectile dysfunction." | 3.70 | Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies. ( Kim, SC; Lee, MY; Lee, SK; Seo, KK; Song, ES, 1999) |
| " The authors' pharmacologic erection program, using a fixed combination of prostaglandin E1 (PGE1) and papaverine, is notable for its simplicity and acceptance by patients who have suffered spinal cord injuries (SCIs)." | 3.70 | A simplified pharmacologic erection program for patients with spinal cord injury. ( Britanico, J; Galea, G; Nicolis, C; Vapnek, JM; Zaslau, S, 1999) |
| "To compare the cost effectiveness of sildenafil and papaverine-phentolamine injections for treating erectile dysfunction." | 3.70 | Cost utility analysis of sildenafil compared with papaverine-phentolamine injections. ( Busschbach, JJ; Caffa, M; Meuleman, EJ; Rutten, FF; Stolk, EA, 2000) |
| " Inability to consummate the marriage was caused by premature ejaculation in 23%, erectile dysfunction in 61%, and a combination in 16%; 70% of patients were able to consummate the union after intracorporeal injection with papaverine +/- phentolamine." | 3.70 | Unconsummated marriage: clarification of aetiology; treatment with intracorporeal injection. ( Zargooshi, J, 2000) |
| "The effectiveness and complications of intracorporeal phenylephrine without aspiration or irrigation as a treatment for priapism were assessed." | 3.69 | Intracorporeal phenylephrine in the treatment of priapism. ( Hosking, DH; Muruve, N, 1996) |
| "One hundred and fifty-nine men with erectile dysfunction were assessed with Rigiscan monitoring of nocturnal penile tumescence (NPT) and response to intracavernosal injections (ICI) of papaverine or prostaglandin E1." | 3.69 | The clinical assessment of erectile dysfunction: a comparison of nocturnal penile tumescence monitoring and intracavernosal injections. ( Bancroft, J; Malone, N, 1995) |
| "One hundred and eighty patients, average age of 58 years (range 24-75) were evaluated for impotence and were advised to undergo pharmacologic self-injection therapy with either papaverine/Regitine (90%) or prostaglandin E1 (10%)." | 3.69 | Reasons for high drop-out rate with self-injection therapy for impotence. ( Badlani, GH; Brettschneider, N; Ravalli, R; Weiss, JN, 1994) |
| "Intracavernosal administration of papaverine or prostaglandin E1 for erectile impotence in paraplegics is being practised widely." | 3.69 | Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics. ( Krishnan, KR; Soni, BM; Vaidyanathan, S, 1994) |
| "To investigate the relaxant action of histamine on human corpus cavernosum in vitro and the erectile response caused by the intracavernous injection of histamine in patients with psychogenic impotence." | 3.69 | The role of histamine in human penile erection. ( Antunes, E; Cará, AM; De Nucci, G; Lopes-Martins, RA; Nahoum, CR, 1995) |
| "Using papaverine, papaverine/phentolamine, or prostaglandin E1 (PGE1), intracavernosal pharmacotherapy has been successful in treating erectile dysfunction." | 3.69 | Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. ( Chao, R; Clowers, DE, 1994) |
| "To compare the effectiveness of topically applied 2% minoxidil to that of intracorporeal injection therapy and vacuum constriction devices for the treatment of erectile dysfunction in the spinal cord injured (SCI) male." | 3.69 | Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury. ( Chancellor, MB; Freedman, MK; Panzer, DE; Rivas, DA; Staas, WE, 1994) |
| "Papaverine has offered new options for therapy in erectile dysfunction." | 3.69 | Fixed drug eruption to papaverine. ( Cohen, R; Kirby, KA; Upson, CV, 1994) |
| "From December 1986 to December 1991, 107 patients with organic impotence were advised to intracavernous pharmacological therapy with papaverine." | 3.69 | Compliance to longterm vasoactive intracavernous therapy. ( Cirillo-Marucco, E; Corvasce, A; Ludovico, GM; Pagliarulo, A; Pagliarulo, G, 1996) |
| "We performed a clinical study, erection test with papaverine-phentolamine and neuroandrologic evaluation (bulbocavernous EMG, S2-S4 evoked potentials, evoked somatosensorial potentials, SPACE, D10-L2 skin sympathetic potentials, cystometrogram, and filling videocystography) in 180 patients consulting for impotence." | 3.69 | [Usefulness of the neuroandrologic profile study in patients with erectile dysfunction: review of a series of 180 cases]. ( Aristizábal Agudelo, JM; Blázquez Izquierdo, J; Delgado Martín, JA; Esteban Fuertes, M; Resel Estévez, L; Salinas Casado, J; Samblas García, R; Vírseda Chamorro, M, 1996) |
| "In this study we aimed to determine the importance of visual erotic stimulation (VES) alone, and in combination with intracavernosal papaverine injection (ICPE) in the differential diagnosis of erectile impotence." | 3.69 | The importance of visual erotic stimulation in the differential diagnosis of erectile impotence. ( Aydoğan, S; Bircan, MK; Korkmaz, K; Sahin, H, 1997) |
| "127 patients with impotence were evaluated by neuroandrologic profile, SPACE, erection test post intracavernous injection of papaverine-phentolamine and a cystometrogram (CMG)." | 3.69 | [Evaluation of electromyography of the corpora cavernosa (single potential analysis of cavernous electric activity--SPACE) as a technique for studying impotence]. ( Aristizábal Agudelo, JM; Blázquez Izquierdo, J; Delgado Martín, JA; Esteban Fuertes, M; Resel Estévez, L; Salinas Casado, J; Samblas García, R; Vírseda Chamorro, M, 1997) |
| "We aimed to compare the electrical activity of corpus cavernosum before and after intracavernous papaverine injection and to determine the blood lipid profile in vascular and non-vascular erectile dysfunction, and also to assess whether vascular pathology and abnormal blood lipid levels impair cavernosal smooth-muscle relaxation." | 3.69 | Electrical activity of corpus cavernosum in vasculogenic and non-vasculogenic erectile dysfunction. ( Atahan, O; Kayigil, O; Metin, A, 1997) |
| "A four-drug vasoactive mixture (papaverine hydrochloride, prostaglandin E1, phentolamine mesylate, atropine sulfate) was used for intracavernous injection therapy in 94 patients with vasculogenic impotence as diagnosed by color Doppler sonography and dynamic infusion cavernosometry-cavernosography." | 3.68 | Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. ( Bergamaschi, F; Dodesini, A; Guazzoni, G; Miani, A; Montorsi, F; Pizzini, G; Rigatti, P, 1993) |
| "A consecutive series of 52 men presenting with erectile dysfunction were assessed with (i) standardized sexual history, (ii) nocturnal penile tumescence and rigidity monitoring (NPTR), (iii) Rigiscan assessment of response to intracavernosal papaverine or prostaglandin injection (ICI), and (iv) duplex ultrasonography." | 3.68 | What does duplex ultrasound add to sexual history, nocturnal penile tumescence and intracavernosal injection of smooth muscle relaxant, in the diagnosis of erectile dysfunction? ( Bancroft, J; Gutierrez, P; Pye, S, 1993) |
| "The corporeal blood gas changes in accordance with the duration of the prolonged erection which developed after intracorporeal pharmacotherapy with papaverine and phentolamine were investigated in 62 impotence patients." | 3.68 | Corporeal blood gas changes according to duration of drug-induced prolonged erection. ( Kim, SC; Oh, CH; Seo, KK, 1993) |
| "We report the successful treatment of an abscess in the corpus cavernosum of a paraplegic man on intracavernous papaverine injection therapy by means of percutaneous aspiration and intravenous antibiotics." | 3.68 | Treatment of corpus cavernosum abscess by aspiration and intravenous antibiotics. ( de la Fuente, RB; Kropman, RF; van Imhoff, WL; Venema, PL, 1993) |
| " A comparative study with intracavernous injection of prostaglandin E1 (PGE1) and papaverine was performed in 60 patients with impotence." | 3.68 | A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence. ( Chiang, CP; Huang, CH; Wang, CJ; Wu, CC, 1992) |
| "Fifty-one patients with chronic erectile dysfunction were selected for this study involving intracavernous self-injection therapy with papaverine or prostaglandin E1 (PGE1)." | 3.68 | Intracavernous self-injection therapy for the treatment of erectile dysfunction. ( Chiang, HS; Chiang, WH; Wen, TC; Wu, CC, 1992) |
| "The change in the cavernous hematocrit following induction of pharmacological erection by an intracavernous injection of papaverine hydrochloride was documented in normal controls and patients with impotence." | 3.68 | Volume-dependent intracavernous hemodilution during pharmacologically induced penile erections. ( Ahmed, M; Bomanji, J; Hilson, AJ; Siraj, QH, 1992) |
| "We prospectively delineated and contrasted the sexual, marital and psychological responses of women to their partner's use of 2 treatments for erectile dysfunction: 1) self-injection of papaverine and phentolamine, and 2) vacuum tumescence therapy." | 3.68 | Through the eyes of women: the sexual and psychological responses of women to their partner's treatment with self-injection or external vacuum therapy. ( Althof, SE; Bodner, D; Kursh, ED; Levine, SB; Resnick, MI; Turner, LA, 1992) |
| "From May 1985 to July 1989, 143 patients suffering from chronic erectile dysfunction (21-70 years old) underwent constant corpus cavernosum auto-injection therapy (CCAT) with papaverine alone (1257 injections) or with a standardized papaverine-phentolamine mixture (11035 injections)." | 3.68 | [Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction]. ( Bähren, W; Gall, H; Holzki, G; Irion, R; Scherb, W; Sparwasser, C, 1992) |
| " These preliminary results suggest that prostaglandin E1 might represent an alternative for papaverine in the angiographic study of male impotence." | 3.68 | Intracavernosal injection of prostaglandin E1 as an alternative for papaverine in penile angiography. ( Baert, AL; Peene, P; Steeno, O; Wilms, G, 1992) |
| "Thirty-three diabetic men were instructed in the use of phentolamine-papaverine injections for the treatment of erectile dysfunction over a two-year period." | 3.68 | Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. ( Bell, DS; Cutter, GR; Hayne, VB; Lloyd, LK, 1992) |
| "Of 615 patients with impotence of varying etiologies who were followed from 12 to 96 months after the institution of intracavernous self-injection therapy with vasoactive drugs (papaverine alone, papaverine and alpha-blockers, and Ceritine, a new multilevel acting drug) 87% (533 patients) returned for followup visits or were regularly contacted." | 3.68 | Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. ( Floresco, J; Greco, E; Nollet, F; Shoukry, K; Virag, R, 1991) |
| "Twenty-five men with psychogenic impotence but without serious psychopathology were considered for intracavernosal therapy with papaverine hydrochloride and phentolamine mesylate." | 3.68 | Intracavernous pharmacotherapy in psychogenic impotence. ( Badlani, GH; Ravalli, R; Weiss, JN, 1991) |
| "We report an unusual complication of papaverine injection therapy for impotence." | 3.68 | Intracorporeal needle breakage: an unusual complication of papaverine injection therapy for impotence. ( Beer, SJ; See, WA, 1992) |
| "This study directly compared two nonsurgical treatments for erectile dysfunction, self-injection of papaverine/phentolamine and external vacuum devices, in terms of usage rates, effectiveness, side effects, dropout rates, and impact on patient sexual and psychologic functioning." | 3.68 | Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Turner, LA, 1992) |
| "Forty men with organic or psychogenic impotence, who were highly motivated for treatment, were offered instruction in the intracavernosal (I-C) self-injection of papaverine and regular ongoing supervision by the investigator." | 3.68 | Evaluation of I-C papaverine in patients with psychogenic and organic impotence. ( Cooper, AJ, 1991) |
| " Arteriogenic impotence falls within the first group and has been assessed with the papaverine test, simple Doppler and arteriography." | 3.68 | [Duplex ultrasound before and after intracavernous papaverine injection in the diagnosis of impotence]. ( Alonso Gorrea, M; Boronat Tormo, F; Jiménez Cruz, JF; Moreno Pardo, B; Pontones Moreno, JL; Vidal Moreno, JF, 1991) |
| "Most studies of duplex Doppler sonography for the assessment of erectile dysfunction involve determination of peak systolic velocities 5 min after intracavernosal injection of papaverine." | 3.68 | Color Doppler sonography in the evaluation of erectile dysfunction: patterns of temporal response to papaverine. ( Erickson, SJ; Fitzgerald, SW; Foley, WD; Lawson, TL; Lipchik, EO, 1991) |
| "The authors present the seamy side of the beneficial practice to handle erectile impotence with papaverine or with the papaverine-Regitin combination." | 3.68 | Induced priapism and its management. ( Götz, F; Jilling, A; Török, A, 1991) |
| "A total of 132 consecutive patients with erectile impotence underwent extensive evaluation, including vascular evaluation with intracavernous injection of papaverine and penile duplex ultrasonography, to determine the etiology of impotence." | 3.68 | Cigarette smoking and other vascular risk factors in vasculogenic impotence. ( Dunn, JK; Fishman, IJ; Schum, C; Shabsigh, R, 1991) |
| "To understand more clearly the role of penile sensitivity in sexual functioning, changes in penile thresholds resulting from papaverine-induced tumescence were studied in men who were either sexually functional or suffering from erectile dysfunction." | 3.68 | Changes in penile sensitivity following papaverine-induced erection in sexually functional and dysfunctional men. ( Blom, JH; Leentvaar, EJ; Rowland, DL; Slob, AK, 1991) |
| "Forty-four patients with impotence were evaluated by intracavernous papaverine injection, penile brachial index (PBI) determination and dynamic cavernosography." | 3.68 | Correlation between intracavernous papaverine injection, Doppler analysis and cavernosography in impotent patients. ( Başar, I; Celebi, I; Ergen, A; Erol, D; Koçal, C; Ozen, HA; Remzi, D; Sargin, YS, 1991) |
| " Eight were evaluated for impotence and on grounds of a comprehensive history, physical examination, penile Doppler investigations, and papaverine tests it was concluded that 3 patients might have achieved an abnormal communication between the corpus cavernosum and corpus spongiosum." | 3.68 | Erectile dysfunction following direct vision internal urethrotomy. ( Colstrup, H; Graversen, PH; Rosenkilde, P, 1991) |
| "We conducted a prospective study to determine the positive predictive value of papaverine testing to select patients in whom a vacuum constriction device would be a successful alternative to operative management of impotence." | 3.68 | Vacuum tumescence devices: the role of papaverine in the selection of patients. ( Allen, G; Broderick, GA; McClure, RD, 1991) |
| "A simple test to predict the outcome of intracavernous papaverine treatment would be helpful in the management of erectile dysfunction." | 3.68 | Penile flow- and blood pressure index and the effective dose of intracavernous papaverine. ( Joosten, EA; Mensink, HJ; Van Driel, MF, 1990) |
| "A total of 50 patients with erectile dysfunction underwent comprehensive evaluation, including vascular evaluation with penile duplex ultrasonography and papaverine injection, as well as nocturnal penile tumescence monitoring." | 3.68 | Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. ( Dunn, JK; Fishman, IJ; Karacan, I; Shabsigh, R; Shotland, Y, 1990) |
| "Between July 1987 and February 1988 selective internal iliac angiography was performed before and after intracavernous injection of papaverine plus phentolamine in 43 patients with erectile dysfunction." | 3.68 | Comparison of selective internal iliac pharmaco-angiography, penile brachial index and duplex sonography with pulsed Doppler analysis for the evaluation of vasculogenic (arteriogenic) impotence. ( Mueller, SC; Schild, HH; Voges, GE; von Wallenberg-Pachaly, H, 1990) |
| "In 70 Patients with erectile dysfunction, ultrasound examination of both corpora cavernosa after intracavernous injection of papaverine was done using B-scan, Duplex scan and Doppler color." | 3.68 | [The value of corpus cavernosum sonography following administration of vasoactive substances in the diagnosis of patients with erectile impotence]. ( Caspari, D; Derouet, H; Scheffler, P; Steffens, J; Ziegler, M, 1990) |
| "In erectile dysfunction formerly, for both diagnostic and therapeutic purposes, intracavernous injections of papaverine and the combination papaverine/phentolamine were employed." | 3.68 | [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities]. ( Schrey, A, 1990) |
| "The papaverine test has been widely used as a diagnostic procedure in erectile impotence." | 3.68 | Gravity cavernosometry--a simple diagnostic test for cavernosal incompetence. ( Chao, S; Glina, S; Puech-Leao, P; Reichelt, AC, 1990) |
| "Priapism occurred in ten patients undergoing treatment of depression with trazodone or impotence with papaverine." | 3.68 | Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. ( Bardin, ED; Krieger, JN, 1990) |
| "From 1986 to 1989 papaverine was used alone or in combination with phentolamine in 165 patients in diagnosis and treatment of erectile dysfunction." | 3.68 | [Priapism following intracavernous injection of vasoactive substances as a urologic emergency]. ( Papadopoulos, I; Wand, H; Weichert-Jacobsen, K, 1990) |
| "We report 3 cases of penile curvature deformity and fibrosis of the tunica albuginea after long-term self-injection with papaverine hydrochloride and phentolamine mesylate." | 3.67 | Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection. ( Burks, C; Christy, WC; Hu, KN, 1987) |
| "This study assessed the sexual, psychosocial, and medical impact of intracavernosal injection of papaverine hydrochloride and phentolamine mesylate in the treatment of impotence." | 3.67 | Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning. ( Althof, SE; Bodner, D; Kursh, ED; Levine, SB; Resnick, M; Risen, C; Turner, LA, 1987) |
| "Of over 300 patients with erectile dysfunction, 186 were selected for intracavernosal autoinjection therapy with a standardized papaverine-phentolamine mixture." | 3.67 | Mid-term results of autoinjection therapy for erectile dysfunction. ( Bähren, W; Gall, H; Scherb, W; Stief, CG, 1988) |
| " phentolamine mesylate used to induce erection in patients with impotence was examined." | 3.67 | Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation. ( Hadzija, BW; Mattocks, AM; Stahl, GM, 1988) |
| "After evaluating approximately 500 patients to identify the cause of erectile dysfunction, I selected 60 patients to receive a therapeutic injection of the vasoactive drugs papaverine and phentolamine mesylate (Regitine) into the corpora cavernosa." | 3.67 | Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients. ( Nelson, RP, 1989) |
| "The usefulness of a chemical prosthesis was studied for the diagnosis and treatment of 20 patients with erectile impotence (14 due to diabetes, 2 due to pelvic surgery and 4 due to psychogenic factors) using papaverine hydrochloride and phentolamine mesilate." | 3.67 | [Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients]. ( Kaneda, S; Matsuoka, K; Nakajima, Y; Shibayama, T; Suzuki, Y; Yamamoto, H, 1989) |
| " The former group (which has papaverine as leader) produces a significant number of side effects, not least of these being priapism; there is a risk of lasting iatrogenic impotence which is not negligible." | 3.67 | [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs]. ( Buvat, J; Buvat-Herbaut, M; Lemaire, A; Marcolin, G, 1989) |
| "To determine the efficacy of the intracavernous administration of papaverine hydrochloride every 2 weeks to treat male impotence, we recruited 50 patients from a sexual dysfunction clinic." | 3.67 | Biweekly intracavernous administration of papaverine for erectile dysfunction. ( Davis, SS; Kaiser, FE; Korenman, SC; Mooradian, AD; Morley, JE; Viosca, SP, 1989) |
| " In the current study, we evaluated 40 SCI patients and 116 patients with vascular based impotence who had been followed for a minimum of 1 month while utilising intracavernous injections of phentolamine and papaverine." | 3.67 | Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury. ( Lloyd, LK; Richards, JS, 1989) |
| "Over a 27 months period papaverine induced erections were routinely used in the treatment of erectile dysfunction (ED)." | 3.67 | Pharmacologically induced prolonged erections produced by papaverine. Follow-up of injection therapy. ( Johannesen, NL; Kirkeby, HJ, 1989) |
| "A new device for the autoinjection of papaverine into the corpus cavernosum for the treatment of impotence is described." | 3.67 | Autoinjection of corpus cavernosum with papaverine: a practical application device. ( Lisboa, J; Sales, N; Souto, CA; Telöken, C; Thorell, E, 1989) |
| " To identify the venous channels into which corporeal blood drains in impotent men, we performed cavernosograms after intracorporeal injection of papaverine in 44 consecutive men presenting with erectile dysfunction and these were compared to studies in 10 potent men." | 3.67 | Anatomy of penile venous drainage in potent and impotent men during cavernosography. ( Fuchs, AM; Mehringer, CM; Rajfer, J, 1989) |
| " orally) for persistent penile erection and priapism resulting from injection of pharmacological agents, such as phentolamine, phenoxybenzamine and papavarine, into the penis for erectile impotence." | 3.67 | Treatment of persistent penile erection and priapism using terbutaline. ( Finnerty, DP; Rodriquez, AP; Shantha, TR, 1989) |
| "Forty milligrams papaverine HCl was intracavernously injected to 28 patients with erectile dysfunction for diagnosis and treatment in 14 cases in which it was injected a few times." | 3.67 | [Investigation of intracavernous injection of papaverine for erectile impotence]. ( Aoki, Y; Hamada, T; Hosokawa, H; Kawazoe, K; Ono, M; Takimoto, Y; Yasuoka, S, 1989) |
| "The papaverine test has become established in the investigation of impotence." | 3.67 | Pharmacocavernometry: a modified papaverine test. ( Dickinson, IK; Pryor, JP, 1989) |
| "The present study evaluates both penile xenon-133 washout (XWT) and papaverine tests (PT) in the diagnosis of vasculogenic impotence." | 3.67 | Diagnosis of vasculogenic impotence: combination of penile xenon-133 washout and papaverine tests. ( Chang, LS; Kuo, JS; Lin, SN; Liu, RS; Yeh, SH; Yu, PC, 1989) |
| "Intracorporeal papaverine injections were performed for evaluation of penile erection on 120 patients with sexual impotence." | 3.67 | [Intracorporeal injection of papaverine for diagnosis of impotence: clinical evaluation of 120 patients]. ( Chiang, HS, 1989) |
| "To delineate neural, arterial, and venous components contributing to impotence, we used a previously described noninvasive screening sequence combined with stimulation of artificial erection with papaverine injection, selective pudendal arteriography (SPA), and dynamic cavernosography (DC)." | 3.67 | Experience in diagnosis and treatment of impotence caused by cavernosal leak syndrome. ( Bergsrud, D; DePalma, RG; Druy, EM; Edwards, CM; Emsellem, HA; Miller, HC; Schwab, F, 1989) |
| "In 5 out of 84 patients suffering from impotence a prolonged erection was observed after intracavernous papaverine injection." | 3.67 | [Priapism as a complication following diagnostic papaverine test]. ( Darewicz, J; Galek, L, 1989) |
| " Pathological Doppler findings and weak response to locally administered papaverine or alpha-blocking agents in these impotent men led to pharmacoangiography in 17 of 372 patients with erectile dysfunction; of these 372 patients 130 (35%) had subnormal penile blood flow according to Doppler ultrasonography." | 3.67 | Severe arterial insufficiency in impotence confirmed with an improved angiographic technique: the impact of smoking and some other etiologic factors. ( Forsberg, L; Hederström, E; Olsson, AM, 1989) |
| "Intracavernous injection (IC) of vasoactive drugs (papaverine (ICP) in 115 cases and different alpha-blockers in 65 cases) were administered to 65 patients with erectile impotence to evaluate diagnostic and therapeutic interest of this procedure." | 3.67 | [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence]. ( Buvat, J; Buvat-Herbaut, M; Dehaene, JL; Lemaire, A; Marcolin, G, 1986) |
| "Intracorporeal papaverine self-injection is a new therapy for erectile dysfunction." | 3.67 | Papaverine-induced fibrosis of the corpus cavernosum. ( Brawer, MK; Fuchs, ME, 1989) |
| "Ten patients with priapism after self-administered intracavernous papaverine injection for erectile impotence had to be treated as emergencies between September 1985 and February 1988." | 3.67 | [Papaverine-induced priapism. Experiences with a new urologic emergency]. ( Busch, R; Gonnermann, D; Klosterhalfen, H; Schneider, AW, 1989) |
| "We investigated 95 patients referred for erectile dysfunction by penile blood pressure measurement, the intracavernous papaverine test and Doppler investigation of the penile arteries." | 3.67 | Standardized evaluation of erectile dysfunction in 95 consecutive patients. ( Gerstenberg, TC; Hald, T; Nordling, J; Wagner, G, 1989) |
| "One hundred and twenty five men with psychogenic or organic impotence used autoinjection of the penile corpora cavernosa with either papaverine or papaverine and phentolamine for a mean period of 10." | 3.67 | Impotence: treatment by autoinjection of vasoactive drugs. ( Kiely, EA; Mulcahy, MJ; Williams, G, 1987) |
| "Intracavernosal self-injection of smooth muscle relaxants, primarily papaverine admixed with phentolamine, have been used to treat impotence in over 300 patients." | 3.67 | Therapeutic roles of intracavernosal papaverine. ( Goldstein, I; Padma-Nathan, H; Payton, T, 1988) |
| "Although the intracorporeal injection of mixtures of phentolamine and papaverine is used commonly in the diagnosis and treatment of erectile dysfunction, pharmacological data relating to the stability of such drug mixtures are lacking." | 3.67 | Is phentolamine stable in solution with papaverine. ( Benson, GS; Seifert, WE, 1988) |
| "A total of 78 patients 17 to 84 years old reported their experience via questionnaire with the papaverine-phentolamine injection technique for impotence." | 3.67 | Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. ( Bruskewitz, RC; Feyzi, J; Gasser, TC; Girdley, FM; Graversen, PH, 1988) |
| "We injected papaverine into the corpus cavernosum of 93 patients with impotence, and compared the results with findings from nocturnal penile tumescence monitoring, psychogenic erection monitoring after sexual stimulation, penile-brachial indexes, and dynamic cavernosography." | 3.67 | Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence? ( Imagawa, A; Kawanishi, Y, 1988) |
| "To evaluate the use of papaverine-induced erection as a diagnostic test in men with erectile dysfunction, 24 patients had papaverine injected into the corpus cavernosum." | 3.67 | The intracavernous injection of papaverine as a diagnostic procedure in patients with erectile dysfunction. ( Frimodt-Møller, C; Lyngdorf, P; Mouritsen, L, 1988) |
| "A total of 148 patients with erectile dysfunction underwent evaluation with Doppler sonography, cavernosography and intracavernous injections of papaverine." | 3.67 | Pharmacocavernosography in the evaluation of erectile failure. ( Jantos, C; Weidner, W, 1988) |
| "The diagnosis and treatment of male impotence have been radically modified by the introduction of intracavernous injections of papaverine." | 3.67 | Diagnosis of male impotence after intracavernous papaverine test. ( De Rose, AF; Giuliani, L; Pittaluga, P; Puppo, P, 1988) |
| "In 61 patients with erectile dysfunction a comparative study with intracavernous injection of prostaglandin E1 (PGE1), papaverine and a mixture of papaverine and phentolamine was performed." | 3.67 | [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction]. ( Porst, H, 1988) |
| "A second Doppler examination after intracavernous injection of papaverine provides more objective data in cases with questionable penile Doppler results and vascular impotence." | 3.67 | Papaverine--injection and Doppler-sonographic examination in the diagnosis of vascular erectile dysfunction. ( Weidner, W; Weiske, WH, 1987) |
| "Intracavernous papaverine injection is often used in the diagnosis and treatment of male impotence." | 3.67 | Systemic complication of intracavernous papaverine injection in patients with venous leakage. ( Schulman, CC; Wespes, E, 1988) |
| "Forty patients with impotence were evaluated by means of nonselective angiography after intracorporal papaverine injection." | 3.67 | Nonselective angiography after intracorporal papaverine injection: an alternative technique for evaluating penile arterial integrity. ( Freidenberg, D; Harley, JD; Schwartz, AN, 1988) |
| "To investigate the etiology of impotence following nerve-sparing radical retropubic prostatectomy we performed papaverine testing on 23 patients who did not regain erections sufficient for vaginal penetration." | 3.67 | Papaverine testing of impotent patients following nerve-sparing radical prostatectomy. ( Bahnson, RR; Catalona, WJ, 1988) |
| "The authors use the intracavernous injection of papaverine (ICP) as a diagnostic test in order to differentiate between organic and psychogenic erectile impotence." | 3.67 | [Intracavernous injection of papaverine. Diagnostic value]. ( Dufeuil, P; Guillé, F; Lobel, B; Nguyen Hoang, T, 1988) |
| " papaverine) for the treatment of erectile dysfunction." | 3.67 | Prolonged erections following intracorporeal injection of medications to overcome impotence. ( Carati, CJ; Earle, CM; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS, 1988) |
| "We present our experience with the intracorporeal injection of papaverine and duplex sonography in the assessment of 47 patients with suspected vasculogenic impotence." | 3.67 | Experience with intracorporeal injection of papaverine and duplex ultrasound scanning for assessment of arteriogenic impotence. ( Collins, JP; Lewandowski, BJ, 1987) |
| "Eight patients with impotence following radical cystectomy and ileal loop surgery for cancer of the bladder were treated with a mixture of papaverine/phentolamine at 30/1 ratio." | 3.67 | Penile self-injection for impotence in patients after radical cystectomy-ileal loop. ( Al-Juburi, AZ; O'Donnell, PD, 1987) |
| "Intracavernosal injection of phenoxybenzamine or papaverine has been tried on 127 men suffering from erectile impotence." | 3.67 | Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection. ( Brindley, GS, 1986) |
| "Cavernometry and cavernography before and after injection of papaverine into the corpus cavernosum were performed in five psychogenically impotent patients and in 30 patients with organic impotence demonstrated by penile plethysmography." | 3.67 | Pharmacocavernometry-cavernography in impotence. ( Delcour, C; Schulman, CC; Struyven, J; Wespes, E, 1986) |
| "We report on our results with the intracavernous injection and self-injection of papaverine-phentolamine in a group of spinal cord injury patients with erectile impotence." | 3.67 | Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. ( Claessens, H; de Meyer, JM; de Sy, WA; Wyndaele, JJ, 1986) |
| "Fourty nine men seeking advice for erectile impotence, in whom the serum flow rate necessary to maintain an artificial erection (MFR) exceeded the upper limit of the normal range proposed by most authors (75 ml/mn), underwent different investigations (including a study of their penile arteries, Nocturnal Penile Tumescence monitoring (NPT) and a papaverine test) in order to ascertain the organic basis of their impotence, and to define the diagnostic criteria for "venous incompetence"." | 3.67 | [Impotence with venous leakage. An extensive study of 49 cases detected by the artificial erection test]. ( Buvat, J; Buvat-Herbaut, M; Dehaene, JL; Desmons, F; Lemaire, A; Marcolin, G, 1986) |
| "Thirty-eight patients with predominantly organic and 29 with psychogenic impotence had intracavernosal injections of a combination of 30 mg papaverine and 1 mg phentolamine on at least one occasion." | 3.67 | Assessment of the immediate and long-term effects of pharmacologically induced penile erections in the treatment of psychogenic and organic impotence. ( Goldie, L; Kiely, EA; Williams, G, 1987) |
| "To determine whether intracavernous injection of papaverine can discriminate vascular versus psychogenic impotence 80 mg." | 3.67 | Is intracavernous injection of papaverine a reliable screening test for vascular impotence? ( Buvat, J; Buvat-Herbaut, M; Dehaene, JL; Lemaire, A, 1986) |
| "Alprostadil was used 51 times, moxisylite nine times and papaverine four times." | 2.70 | [Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients]. ( Boiteau, F; Boyer, F; Dizien, O; Laffont, I; Lebib Ben Achour, S, 2001) |
| " Studies have shown that sildenafil may not be effective in all patients, and has been associated with a variety of adverse effects and an adverse interaction with nitrates and inhibitors of cytochrome P450 enzymes." | 2.70 | Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd ( Castaneda, J; Castell, R; Hurley, D; Lammers, PI; Lipezker, M; Loehr, LA; Lowrey, F; Ponce de Leon, R; Rubio-Aurioles, E, 2002) |
| " Patients were treated with sildenafil citrate alone or in combination with intracavernosal injection therapy." | 2.69 | Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. ( Johnson, H; McMahon, CG; Samali, R, 1999) |
| "Of 20 men with organic impotence 17 completed the trial and 13 of these patients had spinal cord injuries." | 2.68 | Papaverine topical gel for treatment of erectile dysfunction. ( el-Rashidy, R; Kim, ED; McVary, KT, 1995) |
| "The origin of impotence in unmarried patients is believed to be mostly psychogenic and has been diagnosed as such." | 2.67 | Psychogenic versus primary organic impotence. ( Choi, HK; Kim, YC; Lee, WH, 1994) |
| "We performed a double-blind, crossover study using objective measurements to compare maximum rigidity and duration of erections with papaverine hydrochloride in combination with phentolamine mesylate and/or prostaglandin E1." | 2.67 | Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1. ( Allen, RP; Brendler, CB; Engel, RM; Smolev, JK, 1992) |
| "Only one patient had non-organic impotence." | 2.67 | Impotence in diabetes: aetiology, implications for treatment and preferred vacuum device. ( Close, CF; Hardisty, CA; Moore, KT; Moriarty, KT; Ryder, RE, 1992) |
| "Men with impotence of any etiology have been entered on a program to evaluate prospectively the efficacy of intracavernosal injection of vasoactive compounds in producing a satisfactory erection with pharmacologic means." | 2.67 | Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report. ( English, W; Goodman, RL; Hanno, PM; Pierce, LJ; Wein, AJ; Whittington, R, 1991) |
| " At this dosage prostaglandin E1 was most effective in inducing artificial penile erection (11 of 12 patients)." | 2.66 | Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. ( Schramek, P; Waldhauser, M, 1988) |
| "Erectile dysfunction is common in male kidney transplant recipients." | 2.44 | Treating erectile dysfunction in renal transplant recipients. ( Barry, JM, 2007) |
| "Apomorphine SL is a dopamine D1- and D2-receptor agonist which has recently been approved for marketing in Europe." | 2.42 | Pharmacological management of erectile dysfunction. ( Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C, 2003) |
| "Erectile dysfunction has attracted considerable interest and research." | 2.41 | Intracavernosal injection therapy. Does it still have a role in erectile dysfunction? ( Chew, KK, 2001) |
| "Established and new treatments for erectile dysfunction whose effects are mediated via manipulation of the NO pathway are also described." | 2.41 | The role of nitric oxide in penile erection. ( Cartledge, J; Eardley, I; Minhas, S, 2001) |
| "Although the 'Leiden Impotence Screening Test' appears to reliably exclude somatic aetiological factors, it would be preferable if the general physician posed such diagnostic questions." | 2.41 | [Erectile disorders: the reality]. ( Gianotten, WL; Hengeveld, MW, 2001) |
| "For the treatment of erectile dysfunction, the authors recommend that prostheses be reserved for cases refractory to all other treatments." | 2.40 | [Treatment for impotence]. ( Giuliano, F; Jardin, A, 1998) |
| "Pharmacological treatment of erectile dysfunction includes all therapeutic modalities based on the use of erectogenic drugs, regardless of the route of administration." | 2.39 | Pharmacological management of erectile dysfunction. ( Guazzoni, G; Montorsi, F; Pozza, G; Rigatti, P, 1995) |
| "Evaluation in patients with impotence includes thorough history taking and diagnostic testing." | 2.38 | Management of impotence. Diagnostic considerations and therapeutic options. ( Morley, JE, 1993) |
| "In recent years the true incidence of impotence due to organic diseases in comparison with psychogenic disorders could be verified." | 2.38 | [Current diagnosis of impotence]. ( Bast, R; Drawz, B; Drawz, G; Eilitz, B; Hasse, N; Heydel, E; Heydenreich, A; Kmietzyk, HJ; Schultz, J; Seemann, B, 1990) |
| " To minimize complications, careful selection of candidates, cautious dosage determination, and thorough instruction on injection technique are mandatory." | 2.37 | Vasoactive intracavernous pharmacotherapy. ( Sidi, AA, 1988) |
| "Clearly, the choice of therapy for impotence must now be made on an individual basis after a careful diagnostic evaluation and in-depth consultation with the patient." | 2.37 | New therapy for impotence. ( Lue, TF; Orvis, BR, 1987) |
| " Careful investigation of erectile disturbances and search for the appropriate papaverin dosage are therefore crucial." | 2.37 | [Diagnosis and therapy of erectile impotence with special reference to papaverine]. ( Schnyder von Wartensee, M; Studer, UE, 1986) |
| "2), in absence of vascular risk factors, no responder to PDE5-I that undergone to PDDU by PII at high dosage (bimix: prostaglandin E1 20 mcg, papaverine 20 mg)." | 1.43 | Penile vascular diagnostic categorization using penile duplex Doppler ultrasound: Differences in vascular hemodynamics parameters by differences in anatomic sampling location. ( Pezzoni, F; Scroppo, FI, 2016) |
| " Real time rigidity assessment was used for the objective determination of the initial dosage and then doses were regulated in order to introduce an erection suitable for penetration and maintenance of erection for approximately 30 min." | 1.33 | Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. ( Athanasopoulos, A; Gyftopoulos, K; Kartsanis, G; Konstantinopoulos, A; Liatsikos, E; Perimeni, PP; Perimenis, P, 2006) |
| "Priapism is a major side effect of ICI therapy and an uncommon, although important, side effect of other conditions." | 1.32 | The incidence and management of priapism in Western Australia: a 16 year audit. ( Ching, HL; Earle, CM; Stuckey, BG; Wisniewski, ZS, 2003) |
| "Priapism is always a potential phenomenon where no individual, no particular drug and no specific dose are completely safe." | 1.31 | The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction. ( Athanasopoulos, A; Barbalias, G; Geramoutsos, I; Perimenis, P, 2001) |
| "Honeymoon impotence is the inability to perform successful sexual intercourse during the initial experience, especially during the first nights of marriage, and it is relatively frequent in Turkey." | 1.31 | Honeymoon impotence: psychogenic or organic in origin? ( Erdoğru, T; Kadioğlu, A; Köksal, T; Tefekli, A; Usta, MF; Yücel, B, 2001) |
| " Rigiscan was used for the objective determination of the initial dosage and then doses were regulated in order to introduce an erection suitable for penetration and maintenance of erection for 30 min." | 1.31 | Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs. ( Athanasopoulos, A; Barbalias, G; Gyftopoulos, K; Perimenis, P, 2001) |
| "We objectivate 20 psychogenic impotence, 27 arteriogenic impotence, 7 venous leakage and 6 mixed (arteriogenic and venogenic) impotence." | 1.30 | [Methodology of penile isotope imaging. Evaluation]. ( Timmermans, L, 1998) |
| "Papaverine has the greatest deteriorating effect on PGE1." | 1.30 | Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. ( Andrisano, V; Bertaccini, A; Carparelli, F; Cavrini, V; Gotti, R; Martorana, G; Soli, M, 1998) |
| " This progressive method of treatment enabled us to select the optimal dosage and combinations of compounds in 441/452 patients (97." | 1.30 | [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection]. ( Baniel, J; Israilov, S; Livne, P; Segenreich, E; Shmueli, J; Simon, D, 1998) |
| "The aetiology of impotence was psychogenic in > 50% of the patients (13/24)." | 1.29 | Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs. ( Kulmala, RV; Tamella, TL, 1995) |
| "During impotence evaluations a positive intracavernous injection test has been presumed to signify normal erectile hemodynamics." | 1.29 | A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. ( Goldstein, I; Hatzichristou, DG; Namburi, S; Pescatori, ES, 1994) |
| "Subjects at a urology department impotence clinic were asked to estimate orgasm latency prior to impotence and with papaverine-induced erection." | 1.29 | The effect of intracavernosal injection of papaverine hydrochloride on orgasm latency. ( Levitt, EE; Mulcahy, JJ, 1995) |
| "Scarring was documented in one patient." | 1.29 | Intracavernous self-injection of papaverine and verapamil: a clinical experience. ( Bolayir, K; Gökşin, N, 1994) |
| "atropine sulfate was used." | 1.29 | Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. ( Barbieri, L; Bergamaschi, F; Ferini-Strambi, L; Guazzoni, G; Montorsi, F; Rigatti, P, 1993) |
| "Treatment with papaverine injections is generally inexpensive and effective to overcome the multifactorial causes of erectile dysfunction in this population." | 1.29 | Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. ( Boulton, AJ; Chen, TF; Payne, S; Veves, A; Webster, L, 1995) |
| "Papaverine was injected into the base of one corpora cavernosum." | 1.29 | Management of impotence due to spinal cord injury using low dose papaverine. ( Chen, D; Lovell, L; Palmer, J; Rayner, S; Roth, EJ; Yarkony, GM, 1995) |
| "All of the men with impotence and marked pyramidal dysfunction in their legs were found by cystometric studies to have bladder hyperreflexia." | 1.29 | Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition. ( Betts, CD; Fowler, CG; Fowler, CJ; Jones, SJ, 1994) |
| "The management of their impotence was aso reviewed." | 1.29 | Impotence following pelvic fracture urethral injury: incidence, aetiology and management. ( Keane, TE; Mark, SD; Vandemark, RM; Webster, GD, 1995) |
| "Treatments for impotence include injection therapy, vacuum devices, and implants." | 1.29 | Love and sex after 60: how to evaluate and treat the impotent older man. A roundtable discussion: Part 2. ( Butler, RN; Hoffman, E; Lewis, MI; Whitehead, ED, 1994) |
| "We report 7 men (ages 45-61 years) with impotence associated with the Charcot-Marie-Tooth syndrome (CMT)." | 1.29 | Impotence associated with the Charcot-Marie-Tooth syndrome. ( Bird, TD; Crabtree, LD; Lipe, HP, 1994) |
| "Most of the patients with venogenic impotence found the device to be of therapeutic benefit." | 1.29 | A modified papaverine test and the use of venous constriction in erectile dysfunction. ( Choa, RG; Lanigan, D; Roobottom, C, 1993) |
| "Scarring was documented in 7 of 170 patients (4." | 1.29 | Experience with triple-drug therapy in a pharmacological erection program. ( Gibbons, RP; Govier, FE; Kramer-Levien, D; McClure, RD; Pritchett, TR; Weissman, RM, 1993) |
| " We conclude that self-injection with a combination of papaverine and phentolamine is an efficient and safe long-term treatment for erectile dysfunction." | 1.29 | [Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group]. ( Hartmann, U; Thon, WF, 1993) |
| "Venogenic impotence was detected in 37 out of 141 patients who attended our clinic with a complaint of erectile dysfunction." | 1.29 | Experience with penile venous surgery. ( Baxi, HM; Desai, KD; Joshi, SP; Motiwala, HG; Patel, DD; Shah, KN, 1993) |
| "Treatment of impotence was deferred for at least 18 months after injury." | 1.29 | Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management. ( Armenakas, NA; Dixon, CM; Hricak, H; Lue, TF; McAninch, JW, 1993) |
| "Sensitivity and specificity were calculated for each side separately." | 1.29 | [A comparison of color duplex sonography with selective penile DSA in assessing erectile dysfunction]. ( Bautz, W; Brandstetter, K; Lenz, M; Pickl, U; Schwarzer, JU, 1993) |
| "The papaverine tests were negative in 34 of 50 patients." | 1.29 | Evaluation of impotent men with intracorporeal injection of papaverine and colour Doppler ultrasound. ( Cetinkaya, M; Erdoğan, E; Koçak, S; Memiş, A; Oztürk, B, 1995) |
| "If we define erectile impotence as the inability to achieve and maintain a firm erection we can distinguish several pathogens of impotence: psychologic disorders, neurogenic sinusoidal disorders, arterial disorders, venous & sinusoidal disorders and systemic diseases and other disorders can cause erectile impotence." | 1.28 | [Impotence: introductory notes]. ( Belgrano, E; Deriu, M; Pirozzi-Farina, F; Salisci, E; Siracusano, S; Trombetta, C, 1992) |
| "Patients with psychogenic impotence responded fairly well to psychosexual therapy and drug treatment in certain cases." | 1.28 | Erectile dysfunction in Singapore men: presentation, diagnosis, treatment and results. ( Lim, PH; Ng, FC, 1992) |
| "The nitroglycerin plasters were applied on the skin of the penile shaft and a positive response was obtained in 12 men." | 1.28 | Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured. ( Biering-Sørensen, F; Sønksen, J, 1992) |
| "The investigation of vascular impotence requires a simple, reliable and non-invasive method of estimating penile arterial supply." | 1.28 | Combined papaverine test and radionuclide penile blood flow in impotence: method and preliminary results. ( Cunningham, DA; Dave, S; Grech, P; Witherow, RO, 1992) |
| " A portable home nocturnal tumescence monitor classification of severity of sexual dysfunction provided a guideline for the intracavernous pharmacological injection initial dosage and the probability of success or failure in patients who desire this form of therapy for male sexual dysfunction." | 1.28 | Classification of sexual dysfunction for management of intracavernous medication-induced erections. ( Fein, RL, 1990) |
| " This vasoactive drug combination has been used in 116 patients for diagnostic testing and subsequent treatment." | 1.28 | An improved vasoactive drug combination for a pharmacological erection program. ( Barada, JH; Bennett, AH; Carpenter, AJ, 1991) |
| "Results from 31 men with vasculogenic impotence were compared with those from 17 men with non-vasculogenic impotence and a control group of 6 potent men." | 1.28 | The role of colour duplex ultrasonography in the diagnosis of vasculogenic impotence. ( Oates, CP; Pickard, RS; Powell, PH; Sethia, KK, 1991) |
| "Non-surgical treatment of impotence comprises psychotherapy, drug oral administration and injection, drug intracavernous injection and penile vacuum extraction." | 1.28 | [Non-surgical treatment of impotence]. ( Otani, T, 1991) |
| "Impotence affects about 10% of all men." | 1.28 | [Intracavernous pharmacotherapy for treatment and evaluation of impotence]. ( Levin, RD; Lidgi, S; Moskovitz, B; Vardi, Y, 1991) |
| " Dose-dependent response with reversed drug sensitivity was found in the papaverine group, but only elongation to tumescence was found in the PGE1 group, even with double dosage (probably because of scarce PGE1 receptors in monkey's penile tissue)." | 1.28 | Histopathological change of corpora cavernosa after long-term intracavernous injection. ( Chu, HW; Ho, WL; Hwang, TI; Yang, CR, 1991) |
| "The treatment of impotence in diabetic men with vacuum tumescence therapy was studied in a specialist clinic." | 1.28 | The management of impotence in diabetic men by vacuum tumescence therapy. ( Bentley, S; Cooksey, G; Hearnshaw, JR; Jehu, D; Osborn, DE; Price, DE, 1991) |
| "To characterize better elderly men with impotence, and determine whether intracavernous injection therapy is safe and effective in this age group, a retrospective analysis was performed upon patients attending the male sexual dysfunction clinic at our university medical center who received a standard papaverine and phentolamine mixture (30 mg." | 1.28 | Pharmacologically induced erections among geriatric men. ( Carson, CC; Kerfoot, WW, 1991) |
| "A total of 50 patients with impotence underwent cavernosometry and cavernosography with intracavernous injection of vasoactive drugs." | 1.28 | Venous leaks: anatomical and physiological observations. ( Fishman, IJ; Shabsigh, R; Skolkin, M; Toombs, BD, 1991) |
| " prostaglandin E1 in combination with papaverine (although the difference is not statistically significant)." | 1.28 | Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone. ( Floth, A; Schramek, P, 1991) |
| " A further advantage of the method is the lower dosage required, which means that the gonads are exposed to less radiation." | 1.28 | [Cavernosography using digital luminescence radiography (DLR) in the diagnosis of venous induced erectile function and of diseases of the corpus cavernosum]. ( Christiansen, GR; Marks, W; Papadopoulos, I; Weichert-Jacobsen, K, 1991) |
| "He had a phlegmonous infection of both corpora cavernosa without infection of the corpus spongiosum." | 1.28 | [Purulent cavernitis as a complication of self injection into the cavernous body]. ( Hofmann, R; Leyh, H; Schwarzer, JU, 1991) |
| "Venous impotence can be evaluated by cavernosometry, although this is a controversial issue." | 1.28 | Cavernosometry: methodology and reproducibility with and without pharmacological agents in the evaluation of venous impotence. ( Kromann-Andersen, B; Nielsen, KK; Nordling, J, 1991) |
| "Papaverine hydrochloride was administered to the cavernous body of the penis in a total of 262 patients who were diagnosed as impotent at our Reproduction Center, Toho University, during the 5 years' period from 1984 to 1988." | 1.28 | [An attempt to classify vascular impotence using penile erection curve patterns]. ( Kase, T, 1991) |
| "papaverine." | 1.28 | Evaluation of penile dorsal arteries and deep arteries in arteriogenic impotence. ( Hwang, TI; Liu, PZ; Yang, CR, 1991) |
| "The intracavernous pharmacotherapy of impotence results in a relatively normal erection in most cases with minimal alteration of the anatomy, physiology, and psychosocial factor of impotence." | 1.28 | Follow up outcome of intracavernous papaverine. ( al-Juburi, AZ; O'Donnell, PD, 1990) |
| "A successful impotence assessment and treatment service, including self-injection of vasoactive drugs, can be provided by a physician as part of the diabetes care service." | 1.28 | The diabetes physician and an assessment and treatment programme for male erectile impotence. ( Alexander, WD, 1990) |
| "papaverine hydrochloride were administered into the corpus cavernosum to induce erection." | 1.28 | Diagnostic value of the radioisotope erection penogram for vasculogenic impotence. ( Kim, KB; Kim, SC; Oh, CH, 1990) |
| "Arterial aspects of impotence have received considerable attention, but just recently the venous component became widely recognized." | 1.28 | Cavernosometry: corroboratory method to surgical treatment of impotence due to venous leakage. ( Cara, A; Claro, JF; Netto Júnior, NR; Reinato, JA, 1990) |
| " Use of low dosage of papaverine is suggested as an additional mode of therapy in the management of psychogenic impotence." | 1.28 | Intracavernous papaverine in the management of psychogenic impotence. ( Bhutwala, A; Dhabuwala, CB; Kerkar, P; Kumar, A; Pierce, JM, 1990) |
| "Papaverine hydrochloride was injected into the penis in 32 impotent patients, and peripheral blood concentrations were measured at 3, 5, 10, 15 and 30 minutes." | 1.28 | Papaverine hydrochloride in peripheral blood and the degree of penile erection. ( Tanaka, T, 1990) |
| "In the acute study, arteriogenic impotence was induced in 6 dogs by bilateral ligation of the penile arteries just proximal to the crus of the penis." | 1.28 | Cavernous vein arterialization for vasculogenic impotence. An animal model. ( Aboseif, SR; Breza, J; Lue, TF; Tanagho, EA, 1990) |
| "Priapism is a recognized complication of intracavernous self-injection of vasoactive agents for the management of impotence." | 1.28 | Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. ( Lue, TF; Vapnek, J, 1989) |
| "Organicity of impotence was evaluated by Nocturnal Penile Tumescence monitoring and by the results of a sex-therapy." | 1.28 | [Impotence due to venous incompetence. Research on reliable diagnostic criteria]. ( Buvat, J; Buvat-Herbaut, M; Dehaene, JL; Lemaire, A; Marcolin, G, 1989) |
| "Coital impotence was studied in 94 patients." | 1.28 | Surgical treatment of impotence due to venous outflow. ( Götz, F; Márk, B; Székely, J; Török, A, 1989) |
| "Three hundred patients with impotence underwent papaverine (9-60 mg) induced PBFS at the University of California School of Medicine, San Francisco (UCSF), U." | 1.28 | Comparison of penile vascular effect induced by intracavernous injection of papaverine and prostaglandin E1. ( Chang, CH; Chang, CL; Hwang, TI; Lue, TF; Wu, HC; Yang, CR, 1989) |
| "In 97, impotence could be ascribed to venogenic causes, in 210 to arteriogenic causes, and to mixed arteriogenic and venogenic causes in 282 patients." | 1.28 | Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection. ( Hwang, TI; Jow, YR; Lue, TF; Mueller, SC, 1989) |
| "Forty-five men with impotence were included in the study." | 1.28 | Sexual impotence caused by vascular disease: diagnosis with duplex sonography. ( Benson, CB; Vickers, MA, 1989) |
| "The remaining 132 patients had erectile impotence of various etiologies." | 1.28 | Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography. ( Dunn, JK; Fishman, IJ; Quesada, ET; Seale-Hawkins, CK; Shabsigh, R, 1989) |
| " Sixteen volunteers who were taught to self-administer the solution, injected the preadjusted dosage into the corpus cavernosum each time before the intended sexual act." | 1.28 | Papaverine-induced erection. ( Götz, F; Székely, J; Török, A, 1989) |
| " While intracavernosal VIP alone produced disappointing penile responses, its combination with papaverine potentiated the response to this drug, probably by increasing venous outflow resistance." | 1.28 | Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. ( Bloom, SR; Kiely, EA; Williams, G, 1989) |
| "Priapism was not encountered during self-injection but it did occur twice in 329 physician-administered injections." | 1.28 | Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. ( Althof, SE; Bodner, DR; Kursh, ED; Levine, SB; Resnick, MI; Risen, CB; Turner, LA, 1989) |
| "We conclude that diabetic men with impotence have impairment in both the autonomic and the endothelium-dependent mechanisms that mediate the relaxation of the smooth muscle of the corpora cavernosa." | 1.28 | Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. ( Azadzoi, K; Cohen, RA; Goldstein, I; Krane, RJ; Saenz de Tejada, I, 1989) |
| " The dosage of phentolamine mesylate-papaverin hydrochloride injection required was determined in each patient individually." | 1.27 | [Corpus cavernosum autoinjection therapy: initial experiences in erectile dysfunction]. ( Altwein, JE; Bähren, W; Gall, H; Gallwitz, A; Scherb, W; Stief, CG, 1986) |
| "At the Nashville Impotence Center we use intracavernous injections of papaverine-phentolamine to diagnose vascular impotence and to treat certain patients with organic impotence as well as some patients with psychologic impotence." | 1.27 | Pharmacologic erection program for the treatment of male impotence. ( Trapp, JD, 1987) |
| "Priapism was the most significant complication and occurred in 8." | 1.27 | Pharmacological erection: diagnosis and treatment applications in 69 patients. ( Ellis, LR; Kramer-Levien, D; Nellans, RE, 1987) |
| "Fourteen patients with organic impotence received intracorporeal injections of papaverine and were then monitored by Rigiscan." | 1.27 | Utility of Rigiscan and papaverine in diagnosis of erectile impotence. ( Badlani, GH; Weinberg, JJ, 1988) |
| "Pathogenesis of vasculogenic impotence is most adequately revealed by modern methods of the investigation of the hemodynamic mechanisms of erection with the enhancement of arterial perfusion of corpora cavernosa by artificial sexual stimulation." | 1.27 | [Radionuclide diagnosis of vasculogenic impotence]. ( Bogdasarov, IuB; Gerasimov, VB; Lenskaia, OP; Narkevich, BIa, 1988) |
| "Diabetic microangiopathy is regarded as the most important pathogenic factor." | 1.27 | [Disorders of erectile potency in diabetes mellitus]. ( Floth, A; Holzmann, RM; Schramek, P, 1988) |
| "Progress in diagnosis and therapy of impotence is handicapped by the absence of a validated and objective method for evaluating the vascular system; a gold-standard for vasculogenic impotence is needed." | 1.27 | Pharmacoarteriography in the evaluation of impotence. ( Bookstein, JJ; Kessler, W; Parsons, L; Valji, K, 1987) |
| "Phentolamine was added if 80 mg was not sufficient." | 1.27 | Intracavernous self-injection for erectile failure. ( Alfthan, O; Lindström, BL; Ruutu, M; Virtanen, J, 1988) |
| "Many men presenting with impotence can be cured by surgical intervention." | 1.27 | Surgery for impotence. ( Dickinson, IK; Pryor, JP, 1988) |
| "Sixteen of 149 patients complaining of impotence of a non-neurogenic or endocrine aetiology and with a penile brachial index of greater than 0." | 1.27 | Diagnosis and treatment of venous leakage: a curable cause of impotence. ( Hartnell, G; Kiely, E; Mulcahy, MJ; Williams, G, 1988) |
| " Two patients who failed to achieve erections had the lowest penile brachial index values and 1 in whom priapism developed had the highest value, indicating that this may be a useful technique to determine the initial dosage of the injection." | 1.27 | Pharmacological treatment of erectile dysfunction after radical prostatectomy. ( Dennis, RL; McDougal, WS, 1988) |
| " We related their penis-brachial pressure index (PBPI) with the dosage of papaverine necessary to obtain a full erection as measured by tumistore." | 1.27 | Penile-brachial pressure index as a guide for the dosage of intracavernous injection of papaverine. ( Caviglia, C; de Rose, AF; Germinale, F; Giuliani, L; Pittaluga, P; Puppo, P, 1988) |
| "Our recent experience with 2 men whose impotence was subsequently found to be psychogenic in nature suggests that saline erection cavernosometry should routinely incorporate the intracavernosal administration of papaverine, in order to avoid a falsely positive diagnosis of venous leakage." | 1.27 | Saline-induced artificial erection without papaverine: a potential source of error in diagnosing cavernosal venous leakage. ( Desai, KM; Gingell, JC, 1988) |
| "For vasculogenic impotence response rate depended upon impairment severity determined from nocturnal penile tumescence measurements; none of the severe cases versus 90 per cent of the milder cases responded." | 1.27 | Nocturnal penile tumescence predicting response to intracorporeal pharmacological erection testing. ( Allen, RP; Brendler, CB, 1988) |
| "A vascular component to impotence was shown to be common in those with neurological impairment, and may alter management." | 1.27 | Results of investigation of impotence in patients with overt or probable neuropathy. ( Robinson, LQ; Stephenson, TP; Woodcock, JP, 1987) |
| "Lastly, they represent a new treatment for priapism." | 1.27 | [Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases]. ( Bondil, P; Mazeman, E; Nguyen Qui, JL; Rigot, JM, 1987) |
| "172 patients with impotence symptoms were investigated by SBBBV-test, orthostatic blood pressure, Doppler examination of the superficial and deep penile arteries, penile-brachial index, visual sexual stimulation, papaverin test, and measurement of bulbocavernous reflex latency time." | 1.27 | The value of basic investigations in the diagnosis of impotence. ( Alfthan, OS; Lindström, BL; Ruutu, ML; Virtanen, JM, 1987) |
| "Until recently, the only treatments for impotence were testosterone injection, sex therapy, and implantation of a penile prosthesis." | 1.27 | Treatment of impotence. 1. Nonsurgical methods. ( Baum, N, 1987) |
| "We tested 50 patients complaining of impotence with intracavernous injection of 60 mg." | 1.27 | The erectile angle: objective criterion to evaluate the papaverine test in impotence. ( Delcour, C; Rondeux, C; Schulman, CC; Struyven, J; Wespes, E, 1987) |
| "The treatment of this kind of impotence has always been troublesome for the urologist." | 1.27 | Intracavernous therapy in impotence after pelvic trauma. A preliminary study. ( Barbagli, G; Barbanti, G; Beneforti, P; Delle Rose, A; Turini, D, 1986) |
| "Vasculogenic impotence was evaluated by high-resolution sonography and quantitative Doppler spectrum analysis in 21 patients and two normal volunteers." | 1.27 | Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. ( Hricak, H; Lue, TF; Marich, KW; Tanagho, EA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 245 (37.40) | 18.7374 |
| 1990's | 315 (48.09) | 18.2507 |
| 2000's | 74 (11.30) | 29.6817 |
| 2010's | 15 (2.29) | 24.3611 |
| 2020's | 6 (0.92) | 2.80 |
| Authors | Studies |
|---|---|
| Kayigil, Ö | 5 |
| Altay, Y | 1 |
| Okulu, E | 2 |
| Elena, BW | 1 |
| Zachary, M | 1 |
| Haritha, P | 1 |
| Graham, BA | 1 |
| Wayne, HJG | 1 |
| Sussman, H | 2 |
| Labastie, MN | 1 |
| Hauet, P | 1 |
| Allaire, E | 1 |
| Lombion, S | 1 |
| Virag, R | 11 |
| Güler, Y | 1 |
| Erbin, A | 1 |
| Yildirim, C | 1 |
| Erturk, H | 1 |
| Pekkan, K | 1 |
| Deniz, S | 1 |
| Serefoglu, EC | 3 |
| Nashed, A | 1 |
| Lokeshwar, SD | 1 |
| Frech, F | 1 |
| Mann, U | 1 |
| Patel, P | 1 |
| Wang, GY | 1 |
| Xu, CC | 1 |
| Wu, KR | 1 |
| Liu, GL | 1 |
| Zhang, J | 1 |
| Pan, YN | 1 |
| Tang, YF | 1 |
| Berkó, S | 1 |
| Zsikó, S | 1 |
| Deák, G | 1 |
| Gácsi, A | 1 |
| Kovács, A | 1 |
| Budai-Szűcs, M | 1 |
| Pajor, L | 1 |
| Bajory, Z | 1 |
| Csányi, E | 1 |
| Nelson, CJ | 1 |
| Hsiao, W | 1 |
| Balk, E | 1 |
| Narus, J | 1 |
| Tal, R | 1 |
| Bennett, NE | 1 |
| Mulhall, JP | 5 |
| Vieillard, V | 1 |
| Eychenne, N | 1 |
| Astier, A | 1 |
| Yiou, R | 1 |
| Deffaux, C | 1 |
| Paul, M | 1 |
| Sung, HH | 1 |
| Ahn, JS | 1 |
| Kim, JJ | 1 |
| Choo, SH | 1 |
| Han, DH | 1 |
| Lee, SW | 2 |
| Hadiji, N | 1 |
| Benbouzid, R | 1 |
| Previnaire, JG | 1 |
| Leblond, C | 1 |
| Mieusset, R | 1 |
| Enjalbert, M | 1 |
| Soler, JM | 1 |
| Ali, MF | 1 |
| Salem, HF | 1 |
| Abdelmohsen, HF | 1 |
| Attia, SK | 1 |
| Pezzoni, F | 1 |
| Scroppo, FI | 1 |
| Chochina, L | 1 |
| Naudet, F | 1 |
| Chéhensse, C | 1 |
| Manunta, A | 1 |
| Damphousse, M | 1 |
| Bonan, I | 1 |
| Giuliano, F | 3 |
| Zargooshi, J | 2 |
| Kahvecioğlu, N | 1 |
| Kurt, A | 1 |
| Ipek, A | 1 |
| Yazicioğlu, KR | 1 |
| Akbulut, Z | 1 |
| Kilic, M | 1 |
| Ozdemir, AT | 1 |
| Balbay, MD | 2 |
| Yildiz, N | 1 |
| Gokkaya, NK | 1 |
| Koseoglu, F | 1 |
| Gokkaya, S | 1 |
| Comert, D | 1 |
| Aldemir, M | 1 |
| Ağras, K | 2 |
| Ener, K | 1 |
| Dehni, D | 1 |
| Salem, H | 1 |
| Mostafa, T | 1 |
| Wen, MM | 1 |
| El-Kamel, AH | 1 |
| Khalil, SA | 1 |
| Yazir, Y | 1 |
| Gocmez, SS | 1 |
| Utkan, T | 1 |
| Komsuoglu-Celikyurt, I | 1 |
| Gacar, N | 1 |
| Sarioglu, Y | 2 |
| Thomas, JA | 1 |
| Hatzichristou, D | 1 |
| Hatzimouratidis, K | 3 |
| Bekas, M | 1 |
| Apostolidis, A | 2 |
| Tzortzis, V | 1 |
| Yannakoyorgos, K | 2 |
| Asuar Aydillo, S | 1 |
| Yap, RL | 1 |
| McVary, KT | 3 |
| Speel, TG | 2 |
| van Langen, H | 1 |
| Wijkstra, H | 3 |
| Meuleman, EJ | 8 |
| Montorsi, F | 7 |
| Salonia, A | 1 |
| Deho', F | 1 |
| Cestari, A | 1 |
| Guazzoni, G | 7 |
| Rigatti, P | 7 |
| Stief, C | 2 |
| Papp, G | 1 |
| Erdei, E | 1 |
| Jian, HY | 1 |
| Hao, JC | 1 |
| Earle, CM | 7 |
| Stuckey, BG | 1 |
| Ching, HL | 1 |
| Wisniewski, ZS | 6 |
| Raina, R | 2 |
| Lakin, MM | 6 |
| Thukral, M | 1 |
| Agarwal, A | 2 |
| Ausmundson, S | 2 |
| Montague, DK | 7 |
| Klein, E | 1 |
| Zippe, CD | 2 |
| McMahon, CG | 3 |
| Shamloul, R | 3 |
| Ghanem, HM | 2 |
| Salem, A | 1 |
| Kamel, II | 2 |
| Mousa, AA | 1 |
| Moemen, MN | 1 |
| Hamed, HA | 1 |
| Shamloul, RM | 1 |
| Kadioglu, A | 3 |
| Oktar, T | 1 |
| Kandirali, E | 1 |
| Kendirci, M | 1 |
| Sanli, O | 2 |
| Ozsoy, C | 1 |
| Nane, I | 1 |
| Tefekli, A | 2 |
| Armagan, A | 1 |
| Hübler, J | 1 |
| Szántó, A | 1 |
| Könyves, K | 1 |
| Schultheiss, D | 1 |
| Pilatz, A | 1 |
| Gabouev, AI | 1 |
| Schlote, N | 1 |
| Wefer, J | 1 |
| Mertsching, H | 1 |
| Sohn, M | 2 |
| Jonas, U | 5 |
| Stief, CG | 19 |
| Shafik, A | 2 |
| Shafik, I | 1 |
| El-Sibai, O | 1 |
| Shafik, AA | 2 |
| Davila, HH | 1 |
| Rajfer, J | 4 |
| Gonzalez-Cadavid, NF | 1 |
| Lewis, JH | 1 |
| Rosen, R | 1 |
| Goldstein, I | 7 |
| Denys, P | 1 |
| Ben Smail, D | 1 |
| Even-Schneider, A | 1 |
| Chartier-Kastler, E | 1 |
| Ardicoglu, A | 1 |
| Kocakoc, E | 1 |
| Tuygun, UO | 1 |
| Bozgeyik, Z | 1 |
| Orhan, I | 1 |
| Hatzichristou, DG | 4 |
| Pescatori, ES | 4 |
| Morgia, G | 1 |
| Pirozzi-Farina, F | 2 |
| Farina, FP | 1 |
| Mittmann, N | 1 |
| Craven, BC | 1 |
| Gordon, M | 1 |
| MacMillan, DH | 1 |
| Hassouna, M | 2 |
| Raynard, W | 1 |
| Kaiser, A | 1 |
| Lanctôt, LK | 1 |
| Tarride, JE | 1 |
| Ohebshalom, M | 1 |
| Atteya, A | 1 |
| Elnashaar, A | 1 |
| Gadallah, A | 2 |
| Zohdy, W | 1 |
| Abdelsalam, W | 1 |
| El-Dakhly, M | 1 |
| Ghanem, H | 2 |
| Mokhtar, H | 1 |
| Tarhan, F | 3 |
| Canguven, O | 2 |
| Kuyumcuoglu, U | 3 |
| Perimenis, P | 3 |
| Konstantinopoulos, A | 1 |
| Perimeni, PP | 1 |
| Gyftopoulos, K | 2 |
| Kartsanis, G | 1 |
| Liatsikos, E | 1 |
| Athanasopoulos, A | 3 |
| Ahmed, I | 1 |
| El Sibai, O | 1 |
| Huang, ST | 1 |
| Hsieh, ML | 1 |
| Barry, JM | 1 |
| Gurdal, M | 1 |
| Ucgul, Y | 1 |
| Ozkan, MH | 1 |
| Vural, IM | 1 |
| Moralioglu, S | 1 |
| Uma, S | 1 |
| Virag, H | 2 |
| Frydman, D | 1 |
| Legman, M | 1 |
| Muruve, N | 1 |
| Hosking, DH | 1 |
| Bancroft, J | 2 |
| Malone, N | 1 |
| Kulmala, RV | 1 |
| Tamella, TL | 1 |
| Hayashi, S | 1 |
| Iwai, Y | 1 |
| Yasumoto, R | 2 |
| Matsuda, J | 1 |
| Kawano, M | 1 |
| Omachi, T | 1 |
| Kono, T | 1 |
| Yamamoto, S | 1 |
| Sakakura, T | 1 |
| Minami, H | 1 |
| Namburi, S | 2 |
| Levitt, EE | 1 |
| Mulcahy, JJ | 2 |
| Bolayir, K | 1 |
| Gökşin, N | 1 |
| Brindley, GS | 2 |
| Shenfeld, O | 1 |
| Hanani, J | 1 |
| Shalhav, A | 1 |
| Vardi, Y | 3 |
| Goldwasser, B | 1 |
| Bergamaschi, F | 4 |
| Ferini-Strambi, L | 2 |
| Barbieri, L | 2 |
| Orlandini, A | 1 |
| Da Pozzo, L | 1 |
| Dodesini, A | 1 |
| Pizzini, G | 3 |
| Miani, A | 3 |
| Veves, A | 1 |
| Webster, L | 1 |
| Chen, TF | 1 |
| Payne, S | 1 |
| Boulton, AJ | 1 |
| Meinhardt, W | 3 |
| Lycklama à Nijeholt, AA | 5 |
| Kropman, RF | 3 |
| Vermeij, P | 2 |
| Zwartendijk, J | 2 |
| Chen, J | 1 |
| Godschalk, MF | 1 |
| Katz, PG | 1 |
| Mulligan, T | 1 |
| Porst, H | 6 |
| Weiss, JN | 2 |
| Badlani, GH | 3 |
| Ravalli, R | 2 |
| Brettschneider, N | 1 |
| Yarkony, GM | 1 |
| Chen, D | 1 |
| Palmer, J | 1 |
| Roth, EJ | 1 |
| Rayner, S | 1 |
| Lovell, L | 1 |
| Tordjman, G | 1 |
| Kim, ED | 1 |
| el-Rashidy, R | 1 |
| Betts, CD | 1 |
| Jones, SJ | 1 |
| Fowler, CG | 1 |
| Fowler, CJ | 1 |
| Soni, BM | 1 |
| Vaidyanathan, S | 1 |
| Krishnan, KR | 1 |
| Olsson, AM | 2 |
| Abramsson, L | 1 |
| Höjerback, T | 1 |
| Malmberg, L | 1 |
| Pedersen, J | 1 |
| Mark, SD | 2 |
| Keane, TE | 1 |
| Vandemark, RM | 1 |
| Webster, GD | 1 |
| Cará, AM | 1 |
| Lopes-Martins, RA | 1 |
| Antunes, E | 1 |
| Nahoum, CR | 1 |
| De Nucci, G | 1 |
| Saenz de Tejada, I | 3 |
| Kupferman, S | 1 |
| Udelson, D | 1 |
| Rodilla, F | 1 |
| Fuentes, MD | 1 |
| Chuan, P | 1 |
| Ferriols, F | 1 |
| Magraner, J | 1 |
| Lazzeri, M | 1 |
| Barbanti, G | 2 |
| Beneforti, P | 2 |
| Turini, D | 2 |
| Desvaux, P | 1 |
| Mimoun, S | 1 |
| Butler, RN | 1 |
| Lewis, MI | 1 |
| Hoffman, E | 1 |
| Whitehead, ED | 4 |
| Sparwasser, C | 4 |
| Drescher, P | 1 |
| Pust, RA | 1 |
| Madsen, PO | 2 |
| Truss, MC | 1 |
| Becker, AJ | 1 |
| Djamilian, MH | 1 |
| Fontana, D | 1 |
| Rolle, L | 1 |
| Del Noce, G | 1 |
| Tamagnone, A | 1 |
| Rosso, C | 1 |
| Buvat, J | 8 |
| Buvat-Herbaut, M | 8 |
| Lemaire, A | 8 |
| Marcolin, G | 7 |
| Valdevenito, R | 1 |
| Melman, A | 1 |
| Lee, WH | 1 |
| Kim, YC | 1 |
| Choi, HK | 1 |
| Jung, A | 1 |
| Schill, WB | 1 |
| Cosciani Cunico, S | 1 |
| De Luca, V | 1 |
| Thaer, B | 1 |
| Zambolin, T | 1 |
| Giambroni, L | 1 |
| Monticelli, L | 1 |
| Cancarini, G | 1 |
| Frego, E | 1 |
| Lin, JS | 1 |
| Chang, WC | 1 |
| Lui, SM | 1 |
| Bird, TD | 1 |
| Lipe, HP | 1 |
| Crabtree, LD | 1 |
| Zucconi, M | 2 |
| Pozza, G | 2 |
| Armstrong, DK | 1 |
| Convery, AG | 1 |
| Dinsmore, WW | 2 |
| Rakhit, RD | 1 |
| Beck, R | 1 |
| Foster, O | 1 |
| Thompson, AJ | 1 |
| Kendall, B | 1 |
| Jardin, A | 3 |
| Benoit, G | 2 |
| Lanigan, D | 1 |
| Roobottom, C | 1 |
| Choa, RG | 1 |
| Gutierrez, P | 1 |
| Pye, S | 1 |
| Patel, U | 2 |
| Kirby, RS | 3 |
| Rickards, D | 1 |
| Chao, R | 1 |
| Clowers, DE | 1 |
| Chancellor, MB | 1 |
| Rivas, DA | 1 |
| Panzer, DE | 1 |
| Freedman, MK | 1 |
| Staas, WE | 1 |
| Kirby, KA | 1 |
| Cohen, R | 1 |
| Upson, CV | 1 |
| Govier, FE | 1 |
| McClure, RD | 3 |
| Weissman, RM | 1 |
| Gibbons, RP | 1 |
| Pritchett, TR | 1 |
| Kramer-Levien, D | 2 |
| Kim, SC | 5 |
| Seo, KK | 3 |
| Oh, CH | 2 |
| Katlowitz, N | 1 |
| Albano, GJ | 2 |
| Patsias, G | 1 |
| Golimbu, M | 2 |
| Morales, P | 2 |
| Kapoor, VK | 1 |
| Chahal, AS | 1 |
| Jyoti, SP | 1 |
| Mundkur, YJ | 1 |
| Kotwal, SV | 1 |
| Mehta, VK | 1 |
| Pastorini, S | 2 |
| Marino, G | 1 |
| Cocimano, V | 2 |
| Griffa, D | 1 |
| Pugno, E | 2 |
| Thon, WF | 3 |
| Hartmann, U | 2 |
| Smirne, S | 1 |
| Motiwala, HG | 2 |
| Patel, DD | 1 |
| Joshi, SP | 1 |
| Baxi, HM | 1 |
| Desai, KD | 1 |
| Shah, KN | 1 |
| De Rose, AF | 3 |
| Oppezzi, GF | 1 |
| Scotto, S | 1 |
| Yanagi, S | 1 |
| Suzuki, H | 1 |
| Namiki, T | 1 |
| Amin, Z | 1 |
| Friedman, E | 1 |
| Vale, J | 2 |
| Kirby, RW | 1 |
| Lees, WR | 2 |
| Djamilian, M | 2 |
| Freymann, H | 1 |
| Krah, H | 1 |
| Schlik, R | 1 |
| Jonas, J | 1 |
| Derouet, H | 4 |
| Zehl, U | 1 |
| Moriel, EZ | 1 |
| de la Fuente, RB | 2 |
| Venema, PL | 1 |
| van Imhoff, WL | 1 |
| Tamura, M | 3 |
| Iriguchi, H | 2 |
| Miyamoto, T | 2 |
| Kimura, K | 2 |
| Kawanishi, Y | 5 |
| Numata, A | 2 |
| Yuasa, M | 2 |
| Kagawa, S | 3 |
| Schild, HH | 2 |
| Müller, SC | 2 |
| Hermann, M | 1 |
| Kaltenborn, H | 1 |
| Kern, M | 1 |
| Werner, W | 2 |
| Schubert, J | 3 |
| van Deventer, CP | 1 |
| Bierkens, PB | 1 |
| Sabbe, BG | 1 |
| Smals, AG | 1 |
| Morley, JE | 3 |
| Navío, S | 1 |
| Allona, A | 1 |
| Serrano, A | 1 |
| Vallejo, J | 1 |
| del Hoyo, J | 1 |
| Rivas, JA | 1 |
| Escudero, A | 1 |
| Armenakas, NA | 1 |
| McAninch, JW | 1 |
| Lue, TF | 18 |
| Dixon, CM | 1 |
| Hricak, H | 4 |
| von Heyden, B | 1 |
| Donatucci, CF | 1 |
| Kaula, N | 1 |
| Katlowitz, NM | 1 |
| Kaufman, JM | 1 |
| Borges, FD | 1 |
| Fitch, WP | 1 |
| Geller, RA | 1 |
| Gruber, MB | 1 |
| Hubbard, JG | 1 |
| McKay, DL | 1 |
| Tuttle, JP | 1 |
| Witten, FR | 1 |
| Brandstetter, K | 1 |
| Schwarzer, JU | 3 |
| Bautz, W | 1 |
| Pickl, U | 1 |
| Lenz, M | 1 |
| McLoughlin, J | 1 |
| Asopa, R | 1 |
| Williams, G | 11 |
| Hashimoto, H | 2 |
| Terao, N | 1 |
| Hall, MC | 1 |
| Chiang, HS | 3 |
| Kao, YH | 1 |
| Sheu, MT | 1 |
| Bechara, A | 3 |
| Casabé, A | 3 |
| Chéliz, G | 2 |
| Romano, S | 2 |
| Fredotovich, N | 2 |
| Marten Perolino, R | 1 |
| Lukkarinen, O | 1 |
| Pelkonen, R | 1 |
| Millard, RJ | 1 |
| Stricker, PD | 1 |
| Lynch, WJ | 1 |
| Dean, TE | 1 |
| Murnaghan, GF | 1 |
| Breslin, FH | 1 |
| Rodríguez Vela, L | 1 |
| Gonzalvo Ibarra, A | 1 |
| Gil Martínez, P | 1 |
| Benejan Gual, J | 1 |
| Cuesta Presedo, JM | 1 |
| Ríoja Sanz, LA | 1 |
| Cetinkaya, M | 1 |
| Erdoğan, E | 1 |
| Memiş, A | 1 |
| Oztürk, B | 1 |
| Koçak, S | 1 |
| Purvis, K | 2 |
| Brekke, I | 1 |
| Christiansen, E | 2 |
| Bossinger, W | 1 |
| Kümmerling, S | 1 |
| Sasso, F | 2 |
| Gulino, G | 2 |
| Alcini, A | 1 |
| Alcini, E | 2 |
| Johnson, D | 1 |
| Vruggink, PA | 2 |
| Diemont, WL | 2 |
| Pagliarulo, A | 1 |
| Ludovico, GM | 1 |
| Cirillo-Marucco, E | 1 |
| Corvasce, A | 1 |
| Pagliarulo, G | 1 |
| Flynn, RJ | 1 |
| Renganathan, R | 1 |
| Suranjan, B | 1 |
| Kurien, T | 1 |
| Salinas Casado, J | 2 |
| Vírseda Chamorro, M | 2 |
| Samblas García, R | 2 |
| Esteban Fuertes, M | 2 |
| Aristizábal Agudelo, JM | 2 |
| Blázquez Izquierdo, J | 2 |
| Delgado Martín, JA | 2 |
| Resel Estévez, L | 2 |
| Sundaram, CP | 1 |
| Thomas, W | 1 |
| Pryor, LE | 1 |
| Sidi, AA | 4 |
| Billups, K | 1 |
| Pryor, JL | 1 |
| Takanami, M | 1 |
| Nagao, K | 1 |
| Ishii, N | 2 |
| Miura, K | 1 |
| Shirai, M | 2 |
| Soderdahl, DW | 1 |
| Thrasher, JB | 1 |
| Hansberry, KL | 1 |
| Aydoğan, S | 1 |
| Bircan, MK | 1 |
| Sahin, H | 1 |
| Korkmaz, K | 1 |
| Goonawardena, SA | 1 |
| de Silva, WA | 1 |
| Ketheeswaran, T | 1 |
| Garcia-Reboll, L | 1 |
| Kolsuz, A | 1 |
| Ozgül, A | 1 |
| Pagani, E | 1 |
| Puech-Leão, P | 3 |
| Glina, S | 3 |
| Reis, JM | 2 |
| Sogari, PR | 1 |
| Telöken, C | 2 |
| Souto, CA | 2 |
| Atahan, O | 1 |
| Metin, A | 2 |
| Başar, M | 1 |
| Başar, H | 2 |
| Aydoğanli, L | 1 |
| Alkan, K | 1 |
| Gümüş, O | 1 |
| Akalin, Z | 1 |
| Pierpaoli, SM | 1 |
| Rey, H | 1 |
| de Meyer, JM | 2 |
| Thibo, P | 1 |
| Rodrigues, M | 1 |
| Granegger, S | 1 |
| O'Grady, J | 1 |
| Sinzinger, H | 1 |
| Stackl, W | 1 |
| Wunderlich, H | 1 |
| Fazeli-Matin, S | 1 |
| Angermeier, KW | 1 |
| Gingell, JC | 8 |
| Zaher, TF | 1 |
| Smith, EM | 1 |
| Netto, IC | 3 |
| Gladden, KH | 1 |
| Chaudhuri, TK | 3 |
| Fink, S | 3 |
| Kolm, P | 1 |
| Engel, JD | 1 |
| Timmermans, L | 1 |
| Ergen, M | 1 |
| Erbay, ME | 1 |
| Lottman, PE | 1 |
| Hendriks, JC | 1 |
| Soli, M | 1 |
| Bertaccini, A | 1 |
| Carparelli, F | 1 |
| Gotti, R | 1 |
| Cavrini, V | 1 |
| Andrisano, V | 1 |
| Martorana, G | 1 |
| Ergen, A | 4 |
| Nolden, W | 1 |
| Jost, WH | 1 |
| Osterhage, J | 1 |
| Eckert, RE | 1 |
| Ziegler, M | 4 |
| Kaplan, SA | 1 |
| Reis, RB | 1 |
| Kohn, IJ | 1 |
| Shabsigh, R | 6 |
| Te, AE | 1 |
| Brown, SL | 1 |
| Haas, CA | 1 |
| Koehler, M | 1 |
| Bodner, DR | 7 |
| Seftel, AD | 1 |
| Sherif, T | 1 |
| Adbel-Gawad, T | 1 |
| Asaad, T | 1 |
| Abdallah, HM | 1 |
| Shmueli, J | 4 |
| Israilov, S | 5 |
| Segenreich, E | 5 |
| Baniel, J | 5 |
| Livne, P | 2 |
| Mills, RD | 1 |
| Sethia, KK | 2 |
| Ioannidis, E | 1 |
| Kalinderis, A | 1 |
| Başar, MM | 2 |
| Yildiz, M | 1 |
| Ak, F | 1 |
| Akan, H | 1 |
| Atan, A | 2 |
| Egdetveit, I | 1 |
| Samali, R | 1 |
| Johnson, H | 1 |
| Favre, M | 1 |
| Enria, T | 1 |
| Shcheplev, PA | 1 |
| Nesterov, SN | 1 |
| Kukharkin, SA | 1 |
| Abdullaev, IA | 1 |
| Sidorov, DV | 1 |
| Lee, SK | 1 |
| Song, ES | 1 |
| Lee, MY | 1 |
| Moncada Iribarren, I | 1 |
| Zaslau, S | 1 |
| Nicolis, C | 1 |
| Galea, G | 1 |
| Britanico, J | 1 |
| Vapnek, JM | 1 |
| Stolk, EA | 1 |
| Busschbach, JJ | 1 |
| Caffa, M | 1 |
| Rutten, FF | 1 |
| Simon, D | 1 |
| Engelstein, D | 2 |
| Livne, PM | 3 |
| Silingardi, V | 1 |
| Galeazzi, GM | 1 |
| Rigatelli, M | 1 |
| Ranzi, A | 1 |
| Artibani, W | 1 |
| Ozbek, E | 1 |
| Yurekli, M | 1 |
| Soylu, A | 1 |
| Davarci, M | 1 |
| Park, BD | 1 |
| Geramoutsos, I | 1 |
| Barbalias, G | 2 |
| Fu, Q | 1 |
| Yao, DH | 1 |
| Jiang, YQ | 1 |
| Chew, KK | 1 |
| Baçar, MM | 1 |
| Batislam, E | 1 |
| Altinok, D | 1 |
| Yilmaz, E | 1 |
| Baçar, H | 1 |
| Usta, MF | 1 |
| Erdoğru, T | 1 |
| Köksal, T | 1 |
| Yücel, B | 1 |
| Ledda, A | 1 |
| Cartledge, J | 1 |
| Minhas, S | 1 |
| Eardley, I | 2 |
| de Boer, BJ | 1 |
| Kleinjans, HA | 1 |
| Leungwattanakij, S | 1 |
| Flynn, V | 1 |
| Hellstrom, WJ | 1 |
| Arslan, D | 1 |
| Esen, AA | 1 |
| Seçil, M | 1 |
| Aslan, G | 1 |
| Celebi, I | 2 |
| Dicle, O | 1 |
| Ribé, N | 1 |
| Rajmil, O | 2 |
| Bassas, L | 2 |
| Jurado, C | 1 |
| Pomerol, JM | 2 |
| Bleumer, I | 1 |
| van der Maas, MC | 1 |
| Hengeveld, MW | 1 |
| Gianotten, WL | 1 |
| Claro, Jde A | 1 |
| de Aboim, JE | 1 |
| Maríngolo, M | 1 |
| Andrade, E | 1 |
| Aguiar, W | 1 |
| Nogueira, M | 1 |
| Nardozza Júnior, A | 1 |
| Srougi, M | 1 |
| Richter, S | 2 |
| Ringel, A | 1 |
| Shalev, M | 2 |
| Nissenkorn, I | 2 |
| Sahin, M | 1 |
| Bozdoğan, O | 1 |
| Lebib Ben Achour, S | 1 |
| Laffont, I | 1 |
| Boyer, F | 1 |
| Boiteau, F | 1 |
| Dizien, O | 1 |
| Beal, K | 1 |
| Mears, JG | 1 |
| Elhanbly, S | 1 |
| Schoor, R | 1 |
| Elmogy, M | 1 |
| Ross, L | 1 |
| Hegazy, A | 1 |
| Niederberger, C | 1 |
| Lee, KL | 1 |
| Niv, E | 1 |
| Lammers, PI | 1 |
| Rubio-Aurioles, E | 1 |
| Castell, R | 1 |
| Castaneda, J | 1 |
| Ponce de Leon, R | 1 |
| Hurley, D | 1 |
| Lipezker, M | 1 |
| Loehr, LA | 1 |
| Lowrey, F | 1 |
| van der Windt, F | 1 |
| Dohle, GR | 1 |
| van der Tak, J | 1 |
| Slob, AK | 3 |
| McGuffey, E | 1 |
| Kramer, L | 1 |
| Wang, CJ | 2 |
| Wu, CC | 5 |
| Huang, CH | 5 |
| Chiang, CP | 5 |
| Wen, TC | 1 |
| Chiang, WH | 1 |
| Puolakka, VM | 1 |
| Turner, LA | 8 |
| Althof, SE | 9 |
| Allen, RP | 2 |
| Engel, RM | 1 |
| Smolev, JK | 1 |
| Brendler, CB | 2 |
| Carbone, A | 1 |
| Gezeroglu, H | 1 |
| Militello, A | 1 |
| Mander, A | 1 |
| Urigo, F | 1 |
| Pischedda, A | 1 |
| Carpanese, L | 1 |
| Rovasio, SS | 1 |
| Migaleddu, V | 1 |
| Canalis, GC | 1 |
| Belgrano, E | 1 |
| Trombetta, C | 1 |
| Siracusano, S | 1 |
| Deriu, M | 1 |
| Salisci, E | 1 |
| Fehr, JL | 1 |
| Alund, G | 1 |
| Mühlebach, P | 1 |
| Egli, U | 1 |
| Sulser, T | 1 |
| Kreienbühl, B | 1 |
| Hauri, D | 2 |
| Weidner, W | 7 |
| Weiske, WH | 7 |
| Rudnick, J | 4 |
| Becker, HC | 1 |
| Schroeder-Printzen, J | 1 |
| Brähler, E | 1 |
| Siraj, QH | 3 |
| Hilson, AJ | 2 |
| Bomanji, J | 2 |
| Ahmed, M | 2 |
| Bellorofonte, C | 2 |
| Dell'Acqua, S | 2 |
| Ruoppolo, M | 2 |
| Zaatar, C | 2 |
| Tombolini, P | 2 |
| Canale, D | 1 |
| Cilurzo, P | 1 |
| Giorgi, PM | 1 |
| Menchini Fabris, GF | 1 |
| Wizenberg, P | 1 |
| D'Osvaldo, C | 1 |
| Rovegno, A | 1 |
| Fernández, H | 1 |
| Mocellini Iturralde, J | 1 |
| Morales Concepción, JC | 1 |
| Ryder, RE | 1 |
| Close, CF | 1 |
| Moriarty, KT | 1 |
| Moore, KT | 1 |
| Hardisty, CA | 1 |
| Parfitt, VJ | 1 |
| Wong, R | 1 |
| Dobbie, A | 1 |
| Hartog, M | 1 |
| Wespes, E | 7 |
| Delcour, C | 8 |
| Preserowitz, L | 1 |
| Herbaut, AG | 1 |
| Struyven, J | 7 |
| Schulman, C | 2 |
| Löbelenz, M | 1 |
| Jünemann, KP | 3 |
| Köhrmann, KU | 1 |
| Seemann, O | 1 |
| Rassweiler, J | 1 |
| Tschada, R | 1 |
| Alken, P | 1 |
| Biering-Sørensen, F | 3 |
| Sønksen, J | 2 |
| Lim, PH | 1 |
| Ng, FC | 1 |
| Henriet, JP | 1 |
| Maïza, D | 1 |
| Alachkar, F | 1 |
| Maïza, C | 1 |
| Courthéoux, P | 1 |
| Rattez, C | 1 |
| Alsweis, S | 1 |
| Théron, J | 1 |
| Evrard, C | 1 |
| Mahmoud, KZ | 1 |
| el Dakhli, MR | 1 |
| Fahmi, IM | 1 |
| Abdel-Aziz, AB | 1 |
| Rodriguez Antolin, A | 2 |
| Morales, JM | 1 |
| Andrés, A | 1 |
| Fernández Aparicio, T | 1 |
| Díaz González, R | 1 |
| Pamplona, M | 1 |
| Alvarez, E | 1 |
| Levine, SB | 8 |
| Bodner, D | 4 |
| Kursh, ED | 8 |
| Resnick, MI | 7 |
| Gall, H | 10 |
| Bähren, W | 13 |
| Scherb, W | 10 |
| Holzki, G | 4 |
| Irion, R | 1 |
| Lomas, GM | 1 |
| Jarow, JP | 2 |
| Home, P | 1 |
| Hollander, JB | 1 |
| Gonzalez, J | 1 |
| Norman, T | 1 |
| Chen, JK | 1 |
| Hwang, TI | 5 |
| Yang, CR | 4 |
| Grech, P | 1 |
| Dave, S | 1 |
| Cunningham, DA | 1 |
| Witherow, RO | 1 |
| Leffler, B | 1 |
| Frost, F | 1 |
| Oh, MM | 1 |
| Hampson, SJ | 1 |
| Cowie, AG | 1 |
| Richards, D | 1 |
| Bemelmans, BL | 1 |
| Doesburg, WH | 2 |
| van Asten, WN | 1 |
| Skotnicki, SH | 1 |
| Debruyne, FM | 2 |
| Wilms, G | 1 |
| Peene, P | 1 |
| Steeno, O | 1 |
| Baert, AL | 1 |
| Bell, DS | 1 |
| Cutter, GR | 1 |
| Hayne, VB | 1 |
| Lloyd, LK | 2 |
| Chandeck Montesa, K | 1 |
| Chen Jiménez, J | 1 |
| Tamayo, JC | 1 |
| Alvarez González, E | 1 |
| Keogh, EJ | 6 |
| Ker, JK | 1 |
| Cherry, DJ | 1 |
| Tulloch, AG | 5 |
| Lord, DJ | 6 |
| Sobh, MA | 1 |
| Abd el Hamid, IA | 1 |
| Atta, MG | 1 |
| Refaie, AF | 1 |
| Merckx, LA | 1 |
| De Bruyne, RM | 1 |
| Goes, E | 1 |
| Derde, MP | 1 |
| Keuppens, F | 1 |
| Schipper, J | 1 |
| van Oostayen, JA | 1 |
| Shoukry, K | 1 |
| Floresco, J | 1 |
| Nollet, F | 1 |
| Greco, E | 1 |
| Bouchot, O | 1 |
| Bondil, P | 4 |
| Navratil, H | 1 |
| Fein, RL | 1 |
| Davis, BE | 1 |
| Weigel, JW | 1 |
| Whitford, CS | 1 |
| Bennett, AH | 2 |
| Carpenter, AJ | 1 |
| Barada, JH | 1 |
| Elgammal, M | 1 |
| Gafir, S | 1 |
| Stein, L | 1 |
| Elhilali, M | 1 |
| Beer, SJ | 1 |
| See, WA | 1 |
| Esen, A | 2 |
| Kitapci, M | 1 |
| Erbas, B | 1 |
| Remzi, D | 3 |
| Bekdik, C | 1 |
| Sieber, A | 3 |
| Schnyder von Wartensee, M | 5 |
| Thönen, HJ | 1 |
| Studer, UE | 5 |
| Cooper, AJ | 1 |
| Morgentaler, A | 1 |
| Pickard, RS | 1 |
| Oates, CP | 1 |
| Powell, PH | 1 |
| Siegal, YI | 1 |
| Lindner, A | 2 |
| Otani, T | 1 |
| Sargin, S | 1 |
| Ozen, H | 1 |
| Caspari, D | 2 |
| Münch, M | 1 |
| Lidgi, S | 1 |
| Moskovitz, B | 1 |
| Levin, RD | 1 |
| Strohmaier, WL | 1 |
| Thomas, C | 1 |
| Wilbert, DM | 1 |
| Bichler, KH | 1 |
| Claussen, CD | 1 |
| Vidal Moreno, JF | 1 |
| Boronat Tormo, F | 1 |
| Moreno Pardo, B | 1 |
| Alonso Gorrea, M | 1 |
| Pontones Moreno, JL | 1 |
| Jiménez Cruz, JF | 1 |
| Leliefeld, HH | 1 |
| Peulen, GJ | 1 |
| Ho, WL | 1 |
| Chu, HW | 1 |
| Price, DE | 1 |
| Cooksey, G | 1 |
| Jehu, D | 1 |
| Bentley, S | 1 |
| Hearnshaw, JR | 1 |
| Osborn, DE | 1 |
| Ferri, PM | 1 |
| Yamak, R | 1 |
| Tagliaferri, A | 1 |
| Fitzgerald, SW | 1 |
| Erickson, SJ | 1 |
| Foley, WD | 1 |
| Lipchik, EO | 1 |
| Lawson, TL | 1 |
| Lewis, CA | 1 |
| Török, A | 3 |
| Jilling, A | 1 |
| Götz, F | 3 |
| García, F | 1 |
| Fabián, E | 1 |
| Lowe, MA | 1 |
| Schwartz, AN | 5 |
| Berger, RE | 2 |
| Hofmann, R | 2 |
| Stricker, P | 1 |
| Chiang, PH | 1 |
| Chen, MT | 1 |
| Wu, DK | 2 |
| Fishman, IJ | 7 |
| Schum, C | 1 |
| Dunn, JK | 3 |
| Rowland, DL | 2 |
| Blom, JH | 2 |
| van der Werff ten Bosch, JJ | 1 |
| Wetterauer, U | 6 |
| Schaebsdau, FH | 1 |
| Leentvaar, EJ | 1 |
| Kerfoot, WW | 1 |
| Carson, CC | 1 |
| Risen, CB | 3 |
| Treiber, U | 1 |
| Bödecker, R | 1 |
| Rosen, MP | 1 |
| Levine, FJ | 1 |
| Greenfield, AJ | 1 |
| Helmy, AM | 1 |
| Sargin, YS | 1 |
| Ozen, HA | 1 |
| Başar, I | 1 |
| Erol, D | 1 |
| Koçal, C | 1 |
| Pierce, LJ | 1 |
| Whittington, R | 1 |
| Hanno, PM | 1 |
| English, W | 1 |
| Wein, AJ | 1 |
| Goodman, RL | 1 |
| Toombs, BD | 1 |
| Skolkin, M | 1 |
| Lopez, JA | 1 |
| Espeland, MA | 1 |
| Richardson, JD | 1 |
| Graversen, PH | 2 |
| Rosenkilde, P | 1 |
| Colstrup, H | 2 |
| Adaikan, PG | 2 |
| Lau, LC | 1 |
| Vasatha, KS | 1 |
| Susheela, K | 1 |
| Ratnam, SS | 2 |
| Floth, A | 2 |
| Schramek, P | 3 |
| Bassiouny, HS | 1 |
| Levine, LA | 1 |
| Broderick, GA | 1 |
| Allen, G | 1 |
| VanderBurg Mendendorp, S | 1 |
| Tesar, LJ | 1 |
| el-Damanhoury, H | 1 |
| Rüth, J | 1 |
| Liu, LC | 3 |
| Liu, LH | 4 |
| Chou, YH | 3 |
| Tan, LB | 1 |
| Sikora, R | 1 |
| Bohndorf, K | 1 |
| Deutz, FJ | 1 |
| Papadopoulos, I | 2 |
| Marks, W | 1 |
| Christiansen, GR | 1 |
| Weichert-Jacobsen, K | 2 |
| Leyh, H | 1 |
| Amer, M | 2 |
| Lorge, F | 1 |
| Schouman, M | 3 |
| Arvis, G | 1 |
| Kattan, S | 1 |
| Collins, JP | 2 |
| Mohr, D | 1 |
| Kromann-Andersen, B | 1 |
| Nielsen, KK | 1 |
| Nordling, J | 2 |
| Gray, JM | 2 |
| Kase, T | 1 |
| Liu, PZ | 1 |
| Lacroix, P | 1 |
| Cumming, J | 1 |
| Pryor, JP | 3 |
| Kaplan, HS | 1 |
| Van Driel, MF | 2 |
| Joosten, EA | 1 |
| Mensink, HJ | 1 |
| Sun, XJ | 1 |
| Lenk, S | 1 |
| Schönherr, G | 1 |
| Korner, I | 1 |
| Gregoire, A | 1 |
| al-Juburi, AZ | 2 |
| O'Donnell, PD | 2 |
| Alexander, WD | 1 |
| Kim, KB | 1 |
| Dudkin, BP | 1 |
| Vorontsov, VV | 1 |
| Baĭkov, BV | 1 |
| Utkin, VN | 1 |
| Zemskov, VI | 1 |
| Gilbert, HW | 1 |
| Gillatt, DA | 1 |
| Desai, KM | 5 |
| Shotland, Y | 1 |
| Karacan, I | 1 |
| Mueller, SC | 2 |
| von Wallenberg-Pachaly, H | 1 |
| Voges, GE | 1 |
| Steffens, J | 3 |
| Scheffler, P | 1 |
| Vickers, MA | 2 |
| Benson, CB | 2 |
| Richie, JP | 1 |
| Canan, V | 1 |
| Dorey, FJ | 1 |
| Mehringer, CM | 2 |
| Drawz, G | 1 |
| Drawz, B | 1 |
| Seemann, B | 1 |
| Heydel, E | 1 |
| Schultz, J | 1 |
| Heydenreich, A | 1 |
| Kmietzyk, HJ | 1 |
| Hasse, N | 1 |
| Bast, R | 1 |
| Eilitz, B | 1 |
| Klyde, BJ | 2 |
| Zussman, S | 2 |
| Salkin, P | 2 |
| Mellinger, BC | 3 |
| Fried, JJ | 1 |
| Vaughan, ED | 2 |
| Schurch, B | 1 |
| Kuhn, W | 1 |
| Handelsman, H | 1 |
| Sønksen, JO | 1 |
| Hansen, EF | 1 |
| Schrey, A | 1 |
| Kulvelis, F | 1 |
| Popken, G | 1 |
| Staubesand, J | 1 |
| Sommerkamp, H | 2 |
| Watters, GR | 5 |
| Glatthaar, C | 1 |
| Netto Júnior, NR | 1 |
| Reinato, JA | 1 |
| Cara, A | 1 |
| Claro, JF | 1 |
| Holmes, S | 1 |
| Patel, A | 1 |
| Lumley, JS | 1 |
| Dhabuwala, CB | 1 |
| Kerkar, P | 1 |
| Bhutwala, A | 1 |
| Kumar, A | 1 |
| Pierce, JM | 1 |
| Chao, S | 1 |
| Reichelt, AC | 2 |
| Tanaka, T | 1 |
| VanderBrug Medendorp, S | 1 |
| Tesar, L | 1 |
| Schover, LR | 1 |
| Summers, JL | 1 |
| Breza, J | 1 |
| Aboseif, SR | 1 |
| Tanagho, EA | 7 |
| Bardin, ED | 1 |
| Krieger, JN | 1 |
| Swartz, DA | 1 |
| Todd, MW | 1 |
| Fried, FA | 1 |
| Akhtar, MA | 2 |
| Rana, MH | 1 |
| Sadiq, M | 1 |
| Wand, H | 1 |
| DePalma, RG | 3 |
| Schwab, FJ | 1 |
| Emsellem, HA | 3 |
| Massarin, E | 1 |
| Bergsrud, D | 3 |
| Cameron, JS | 2 |
| Duffy, LM | 1 |
| Lange, PH | 2 |
| Gallwitz, A | 2 |
| Altwein, JE | 6 |
| Gilbert, P | 2 |
| Wetterhauer, U | 1 |
| Thon, W | 4 |
| Beckert, R | 4 |
| Trapp, JD | 1 |
| Kiely, EA | 6 |
| Blank, MA | 1 |
| Bloom, SR | 2 |
| Nellans, RE | 1 |
| Ellis, LR | 1 |
| Hu, KN | 1 |
| Burks, C | 1 |
| Christy, WC | 1 |
| Dykstra, DD | 1 |
| Reinberg, Y | 1 |
| Risen, C | 3 |
| Resnick, M | 2 |
| Weinberg, JJ | 1 |
| Asakawa, M | 1 |
| Kawashima, H | 1 |
| Yoshimura, R | 1 |
| Maekawa, T | 1 |
| Kashiwara, N | 1 |
| Tanaka, H | 1 |
| Nishio, S | 1 |
| Hadzija, BW | 1 |
| Mattocks, AM | 1 |
| Stahl, GM | 1 |
| Wang, ZR | 1 |
| Nelson, RP | 3 |
| Nakajima, Y | 1 |
| Shibayama, T | 1 |
| Yamamoto, H | 1 |
| Suzuki, Y | 1 |
| Matsuoka, K | 1 |
| Kaneda, S | 1 |
| Vapnek, J | 1 |
| Kirkeby, HJ | 4 |
| Forman, A | 1 |
| Sørensen, S | 1 |
| Andersson, KE | 1 |
| Zorgniotti, AW | 6 |
| Lefleur, RS | 1 |
| Graham, MM | 1 |
| Ferency, GF | 1 |
| Miura, RS | 1 |
| Dehaene, JL | 4 |
| Babula, V | 1 |
| Sedmík, J | 1 |
| Zvĕrina, J | 1 |
| Mooradian, AD | 1 |
| Kaiser, FE | 1 |
| Davis, SS | 1 |
| Viosca, SP | 1 |
| Korenman, SC | 1 |
| Richards, JS | 1 |
| Dillard, FT | 1 |
| Miller, BS | 1 |
| Sommer, BG | 1 |
| Horchak, AM | 1 |
| York, JP | 1 |
| Nesbitt, JA | 1 |
| Székely, J | 2 |
| Márk, B | 1 |
| Gorpinchenko, II | 1 |
| Khudaĭberdiev, NA | 1 |
| Johannesen, NL | 1 |
| Chang, CL | 1 |
| Chang, CH | 1 |
| Wu, HC | 1 |
| Sarosdy, MF | 1 |
| Hudnall, CH | 1 |
| Erickson, DR | 1 |
| Hardin, TC | 1 |
| Novicki, DE | 1 |
| Sparwasser, CH | 1 |
| Robinson, LQ | 2 |
| Woodcock, JP | 2 |
| Stephenson, TP | 2 |
| Martin-du Pan, R | 1 |
| Zentgraf, M | 3 |
| Ludwig, G | 2 |
| Burger, RH | 1 |
| Palmer, JD | 1 |
| Carati, CJ | 4 |
| Tulloch, GS | 1 |
| Jow, YR | 1 |
| Keuler, F | 1 |
| Pauthner, H | 1 |
| Krysiewicz, S | 1 |
| Quam, JP | 1 |
| King, BF | 1 |
| James, EM | 1 |
| Lewis, RW | 3 |
| Brakke, DM | 1 |
| Ilstrup, DM | 1 |
| Parulkar, BG | 1 |
| Hattery, RR | 1 |
| Persson, C | 1 |
| Diederichs, W | 2 |
| Yen, TS | 1 |
| McLin, PH | 1 |
| Quesada, ET | 1 |
| Seale-Hawkins, CK | 1 |
| Chen, LM | 1 |
| Thorell, E | 1 |
| Sales, N | 1 |
| Lisboa, J | 1 |
| Zenico, T | 1 |
| Zoli, M | 1 |
| Maltoni, G | 1 |
| Fuchs, AM | 1 |
| Shantha, TR | 1 |
| Finnerty, DP | 1 |
| Rodriquez, AP | 1 |
| Seidmon, EJ | 1 |
| Samaha, AM | 1 |
| Takimoto, Y | 1 |
| Kawazoe, K | 1 |
| Hosokawa, H | 1 |
| Hamada, T | 1 |
| Ono, M | 1 |
| Aoki, Y | 1 |
| Yasuoka, S | 1 |
| Dickinson, IK | 2 |
| Lin, SN | 2 |
| Liu, RS | 2 |
| Yu, PC | 1 |
| Chang, LS | 2 |
| Yeh, SH | 2 |
| Kuo, JS | 1 |
| Schwab, F | 1 |
| Druy, EM | 2 |
| Miller, HC | 2 |
| Edwards, CM | 2 |
| Darewicz, J | 1 |
| Galek, L | 1 |
| Kursh, E | 1 |
| Forsberg, L | 1 |
| Hederström, E | 1 |
| Andrianne, R | 1 |
| Giordanengo, F | 1 |
| Bergamaschi, E | 1 |
| Giuffrida, GF | 1 |
| Cugnasca, M | 1 |
| Imagawa, A | 3 |
| Garofalo, FA | 1 |
| Gerasimov, VB | 1 |
| Lenskaia, OP | 1 |
| Narkevich, BIa | 1 |
| Bogdasarov, IuB | 1 |
| Dorémieux, J | 2 |
| Orvis, BR | 2 |
| Fuchs, ME | 1 |
| Brawer, MK | 1 |
| Reiss, H | 1 |
| Schneider, AW | 1 |
| Busch, R | 1 |
| Gonnermann, D | 1 |
| Klosterhalfen, H | 1 |
| Lee, LM | 1 |
| Stevenson, RW | 2 |
| Szasz, G | 2 |
| Gerstenberg, TC | 1 |
| Hald, T | 1 |
| Wagner, G | 1 |
| Azadzoi, K | 1 |
| Krane, RJ | 2 |
| Cohen, RA | 1 |
| van Ahlen, H | 3 |
| Thompson, SL | 1 |
| Goldstein, M | 2 |
| Bensadoun, H | 1 |
| Puech, A | 1 |
| Alexandre, L | 1 |
| Biedermann, H | 1 |
| Scott, FB | 1 |
| Sellam, R | 1 |
| Laurian, C | 1 |
| Franceschi, C | 1 |
| Vandenbosch, G | 2 |
| Delatte, P | 1 |
| Holzmann, RM | 1 |
| Waldhauser, M | 1 |
| Turner, L | 1 |
| Küchler, J | 1 |
| Bookstein, JJ | 5 |
| Valji, K | 2 |
| Parsons, L | 2 |
| Kessler, W | 2 |
| Lang, EV | 1 |
| Mulcahy, MJ | 2 |
| Zasler, ND | 1 |
| Fellmeth, B | 1 |
| Moreland, S | 1 |
| Lurie, AL | 1 |
| Payton, T | 1 |
| Padma-Nathan, H | 2 |
| Chang, JM | 1 |
| Benson, GS | 2 |
| Seifert, WE | 1 |
| Girdley, FM | 1 |
| Bruskewitz, RC | 3 |
| Feyzi, J | 1 |
| Gasser, TC | 3 |
| Marmar, JL | 1 |
| DeBenedictis, TJ | 1 |
| Praiss, DE | 1 |
| Ruutu, ML | 2 |
| Lindström, BL | 3 |
| Virtanen, JM | 2 |
| Alfthan, OS | 2 |
| Mouritsen, L | 1 |
| Lyngdorf, P | 1 |
| Frimodt-Møller, C | 1 |
| Jantos, C | 2 |
| Benard, F | 1 |
| Bosch, R | 1 |
| Lavoisier, P | 1 |
| Delcour, CP | 1 |
| Vandenbosch, GA | 1 |
| Struyven, JL | 1 |
| Lizza, E | 1 |
| Ruutu, M | 1 |
| Virtanen, J | 1 |
| Alfthan, O | 1 |
| Puppo, P | 2 |
| Pittaluga, P | 2 |
| Giuliani, L | 2 |
| Aoki, H | 1 |
| Matsuzaka, J | 1 |
| Takagane, H | 1 |
| Banya, Y | 1 |
| Fujioka, T | 1 |
| Kubo, T | 1 |
| Ohhori, T | 1 |
| Hartnell, G | 1 |
| Kiely, E | 1 |
| Rousseau, P | 1 |
| Jecht, E | 1 |
| Müller-Mattheis, V | 1 |
| Baccouche, M | 2 |
| Lühmann, R | 1 |
| Köster, O | 1 |
| Schlolaut, KH | 1 |
| Taib, E | 1 |
| Richaud, C | 1 |
| Juhan, C | 1 |
| Barthélémy, P | 1 |
| Aubry, M | 1 |
| Michelon, P | 1 |
| Golomb, J | 1 |
| Korczak, D | 1 |
| Schulman, CC | 4 |
| Freidenberg, D | 1 |
| Harley, JD | 1 |
| Bahnson, RR | 1 |
| Catalona, WJ | 1 |
| Dennis, RL | 2 |
| McDougal, WS | 1 |
| Brosman, S | 1 |
| Postma, HJ | 2 |
| Steffens, L | 2 |
| Krause, W | 1 |
| Kauss, E | 1 |
| Wehnert, J | 1 |
| Kramer, J | 1 |
| Weller, J | 1 |
| Leike, S | 1 |
| Nguyen Hoang, T | 1 |
| Guillé, F | 1 |
| Dufeuil, P | 1 |
| Lobel, B | 1 |
| Ferrière, JM | 1 |
| Gaston, R | 1 |
| Piechaud, T | 1 |
| Le Guillou, M | 1 |
| Germinale, F | 1 |
| Caviglia, C | 1 |
| Sanfelippo, CJ | 1 |
| Deason, AM | 1 |
| Tully, AJ | 1 |
| Leitner, WA | 1 |
| Spivey, C | 1 |
| Morgan, C | 1 |
| Holmes, B | 1 |
| Russell, RT | 1 |
| Gilling, PJ | 1 |
| Wright, WL | 1 |
| Meyer, JJ | 1 |
| Giesbers, AA | 1 |
| Kramer, AE | 1 |
| Pettirossi, O | 1 |
| Serenelli, G | 1 |
| Quadraccia, A | 1 |
| Salvini, A | 1 |
| Cordani, C | 1 |
| Pizzi, P | 1 |
| Bellinzoni, G | 1 |
| Tshipeta, N | 1 |
| Corriere, JN | 1 |
| Carlton, CE | 1 |
| Poulsen, EU | 1 |
| Petersen, T | 1 |
| Dørup, J | 1 |
| Reziciner, S | 1 |
| Grinenwald, P | 1 |
| Kurokawa, K | 1 |
| Rigot, JM | 1 |
| Nguyen Qui, JL | 1 |
| Mazeman, E | 1 |
| Janosko, EO | 1 |
| Nankin, HR | 1 |
| Osterman, J | 1 |
| Lin, T | 1 |
| Snoddy, W | 1 |
| Lewandowski, BJ | 1 |
| Roach, RM | 1 |
| Larsen, EH | 2 |
| Bouilly, P | 1 |
| Daniel, C | 1 |
| Lee, M | 1 |
| Sharifi, R | 1 |
| Baum, N | 1 |
| Vahlensieck, W | 1 |
| Puyau, FA | 2 |
| Balkin, P | 1 |
| Kaack, MB | 1 |
| Hirsch, A | 1 |
| Martin-Du-Pan, RC | 1 |
| Ignotus, P | 1 |
| Lindan, R | 1 |
| Leffler, E | 1 |
| Freidenberg, DH | 1 |
| Chew, DE | 1 |
| Ireton, R | 1 |
| Ansell, JS | 1 |
| Rondeux, C | 1 |
| Nadig, PW | 1 |
| Floyd, TJ | 1 |
| Momose, H | 1 |
| Natsume, O | 1 |
| Yamamoto, M | 1 |
| Suemori, T | 1 |
| Yamada, K | 1 |
| Lee, L | 1 |
| Sanders, HD | 1 |
| Zwiers, W | 1 |
| Hooykaas, JA | 1 |
| Brouwer, OF | 1 |
| Boonstra, S | 1 |
| Bell, DP | 1 |
| Wyndaele, JJ | 1 |
| de Sy, WA | 1 |
| Claessens, H | 1 |
| Bar Moshe, O | 1 |
| Soeiro Fidalgo de Matos, JM | 1 |
| Vandendris, M | 1 |
| Desmons, F | 1 |
| Robinette, MA | 1 |
| Moffat, MJ | 1 |
| Delle Rose, A | 1 |
| Barbagli, G | 1 |
| Shultz, SW | 1 |
| Goldie, L | 1 |
| Marich, KW | 2 |
| Schmidt, RA | 1 |
| Cameron, L | 1 |
| Woodruff, P | 1 |
| Abber, JC | 1 |
| Williams, RD | 1 |
| Takamura, T | 1 |
| Miyata, M | 1 |
| Nakata, Y | 1 |
| Osanai, H | 1 |
| Yachiku, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Influence of Treatment With the HMG-CoA-Reductase Inhibitor Fluvastatin on Erectile Function in Patients With Cardiovascular Risk-Factors and Erectile Dysfunction[NCT00382161] | Phase 3 | 20 participants (Anticipated) | Interventional | 2006-10-31 | Withdrawn (stopped due to not enough patients meeting inclusion criteria) | ||
| Sirolimus Eluting Balloon Utilization for Treatment of Vasculogenic Erectile Dysfunction - The SUASION Study[NCT04345965] | 100 participants (Anticipated) | Observational | 2019-09-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
68 reviews available for papaverine and Impotence
| Article | Year |
|---|---|
Current status of intracavernosal injection therapy in erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Vasodilator Agents | 2023 |
The Efficacy of Penile Duplex Ultrasound in Erectile Dysfunction Management Decision-Making: A Systematic Review.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penis; Surveys and Questionnaires | 2021 |
Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Penile Erection; Prospectiv | 2016 |
Pharmacological aspects of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Apomorphine; Drug Interactions; Erectile Dysfunction; Humans; Male; Middle | 2002 |
Topical agents and erectile dysfunction: is there a place?
Topics: Administration, Topical; Alprostadil; Erectile Dysfunction; Humans; Male; Minoxidil; Nitroglycerin; | 2002 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combi | 2003 |
[Conservative treatment of erectile dysfunction].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Ere | 2003 |
Erectile dysfunction in primary care.
Topics: Aftercare; Alprostadil; Causality; Communication; Diagnosis, Differential; Erectile Dysfunction; Hum | 2004 |
[Genito-sexual dysfunction in patients with a medullary lesion].
Topics: Adult; Electric Stimulation Therapy; Erectile Dysfunction; Humans; Insemination, Artificial; Male; P | 2004 |
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamin | 2005 |
Diagnosing erectile dysfunction: instruments for the study of smooth muscle relaxation.
Topics: Erectile Dysfunction; Hemodynamics; Humans; Male; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; P | 2005 |
Transdermal and topical pharmacotherapy for male sexual dysfunction.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Androgens; Animals; Erectile Dysfun | 2005 |
Treating erectile dysfunction in renal transplant recipients.
Topics: Alprostadil; Erectile Dysfunction; Humans; Kidney Transplantation; Male; Papaverine; Penile Erection | 2007 |
Neuroprostheses used to restore male sexual or reproductive function.
Topics: Ejaculation; Electric Stimulation Therapy; Equipment Design; Erectile Dysfunction; Humans; Hypogastr | 1995 |
[Treatment of impotence].
Topics: Alprostadil; Androgens; Attitude to Health; Erectile Dysfunction; Humans; Male; Papaverine; Penile P | 1994 |
[Intracavernous injections: role in the diagnosis and therapy of problems in erection].
Topics: Adrenergic alpha-Antagonists; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Ere | 1993 |
Impotence: diagnosis and management of male erectile dysfunction.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Physical Examination; Risk F | 1994 |
[Diagnosis and therapy of erectile dysfunction].
Topics: Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Papaverine; Patient Care Team; Penile E | 1993 |
Management of impotence. Diagnostic considerations and therapeutic options.
Topics: Age Factors; Causality; Comorbidity; Equipment and Supplies; Erectile Dysfunction; Family Practice; | 1993 |
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Drug Therapy, Combination; Erectile Dysfuncti | 1993 |
Management of erectile dysfunction after radical prostatectomy.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Prostatectomy; Vacuum; Vasodilato | 1995 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Nitroglycerin; Pa | 1995 |
[Drugs for impotence].
Topics: Adult; Aged; Aphrodisiacs; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Middle Aged; | 1995 |
[Long-term results of the treatment with intracavernous injection of vasoactive drugs].
Topics: Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Papaverine; Penis; T | 1996 |
Drugs for the treatment of impotence.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Administration, Oral; Administration, Topical; Adren | 1997 |
New developments in self-injection therapy for erectile dysfunction.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Chlorpromazine; Dose-Response Relationship, Drug; Erec | 1998 |
[Treatment for impotence].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Alprostadil; Erectile Dysfunction; Humans | 1998 |
[Pharmacotherapy of erectile dysfunction].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Alprostadil; Drug Therapy, Combin | 1999 |
Pharmacological treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Hum | 1999 |
Erectile function after radical prostatectomy.
Topics: Age Factors; Costs and Cost Analysis; Erectile Dysfunction; Humans; Male; Papaverine; Penile Implant | 2000 |
Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
Topics: Adult; Aged; Alprostadil; Australia; Erectile Dysfunction; Humans; Injections, Intralesional; Male; | 2001 |
Erectile dysfunction: intracavernous treatment.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverin | 2000 |
The role of nitric oxide in penile erection.
Topics: Animals; Arginine; Erectile Dysfunction; Genetic Therapy; Humans; Male; Muscle Relaxation; Muscle, S | 2001 |
Intracavernosal injection and intraurethral therapy for erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaver | 2001 |
[Erectile disorders: the reality].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Insurance Coverage; Male; Middle Aged; Nether | 2001 |
Pharmacotherapy for erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Nitric Oxide Donors; Papaverine; Phentolamine; Pipe | 2000 |
[Bladder dysfunction and sexual dysfunction and their management in patients with MS disease].
Topics: Alprostadil; Erectile Dysfunction; Female; Humans; Male; Multiple Sclerosis; Papaverine; Sexual Dysf | 1992 |
Penile erection in men with spinal cord or cauda equina lesions.
Topics: Adult; Cauda Equina; Equipment and Supplies; Erectile Dysfunction; Female; Humans; Male; Nitroglycer | 1992 |
[Impotence of vascular origin. Techniques of exploration and therapeutic orientations].
Topics: Adult; Alprostadil; Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Pe | 1992 |
Risk factors for papaverine-induced priapism.
Topics: Adult; Erectile Dysfunction; Humans; Incidence; Male; Middle Aged; Papaverine; Priapism; Risk Factor | 1992 |
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prosp | 1992 |
[A year in male impotence].
Topics: Age Factors; Alprostadil; Animals; Castration; Clinical Trials as Topic; Disease Models, Animal; Dog | 1991 |
Current diagnosis and management of impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Reperfusion; Yohimbine | 1991 |
[Intracavernous injections for the treatment of erectile dysfunction].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine | 1991 |
[Endocavernous drug infusions revisited].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penile Erection | 1991 |
Radionuclide studies in impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Radionuclide Imaging; Xenon Radioisotop | 1991 |
Radiologic assessment of impotence: angiography, sonography, cavernosography, and scintigraphy.
Topics: Diagnostic Imaging; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis | 1991 |
Erectile dysfunction-advances.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penile Prosthesis; Phen | 1991 |
[Male impotence. Radiologic venous evaluation].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penis; Radiography; Vasoconstrictor Agents | 1991 |
[Current diagnosis of impotence].
Topics: Adult; Aged; Blood Pressure; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Middle Age | 1990 |
Diagnostic evaluation of impotence.
Topics: Diabetes Complications; Erectile Dysfunction; Humans; Hyperprolactinemia; Hypogonadism; Male; Papave | 1990 |
Treatment alternatives for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Prosthesis Failure; Psychotherapy | 1990 |
Diagnosis and treatment of impotence.
Topics: Angiography; Equipment and Supplies; Erectile Dysfunction; Humans; Male; Monitoring, Physiologic; Ne | 1990 |
Vasoactive intracavernous pharmacotherapy.
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies | 1988 |
[Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Plea for the use of facilitator drugs. 2. Diagnostic and therapeutic applications].
Topics: Adrenergic alpha-Antagonists; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Ere | 1989 |
[Efficacy of intracavernous injection of papaverine and prostaglandin in the diagnosis and treatment of erectile impotence].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penis; Phentolamine; Pr | 1989 |
How safe is the treatment of impotence with intracavernous autoinjection?
Topics: Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Male; Papaverine; Penile Erection; Penis; | 1989 |
Physiological considerations in radionuclide imaging of the penis during impotence therapy.
Topics: Drug Combinations; Erectile Dysfunction; Erythrocytes; Humans; Male; Papaverine; Penile Erection; Pe | 1989 |
[Diagnosis of erectile impotence].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Regional Blood | 1989 |
New therapy for impotence.
Topics: Adrenergic alpha-Antagonists; Animals; Arterial Occlusive Diseases; Erectile Dysfunction; Humans; In | 1987 |
Evaluation of erectile impotence.
Topics: Erectile Dysfunction; Humans; Male; Medical History Taking; Middle Aged; Papaverine; Penile Erection | 1988 |
Injection therapy for impotence.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunct | 1988 |
[Erectile impotence. Drug therapy with papaverine--a review of the literature].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection | 1988 |
Nonoperative management of impotence.
Topics: Equipment and Supplies; Erectile Dysfunction; Humans; Isoxsuprine; Male; Papaverine; Penis; Prosthes | 1988 |
Impotence in elderly men.
Topics: Aged; Aging; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Phentolamine; Physical Examinati | 1988 |
Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentola | 1988 |
[Treatment of organic impotence].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Prostheses and Implants | 1987 |
[Diagnosis and therapy of erectile impotence with special reference to papaverine].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penis; Time Factors | 1986 |
64 trials available for papaverine and Impotence
| Article | Year |
|---|---|
[Comparing effect in the management of erectile dysfunction by using 2 sets of drugs of intracavernosal injection].
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Phentolamine; Pyrazi | 2003 |
The value of penile duplex in the prediction of intracavernous drug-induced priapism.
Topics: Alprostadil; Antihypertensive Agents; Erectile Dysfunction; Humans; Ischemia; Male; Middle Aged; Pap | 2004 |
Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances.
Topics: Adult; Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Injections, Intralesi | 2004 |
Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
Topics: Adrenergic alpha-Antagonists; Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inject | 2005 |
Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study.
Topics: Adrenergic alpha-Antagonists; Chlorpromazine; Double-Blind Method; Drug Administration Routes; Drug | 2004 |
Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Topics: Adult; Aged; Alprostadil; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Impo | 1995 |
Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Follow-Up Studies; Humans; Injection | 1994 |
Papaverine topical gel for treatment of erectile dysfunction.
Topics: Administration, Cutaneous; Adult; Aged; Blood Flow Velocity; Dose-Response Relationship, Drug; Erect | 1995 |
Intraurethrally infused capsaicin induces penile erection in humans.
Topics: Capsaicin; Catheterization; Drug Therapy, Combination; Erectile Dysfunction; Humans; Infusion Pumps; | 1994 |
Long-term results of therapy with intracavernousal injections and penile venous surgery in chronic erectile dysfunction.
Topics: Adult; Age Factors; Chronic Disease; Drug Combinations; Erectile Dysfunction; Humans; Impotence, Vas | 1994 |
Role of the nitric oxide donor linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.
Topics: Adult; Aged; Drug Therapy, Combination; Electromyography; Erectile Dysfunction; Follow-Up Studies; H | 1994 |
[Treatment of impotence with intracavernous auto-injections: moxisylyte diminishes the risks compared to papaverine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Moxisylyte; Papaverine; Pe | 1993 |
Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Impote | 1994 |
Psychogenic versus primary organic impotence.
Topics: Adult; Angiography; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Papaverine; Penile | 1994 |
Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Bicarbonates; Double-Blind Method; Drug Combinations; Erectile Dysfunction | 1993 |
[A program of intracavernous drug-induced erection for the treatment of impotence].
Topics: Administration, Topical; Dose-Response Relationship, Drug; Drug Evaluation; Ejaculatory Ducts; Erect | 1993 |
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Drug Therapy, Combination; Erectile Dysfuncti | 1993 |
Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged | 1996 |
Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Topics: Adrenergic alpha-Antagonists; Aging; Alprostadil; Drug Combinations; Erectile Dysfunction; Gonadal S | 1996 |
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drug Combinations; Erectile Dysfunction; Hum | 1996 |
Comparison of transdermal nitroglycerin and intracavernous injection of papaverine in the treatment of erectile dysfunction in patients with spinal cord lesions.
Topics: Administration, Cutaneous; Adult; Cross-Over Studies; Erectile Dysfunction; Humans; Injections; Male | 1997 |
Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Attitude to Health; Coitus; Cross-Over Studies; Erectil | 1997 |
Atropine role in the pharmacological erection test: study of 228 patients.
Topics: Adult; Aged; Alprostadil; Atropine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; M | 1997 |
Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Middl | 1998 |
Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; | 1998 |
Treatment of erectile dysfunction by an external ischiocavernous muscle stimulator.
Topics: Adult; Aged; Combined Modality Therapy; Electric Stimulation Therapy; Erectile Dysfunction; Humans; | 1998 |
Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Doxazosin; Drug Therap | 1998 |
Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test.
Topics: Adult; Alprostadil; Constriction, Pathologic; Erectile Dysfunction; Hemodynamics; Humans; Impotence, | 1999 |
Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Middl | 1999 |
Three-year outcome of a progressive treatment program for erectile dysfunction with intracavernous injections of vasoactive drugs.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow | 2000 |
Audiovisual sexual stimulation by virtual glasses is effective in inducing complete cavernosal smooth muscle relaxation: a pharmacocavernosometric study.
Topics: Adult; Aged; Audiovisual Aids; Erectile Dysfunction; Eyeglasses; Humans; Male; Middle Aged; Muscle R | 2000 |
The role of adrenomedullin in varicocele and impotence.
Topics: Adrenomedullin; Adult; Biomarkers; Erectile Dysfunction; Humans; Infertility, Male; Injections; Male | 2000 |
Risk factors for an early increase in dose of vasoactive agents for intracavernous pharmacotherapy.
Topics: Adult; Aged; Alprostadil; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Thera | 2000 |
A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
Topics: Adult; Aged; Drug Administration Routes; Drug Therapy, Combination; Erectile Dysfunction; Humans; Ma | 2000 |
Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction.
Topics: Adult; Alprostadil; Erectile Dysfunction; Hemodynamics; Humans; Impotence, Vasculogenic; Male; Middl | 2001 |
A new method for the evaluation of erectile dysfunction: sildenafil plus Doppler ultrasonography.
Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Image Enhancem | 2001 |
[Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverin | 2001 |
[Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Patient Satisfaction | 2001 |
Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hyd
Topics: Adrenergic alpha-Antagonists; Apomorphine; Cross-Over Studies; Double-Blind Method; Drug Combination | 2002 |
Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction.
Topics: Adult; Aged; Attitude to Health; Coitus; Drug Therapy, Combination; Erectile Dysfunction; Humans; In | 2002 |
Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
Topics: Alprostadil; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Pap | 1992 |
[Transdermal therapy of erectile insufficiency].
Topics: Erectile Dysfunction; Humans; Iontophoresis; Male; Papaverine; Yohimbine | 1992 |
Impotence in diabetes: aetiology, implications for treatment and preferred vacuum device.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Erec | 1992 |
Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients.
Topics: Alprostadil; Double-Blind Method; Egypt; Erectile Dysfunction; Humans; Male; Papaverine; Prospective | 1992 |
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prosp | 1992 |
Pharmacologic erection with intracavernosal injection for men with sexual dysfunction following irradiation: a preliminary report.
Topics: Adenoma; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentol | 1991 |
Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.
Topics: Alprostadil; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penil | 1991 |
Intracorporeal papaverine injection in androgen deprived men.
Topics: Erectile Dysfunction; Humans; Injections; Libido; Male; Multicenter Studies as Topic; Papaverine; Pe | 1990 |
Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentol | 1990 |
Prostaglandin E1 therapy for impotence, comparison with papaverine.
Topics: Adult; Aged; Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papav | 1990 |
Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Erectile | 1986 |
Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury.
Topics: Adult; Clinical Trials as Topic; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; | 1987 |
Safety of intracavernous injections using an alpha-blocking agent.
Topics: Adult; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Moxisylyte; Papaverine; | 1989 |
A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
Topics: Adult; Aged; Alprostadil; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Human | 1989 |
Treatment of impotence by intrapenile injections of papaverine and phenoxybenzamine: a double blind, controlled trial.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Injections; Inje | 1989 |
Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Erectile Dysfunction; | 1989 |
Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Topics: Alprostadil; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Pap | 1989 |
Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
Topics: Alprostadil; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Male; Midd | 1988 |
Injection therapy for impotence.
Topics: Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunct | 1988 |
[Open multicenter study of the differential diagnosis of erectile dysfunction with a papaverine-phentolamine combination (BY023)].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Diagnosis, Differential; Drug Combinations; Erect | 1988 |
[Study and treatment of erection disorders. Value of intracavernous injections].
Topics: Clinical Trials as Topic; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1987 |
Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Injections; Male; | 1987 |
Penile function following intracavernosal injection of vasoactive agents or saline.
Topics: Adult; Aged; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged | 1987 |
Induction of penile erection by intracavernosal injection: a double-blind comparison of phenoxybenzamine versus papaverine-phentolamine versus saline.
Topics: Adult; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middl | 1987 |
526 other studies available for papaverine and Impotence
| Article | Year |
|---|---|
A new diagnostic definition for patients with lower urinary tract symptoms evaluated by corpus cavernosum electromyography: 'Pelvic autonomic dysfunction'.
Topics: Electromyography; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pap | 2022 |
Ultrasonography after pharmacological stimulation of erection for the diagnosis and therapeutic follow-up of erectile dysfunction due to cavernovenous leakage.
Topics: Adult; Aged; Atropine; Blood Flow Velocity; Computed Tomography Angiography; Dipyridamole; Drug Comb | 2020 |
Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection.
Topics: Adult; Erectile Dysfunction; Humans; Injections, Intralesional; Ischemia; Male; Middle Aged; Papaver | 2020 |
A novel method for hemodynamic analysis of penile erection.
Topics: Erectile Dysfunction; Hemodynamics; Humans; Male; Papaverine; Penile Erection; Penis | 2022 |
[Application value of Toshiba 320-row dynamic volumetric CT angiography in the diagnosis of venous erectile dysfunction].
Topics: Adult; Arteries; Computed Tomography Angiography; Contrast Media; Drug Combinations; Erectile Dysfun | 2016 |
Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction.
Topics: Diffusion; Drug Delivery Systems; Drug Liberation; Erectile Dysfunction; Humans; Liquid Crystals; Ma | 2018 |
Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
Topics: Aged; Alprostadil; Anxiety; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middl | 2013 |
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Topics: Alprostadil; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Dru | 2013 |
The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
Topics: Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Patien | 2014 |
[Evaluation of the management of erectile and ejaculatory dysfunction in a series of 90 patients with spinal cord injuries].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Alprostadil; Ejaculation; Erectile Dysfunction; | 2013 |
Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction.
Topics: Administration, Cutaneous; Adult; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug S | 2015 |
Penile vascular diagnostic categorization using penile duplex Doppler ultrasound: Differences in vascular hemodynamics parameters by differences in anatomic sampling location.
Topics: Alprostadil; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erect | 2016 |
Male sexual dysfunction in unconsummated marriage: long-term outcome in 417 patients.
Topics: Adolescent; Adult; Aged; Clomipramine; Erectile Dysfunction; Female; Fluoxetine; Follow-Up Studies; | 2008 |
Predictive value of cavernosal peak systolic velocity in the flaccid penis.
Topics: Adult; Aged; Arteries; Blood Flow Velocity; Diabetes Mellitus, Type 2; Diagnosis, Differential; Erec | 2009 |
The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Incidence; Male; Middle Aged; Papaverine; Penis; Priapism | 2010 |
Efficacies of papaverine and sildenafil in the treatment of erectile dysfunction in early-stage paraplegic men.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Paraplegia; Penis; Piperazines; | 2011 |
Corpus cavernosum electromyography: could it be a parameter to predict ageing?
Topics: Adult; Aged; Aging; Electromyography; Erectile Dysfunction; Humans; Male; Middle Aged; Muscle, Smoot | 2010 |
Rehabilitation of the cavernous smooth muscle in patients with organic erectile dysfunction.
Topics: Adult; Alprostadil; Arteries; Coitus; Constriction; Drug Combinations; Erectile Dysfunction; Humans; | 2012 |
Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
Topics: Acrylic Resins; Administration, Cutaneous; Adult; Animals; Biological Availability; Calorimetry, Dif | 2012 |
Effects of chronic low- and high-dose ethanol intake on the nitrergic relaxations of corpus cavernosum and penile nitric oxide synthase in the rabbit.
Topics: Animals; Dose-Response Relationship, Drug; Electric Stimulation; Erectile Dysfunction; Ethanol; Male | 2012 |
Diagnostic steps in the evaluation of patients with erectile dysfunction.
Topics: Adult; Aged; Algorithms; Alprostadil; Diagnosis, Differential; Erectile Dysfunction; Humans; Impoten | 2002 |
[Current role of intracavernous therapy in the treatment of erectile dysfunction].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Clinical Trials as Topic; Drug Combinations; Erectile Dys | 2002 |
Penile duplex pharmaco-ultrasonography revisited: revalidation of the parameters of the cavernous arterial response.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Arteries; Arteriosclerosis; Blood Flow Velocity; Carotid | 2003 |
The incidence and management of priapism in Western Australia: a 16 year audit.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drainage; Drug Co | 2003 |
Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Topics: Aged; Alprostadil; Antihypertensive Agents; Drug Therapy, Combination; Erectile Dysfunction; Follow- | 2003 |
Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papa | 2003 |
Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Topics: Administration, Oral; Aged; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections | 2004 |
Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction.
Topics: Adult; Aged; Diabetes Complications; Erectile Dysfunction; Humans; Hypercholesterolemia; Impotence, | 2004 |
Penile vascular abnormalities observed long-term after surgical repair of penile fractures.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Piperazines; Postoperativ | 2004 |
Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction.
Topics: Enzyme Inhibitors; Erectile Dysfunction; Humans; Injections; Male; Methylene Blue; Papaverine; Phent | 2003 |
Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
Topics: Alprostadil; Cell Death; Cells, Cultured; Drug Interactions; Endothelial Cells; Endothelium, Vascula | 2004 |
Overactive corpus cavernosum: a novel cause of erectile dysfunction.
Topics: Action Potentials; Administration, Oral; Adult; Case-Control Studies; Electromyography; Erectile Dys | 2004 |
Corporal veno-occlusive dysfunction in aging rats: evaluation by cavernosometry and cavernosography.
Topics: Absorptiometry, Photon; Aging; Animals; Castration; Disease Models, Animal; Erectile Dysfunction; Ma | 2004 |
Effectiveness of vardenafil versus papaverine in penile Doppler ultrasonography.
Topics: Adult; Arteries; Blood Flow Velocity; Drug Administration Routes; Erectile Dysfunction; Follow-Up St | 2005 |
Erectile dysfunction in spinal cord injury: a cost-utility analysis.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Cost-Benefit Analysis; Drug Costs; Erectile | 2005 |
Comments from Ronald Virag on intracavernous injection: 25 years later.
Topics: Drug Administration Routes; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Vasodilator Agent | 2005 |
Intracavernous sodium nitroprusside (SNP) versus papaverine/phentolamine in erectile dysfunction: a comparative study of short-term efficacy and side-effects.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Nitroprusside; Papaverine; Phentolami | 2006 |
Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Topics: Alprostadil; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Erectile D | 2006 |
The hypoactive corpora cavernosa with degenerative erectile dysfunction: a new syndrome.
Topics: Adult; Electromyography; Erectile Dysfunction; Humans; Male; Middle Aged; Muscle, Smooth; Papaverine | 2006 |
Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; | 2007 |
Effects of transanal pelvic plexus stimulation on penile erection: clinical implications.
Topics: Adult; Anal Canal; Chi-Square Distribution; Electric Stimulation Therapy; Electromyography; Erectile | 2007 |
Torsion/detorsion of the testis does not modify responses to nitric oxide in rat isolated penile bulb.
Topics: Animals; Electric Stimulation; Endothelium-Dependent Relaxing Factors; Erectile Dysfunction; Male; M | 2007 |
Intracavernous injection of papaverine for erectile failure.
Topics: Blood Pressure Determination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1982 |
[Trial of intracavernous papaverine in the treatment of impotence. Therapeutic prospects].
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Vascular Diseases | 1983 |
Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Diabetic Angiopathies; Erectile Dysfunctio | 1984 |
Intracorporeal phenylephrine in the treatment of priapism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alprostadil; Blood Pressure; Erectile Dysfu | 1996 |
The clinical assessment of erectile dysfunction: a comparison of nocturnal penile tumescence monitoring and intracavernosal injections.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1995 |
Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs.
Topics: Adult; Aged; Erectile Dysfunction; Finland; Humans; Male; Middle Aged; Papaverine; Priapism; Punctur | 1995 |
[Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
Topics: Adult; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; | 1994 |
A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study.
Topics: Adolescent; Adult; Aged; Alprostadil; Arteries; Blood Pressure; Erectile Dysfunction; Humans; Inject | 1994 |
The effect of intracavernosal injection of papaverine hydrochloride on orgasm latency.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Orgasm; Papaverine; Penile Erection | 1995 |
Intracavernous self-injection of papaverine and verapamil: a clinical experience.
Topics: Adult; Aged; Cicatrix; Drug Combinations; Erectile Dysfunction; Hematoma; Humans; Injections; Male; | 1994 |
Intracavernous injection of alprostadil for erectile dysfunction.
Topics: Alprostadil; Clinical Trials as Topic; Costs and Cost Analysis; Cross-Over Studies; Double-Blind Met | 1995 |
Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
Topics: Alprostadil; Atropine; Drug Administration Schedule; Drug Combinations; Erectile Dysfunction; Follow | 1993 |
Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
Topics: Alprostadil; Atropine; Drug Combinations; Equipment Design; Erectile Dysfunction; Humans; Injections | 1993 |
Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence.
Topics: Alprostadil; Atropine; Drug Synergism; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inje | 1993 |
Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic.
Topics: Adult; Aged; Algorithms; Counseling; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus | 1995 |
Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.
Topics: Aged; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Impot | 1995 |
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; P | 1995 |
Reasons for high drop-out rate with self-injection therapy for impotence.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaver | 1994 |
Management of impotence due to spinal cord injury using low dose papaverine.
Topics: Adult; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Papaverine; Sexual Beha | 1995 |
Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition.
Topics: Adult; Brain Mapping; Ejaculation; Erectile Dysfunction; Evoked Potentials; Humans; Leg; Male; Middl | 1994 |
Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics.
Topics: Administration, Oral; Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverin | 1994 |
[Technical aids, injections, implants. Is it possible to cure impotence?].
Topics: Erectile Dysfunction; Humans; Injections, Intravenous; Male; Papaverine; Penile Prosthesis; Prognosi | 1995 |
Impotence following pelvic fracture urethral injury: incidence, aetiology and management.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Erectile Dysfunction; Follow-Up Studies; Fractures, Bon | 1995 |
The role of histamine in human penile erection.
Topics: Adult; Aged; Erectile Dysfunction; Histamine; Humans; In Vitro Techniques; Injections; Male; Middle | 1995 |
In vivo assessment of trabecular smooth muscle tone, its application in pharmaco-cavernosometry and analysis of intracavernous pressure determinants.
Topics: Adrenergic Agonists; Adult; Blood Flow Velocity; Blood Pressure; Erectile Dysfunction; Humans; Male; | 1995 |
Penile self-injection for impotence in patients after radical cystectomy.
Topics: Aged; Cystectomy; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phen | 1994 |
[Prostaglandin E1 in the treatment of erectile insufficiency. Comparison of efficacy and tolerance based on different etiologies].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination | 1994 |
Love and sex after 60: how to evaluate and treat the impotent older man. A roundtable discussion: Part 2.
Topics: Aged; Alprostadil; Erectile Dysfunction; Female; Heart Diseases; Humans; Male; Middle Aged; Papaveri | 1994 |
[The pharmaco-erection test].
Topics: Alprostadil; Atropine; Diagnosis, Differential; Drug Combinations; Erectile Dysfunction; Humans; Imp | 1994 |
[Corpus cavernosum autoinjection therapy in erectile dysfunction?].
Topics: Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections; | 1994 |
[Sex-dynamic characterization of patients subjected to radical pelvic cavity surgery].
Topics: Adult; Aged; Blood Vessels; Cystectomy; Erectile Dysfunction; Gonadotropins, Pituitary; Humans; Hypo | 1994 |
The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alprostadil; Diabetes Complications; Epoprostenol; Erecti | 1994 |
Impotence associated with the Charcot-Marie-Tooth syndrome.
Topics: Adult; Charcot-Marie-Tooth Disease; Combined Modality Therapy; Erectile Dysfunction; Humans; Male; M | 1994 |
Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Topics: Adult; Aged; Alprostadil; Atropine; Diabetes Complications; Drug Combinations; Erectile Dysfunction; | 1994 |
Reasons for patient drop-out from an intracavernous auto-injection programme for erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1994 |
Resolution of lower limb neurological deficit with penile papaverine in spinal arteriovenous malformation.
Topics: Arteriovenous Malformations; Erectile Dysfunction; Humans; Leg; Male; Middle Aged; Papaverine; Pares | 1993 |
A modified papaverine test and the use of venous constriction in erectile dysfunction.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Re | 1993 |
What does duplex ultrasound add to sexual history, nocturnal penile tumescence and intracavernosal injection of smooth muscle relaxant, in the diagnosis of erectile dysfunction?
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Medical History Taking; Middle A | 1993 |
Impotence: the radiologist's role.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Radiography; Radiology; Ultrasonography | 1994 |
Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Topics: Adult; Alprostadil; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Drug Monitoring; Drug Syne | 1994 |
Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury.
Topics: Administration, Topical; Adult; Aged; Combined Modality Therapy; Constriction; Erectile Dysfunction; | 1994 |
Fixed drug eruption to papaverine.
Topics: Drug Eruptions; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis | 1994 |
Experience with triple-drug therapy in a pharmacological erection program.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Cicatrix; Costs and Cost Analysis; Drug Combinations; E | 1993 |
Treatment of erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penile Pro | 1993 |
Corporeal blood gas changes according to duration of drug-induced prolonged erection.
Topics: Adult; Carbon Dioxide; Erectile Dysfunction; Femoral Artery; Humans; Hydrogen-Ion Concentration; Mal | 1993 |
Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
Topics: Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erect | 1993 |
Intracavernous papaverine for impotence in spinal cord injured patients.
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Pen | 1993 |
[Complications of intracavernous pharmacologic infusion in impotence. Long-term results].
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans | 1993 |
[Effectiveness and safety of cavernous body auto-injection therapy with papaverine/phentolamine. Study group].
Topics: Adult; Aged; Drug Therapy, Combination; Ejaculation; Erectile Dysfunction; Humans; Injections, Intra | 1993 |
Significance of full nocturnal erections with short duration.
Topics: Adult; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erec | 1994 |
Dynamic pharmacocavernosometry: a search for an ideal approach.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Pressure; Radiography; Regio | 1993 |
Experience with penile venous surgery.
Topics: Adult; Erectile Dysfunction; Humans; Ligation; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1993 |
[Local complications of papaverine-induced erection: follow-up at 7 years].
Topics: Adult; Aged; Erectile Dysfunction; Fibrosis; Follow-Up Studies; Humans; Hypertrophy; Male; Middle Ag | 1993 |
[Evaluation of vasculogenic erectile impotence using DICC (dynamic infusion cavernosometry & cevernosography) with intracavernous injection of papaverine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Manometry; Middle Aged; Papaverine; Pen | 1993 |
Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies.
Topics: Adult; Aged; Blood Flow Velocity; Color; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine | 1993 |
[Results of surgical therapy for venous insufficiency as a cause of erectile disorders].
Topics: Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis | 1993 |
[Treatment of erectile dysfunction with vacuum pumps].
Topics: Adult; Aged; Alprostadil; Combined Modality Therapy; Drug Therapy, Combination; Erectile Dysfunction | 1993 |
Treatment of corpus cavernosum abscess by aspiration and intravenous antibiotics.
Topics: Abscess; Cefuroxime; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middle Aged; Papav | 1993 |
[Transition of diagnosis and treatment for impotence].
Topics: Adolescent; Adult; Aged; Counseling; Diabetes Complications; Erectile Dysfunction; Humans; Ligation; | 1993 |
[Penile venous outflow occlusion: a comparison of erectile function and cavernosometry before and after percutaneous interventions].
Topics: Embolization, Therapeutic; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; P | 1993 |
[Therapy of erectile dysfunction with corpus cavernosum autoinjection and current legal aspects].
Topics: Erectile Dysfunction; Humans; Male; Malpractice; Papaverine; Patient Education as Topic; Penile Erec | 1993 |
[Experiences with intracavernous auto-injection for the treatment of erection disorders].
Topics: Adult; Aged; Anxiety; Erectile Dysfunction; Humans; Injections; Interpersonal Relations; Male; Middl | 1993 |
Predictive value of real-time RigiScan monitoring for the etiology of organogenic impotence.
Topics: Erectile Dysfunction; Humans; Injections; Male; Monitoring, Physiologic; Papaverine; Penile Erection | 1993 |
Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management.
Topics: Adolescent; Adult; Alprostadil; Arteries; Erectile Dysfunction; Follow-Up Studies; Humans; Injection | 1993 |
Potentiation of drug-induced erection with audiovisual sexual stimulation.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Erotica; Humans; Male; Middle Aged; Motion Pic | 1993 |
Evaluation of erectile dysfunction by dynamic infusion cavernosometry and cavernosography (DICC). Multi-institutional study.
Topics: Blood Pressure; Diabetic Angiopathies; Erectile Dysfunction; Humans; Male; Manometry; Middle Aged; P | 1993 |
[A comparison of color duplex sonography with selective penile DSA in assessing erectile dysfunction].
Topics: Adult; Aged; Angiography, Digital Subtraction; Color; Erectile Dysfunction; Evaluation Studies as To | 1993 |
Surgical treatment of venous leakage: medium-term follow-up.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Ligation; Male; Middle Aged; Papaverin | 1993 |
[Postoperative results of ligation of crura penis for impotence with corporal veno-occlusive insufficiency].
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Ligation; Male; Middle Aged; Papaverin | 1993 |
Papaverine and prostaglandin E1 gel applications for impotence.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Animals; Erectile Dysfunction; Gels | 1995 |
[Topical treatment of erectile dysfunction. Possibilities and perspectives].
Topics: Administration, Cutaneous; Erectile Dysfunction; Humans; Male; Minoxidil; Papaverine; Phentolamine; | 1995 |
Risks of self-injection therapy for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Priapism; Self Admini | 1996 |
Evaluation of impotent men with intracorporeal injection of papaverine and colour Doppler ultrasound.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Parasympatholy | 1995 |
[Erectile impotence].
Topics: Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Injections; Male; Papaverine; Penil | 1996 |
Peyronie's disease. Investigation of staging, erectile failure and operative management.
Topics: Erectile Dysfunction; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile | 1995 |
Early experience of corpora cavernosa electromyography in impotent patients after radical cystoprostatectomy.
Topics: Adult; Case-Control Studies; Cystectomy; Electromyography; Erectile Dysfunction; Humans; Male; Middl | 1996 |
Managing impotence. A general practice approach.
Topics: Erectile Dysfunction; Family Practice; Humans; Male; Papaverine; Parasympatholytics; Penile Prosthes | 1996 |
The post-investigation questionnaire (PIO-R): a practical instrument to assess erectile response after intracavernous injection.
Topics: Erectile Dysfunction; False Positive Reactions; Humans; Impotence, Vasculogenic; Injections; Male; M | 1996 |
Compliance to longterm vasoactive intracavernous therapy.
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Patient Compliance; | 1996 |
Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; M | 1996 |
[Usefulness of the neuroandrologic profile study in patients with erectile dysfunction: review of a series of 180 cases].
Topics: Adult; Aged; Algorithms; Electromyography; Erectile Dysfunction; Evoked Potentials, Somatosensory; H | 1996 |
Corpus cavernosum electromyography (CC-EMG): a new technique in the diagnostic work-up of impotence.
Topics: Adolescent; Adult; Autonomic Pathways; Electromyography; Erectile Dysfunction; Humans; Male; Middle | 1996 |
[Vascular and functional evaluation of erectile dysfunctions using erection provocation tests].
Topics: Alprostadil; Blood Pressure Determination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Er | 1997 |
Long-term follow-up of patients receiving injection therapy for erectile dysfunction.
Topics: Adult; Erectile Dysfunction; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; | 1997 |
Is diabetic neuropathy responsible for diabetic impotence?
Topics: Algorithms; Alprostadil; Diabetic Neuropathies; Diagnosis, Differential; Erectile Dysfunction; Human | 1997 |
The importance of visual erotic stimulation in the differential diagnosis of erectile impotence.
Topics: Adult; Aged; Diagnosis, Differential; Erectile Dysfunction; Erotica; Humans; Male; Middle Aged; Papa | 1997 |
Pharmacologically induced penile erections in the assessment and treatment of erectile impotence: a preliminary study of 100 patients.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Vasodilat | 1997 |
Cavernous oxygen tension in the patients with erectile dysfunction.
Topics: Adult; Aged; Arteries; Blood Gas Analysis; Carbon Dioxide; Erectile Dysfunction; Femoral Artery; Hum | 1997 |
The value of a second injection on the pharmaco-induced erection test.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverin | 1997 |
[Evaluation of electromyography of the corpora cavernosa (single potential analysis of cavernous electric activity--SPACE) as a technique for studying impotence].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Electromyography; Erectile Dysfunction; Humans; Male; Mi | 1997 |
Intracavernosal injection therapy: a practical guide.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Patient Compliance; Patient Education as | 1997 |
Electrical activity of corpus cavernosum in vasculogenic and non-vasculogenic erectile dysfunction.
Topics: Adult; Cholesterol; Electromyography; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injecti | 1997 |
Colour penile Doppler ultrasonography with intraurethral prostaglandin-E2: preliminary results.
Topics: Adult; Dinoprostone; Erectile Dysfunction; Hemodynamics; Humans; Instillation, Drug; Male; Middle Ag | 1997 |
A positive urine opiate screen following intracavernosal papaverine injection.
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Narcotics; Papaverine; Penis; Substance Abuse | 1998 |
Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Pen | 1998 |
The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity.
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Erectile D | 1998 |
Accumulation of platelets as a key mechanism of human erection. A scintigraphic study in patients with erectile dysfunction receiving intracavernous injection of PGE1, papaverine/phentolamine.
Topics: Adult; Aged; Alprostadil; Blood Platelets; Erectile Dysfunction; Humans; Indium Radioisotopes; Male; | 1997 |
Coincidence of induratio penis plastica and erectile dysfunction.
Topics: Adult; Aged; Diagnosis, Differential; Erectile Dysfunction; Follow-Up Studies; Humans; Injections, I | 1998 |
Penile fracture after intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papav | 1998 |
Role of radionuclide phallogram in therapeutic decision-making for erectile dysfunction.
Topics: Adult; Aged; Erectile Dysfunction; Erythrocytes; Humans; Male; Middle Aged; Papaverine; Penis; Phent | 1998 |
[Methodology of penile isotope imaging. Evaluation].
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Evaluation Studies as Topic; Humans; Image Processin | 1998 |
Congenitally isolated cavernous bodies.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Radiography; Vasodilator Agents | 1998 |
The impact of marital satisfaction and psychological counselling on the outcome of ICI-treatment in men with ED.
Topics: Erectile Dysfunction; Female; Humans; Injections; Male; Marriage; Papaverine; Patient Dropouts; Pati | 1998 |
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Chromatography, High Pressure Liquid; Drug Combinations; | 1998 |
Caverno-occlusive and autonomic dysfunction: a new concept in young patients.
Topics: Adult; Biomarkers; Electromyography; Erectile Dysfunction; Humans; Male; Muscle Contraction; Muscle, | 1998 |
Hepatotoxicity related to intracavernous pharmacotherapy with papaverine.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Erectile Dysfunction; Follow-Up Studies; Humans | 1998 |
Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
Topics: Adult; Alprostadil; Anxiety; Erectile Dysfunction; Humans; Male; Marriage; Middle Aged; Papaverine; | 1998 |
Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phentolamine; Sympatholytic | 1998 |
Progressive treatment of erectile dysfunction with intracorporeal injections of different combinations of vasoactive agents.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Erectile Dysfunction; Humans; Male; Middle Ag | 1999 |
Maximisation of the erectile response in the investigation of impotence.
Topics: Aged; Alprostadil; Audiovisual Aids; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pe | 1999 |
Electrical activity of the corpus cavernosum in denervated rats.
Topics: Animals; Autonomic Nervous System; Denervation; Disease Models, Animal; Electromyography; Erectile D | 1999 |
Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Libid | 1999 |
[Pharmaco-erection in erectile deficiency after surgical therapy].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Cystectomy; Erectile Dysfunction; Humans; Injections; Mal | 1999 |
Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Animals; Blood Pressure; Dogs; Drug Synergism; Erectile D | 1999 |
A simplified pharmacologic erection program for patients with spinal cord injury.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1999 |
Cost utility analysis of sildenafil compared with papaverine-phentolamine injections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combina | 2000 |
Unconsummated marriage: clarification of aetiology; treatment with intracorporeal injection.
Topics: Adolescent; Adult; Ejaculation; Erectile Dysfunction; Female; Humans; Injections; Iran; Male; Marria | 2000 |
[Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans | 1998 |
Erectile dysfunction.
Topics: Alprostadil; Drug Interactions; Erectile Dysfunction; Humans; Male; Papaverine; Piperazines; Purines | 2000 |
The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Dose-Response Relationship, Drug; Erectile Dysfuncti | 2001 |
Honeymoon impotence: psychogenic or organic in origin?
Topics: Adult; Anxiety; Coitus; Diagnosis, Differential; Erectile Dysfunction; Health Knowledge, Attitudes, | 2001 |
[Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Drug Combinations; Erectile Dysfunctio | 2001 |
Comparative evaluation of treatments for erectile dysfunction in patients with prostate cancer after radical retropubic prostatectomy.
Topics: Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Phosphodiesterase Inh | 2001 |
The value of sildenafil as mode of stimulation in pharmaco-penile duplex ultrasonography.
Topics: Administration, Oral; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combin | 2001 |
Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 2001 |
Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
Topics: Aged; Aged, 80 and over; Aging; Alprostadil; Case-Control Studies; Dose-Response Relationship, Drug; | 2001 |
Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
Topics: Alprostadil; Animals; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Disease Mode | 2001 |
Short report: penile lymphoma following local injections for erectile dysfunction.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Lymphoma, Large B-Cell, Diffuse | 2001 |
Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs.
Topics: Alprostadil; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Erectile D | 2001 |
What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
Topics: Adrenergic alpha-Antagonists; Adult; Age Factors; Alprostadil; Erectile Dysfunction; Humans; Injecti | 2002 |
Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Cardiovascular | 2002 |
Intracavernous injection of papaverine for erectile failure. 1982.
Topics: Erectile Dysfunction; History, 20th Century; Humans; Male; Papaverine; Penile Erection; Phosphodiest | 2002 |
Relaxation degree: a new concept in erectile dysfunction.
Topics: Adult; Case-Control Studies; Electromyography; Erectile Dysfunction; Humans; Male; Muscle Relaxation | 2001 |
Drugs for impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Minoxidil; Nitroglycerin; Papaverine | 1992 |
A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erecti | 1992 |
Intracavernous self-injection therapy for the treatment of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1992 |
The clinical effectiveness of self-injection and external vacuum devices in the treatment of erectile dysfunction: a six-month comparison.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penile | 1992 |
[Duplex scanner in the diagnosis of vasculogenic impotence].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Ul | 1992 |
[Selective arteriography in the study of arterial vasculogenic impotence].
Topics: Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Penis | 1992 |
[Impotence: introductory notes].
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penile Prosthesis; Phe | 1992 |
Significance of cavernosography in standardized cavernosometry.
Topics: Blood Flow Velocity; Blood Pressure; Erectile Dysfunction; Humans; Male; Manometry; Papaverine; Peni | 1992 |
Venous surgery in veno-occlusive dysfunction: long-time results after deep dorsal vein resection.
Topics: Adult; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Male | 1992 |
Volume-dependent intracavernous hemodilution during pharmacologically induced penile erections.
Topics: Adult; Aged; Erectile Dysfunction; Hematocrit; Humans; Male; Middle Aged; Papaverine; Penile Erectio | 1992 |
[Intracavernous infusion of drugs].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penis; Phentola | 1992 |
[Test with vasoactive drugs: its predictive value in the diagnosis of erectile sexual dysfunction of venous origin].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Phentolamine; Predi | 1992 |
[Priapism induced by intracavernous injection].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papav | 1992 |
Staphylococcal septicaemia complicating intracavernosal autoinjection therapy for impotence in a man with diabetes.
Topics: Bacteremia; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Floxacillin; | 1992 |
Impotence due to corporeal veno-occlusive dysfunction: long-term follow-up of venous surgery.
Topics: Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penile Erection; Pen | 1992 |
Penile revascularization in nonresponders to intracavernous injections using a modified microsurgical technique.
Topics: Alprostadil; Arteriovenous Shunt, Surgical; Erectile Dysfunction; Humans; Male; Microsurgery; Middle | 1992 |
Erectile dysfunction in Singapore men: presentation, diagnosis, treatment and results.
Topics: Adult; Age Factors; Aged; Causality; Erectile Dysfunction; Ethnicity; Follow-Up Studies; Humans; Mal | 1992 |
Transcutaneous nitroglycerin in the treatment of erectile dysfunction in spinal cord injured.
Topics: Administration, Cutaneous; Adult; Aging; Erectile Dysfunction; Humans; Male; Middle Aged; Nitroglyce | 1992 |
Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
Topics: Alprostadil; Erectile Dysfunction; Estradiol; Follicle Stimulating Hormone; Humans; Kidney Transplan | 1992 |
Through the eyes of women: the sexual and psychological responses of women to their partner's treatment with self-injection or external vacuum therapy.
Topics: Coitus; Consumer Behavior; Erectile Dysfunction; Female; Humans; Male; Papaverine; Phentolamine; Pro | 1992 |
[Long-term results of corpus cavernosum auto-injection therapy in treatment of patients with chronic erectile dysfunction].
Topics: Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Injections; Long-Term Care; Male; Ma | 1992 |
A depressing problem.
Topics: Diabetes Complications; Diabetes Mellitus; Erectile Dysfunction; Humans; Male; Papaverine; Penile Pr | 1992 |
Patient satisfaction with pharmacologic erection program.
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Patient Satisfaction; Penile Ere | 1992 |
Comparison of effects following the intracorporeal injection of papaverine and prostaglandin E1.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Erectile Dysfunction; Humans; Injections, Intramuscular | 1992 |
Combined papaverine test and radionuclide penile blood flow in impotence: method and preliminary results.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Pr | 1992 |
The role of intracavernous injection of vasoactive medications for the restoration of erection in spinal cord injured males: a three year follow up.
Topics: Adult; Aged; Erectile Dysfunction; Female; Humans; Injections; Male; Middle Aged; Papaverine; Penile | 1992 |
Norepinephrine involvement in response to intracorporeal injection of papaverine in psychogenic impotence.
Topics: Adult; Epinephrine; Erectile Dysfunction; Humans; Male; Middle Aged; Norepinephrine; Papaverine; Psy | 1992 |
Impotence.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1992 |
Independent evaluation of impotence by colour Doppler imaging and cavernosometry.
Topics: Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Pressure; Regio | 1992 |
Penile pharmacological duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1.
Topics: Aged; Alprostadil; Blood Flow Velocity; Dose-Response Relationship, Drug; Erectile Dysfunction; Huma | 1992 |
Intracavernosal injection of prostaglandin E1 as an alternative for papaverine in penile angiography.
Topics: Alprostadil; Angiography; Angiography, Digital Subtraction; Erectile Dysfunction; Humans; Injections | 1992 |
Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male.
Topics: Age Factors; Diabetes Complications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; | 1992 |
The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.
Topics: Adult; Alprostadil; Blood Pressure; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Pap | 1992 |
Effect of erythropoietin on sexual potency in chronic haemodialysis patients. A preliminary study.
Topics: Adult; Erectile Dysfunction; Erythropoietin; Hemoglobinometry; Humans; Kidney Failure, Chronic; Male | 1992 |
The value of dynamic color duplex scanning in the diagnosis of venogenic impotence.
Topics: Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erect | 1992 |
The value of increased end diastolic velocity during penile duplex sonography in relation to pathological venous leakage in erectile dysfunction.
Topics: Adult; Aged; Arteries; Blood Flow Velocity; Diastole; Erectile Dysfunction; Humans; Male; Middle Age | 1992 |
Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases.
Topics: Adrenergic alpha-Antagonists; Atropine; Consumer Behavior; Dipyridamole; Drug Combinations; Drug The | 1991 |
Iatrogenic priapism.
Topics: Benzodiazepines; Erectile Dysfunction; Humans; Male; Papaverine; Priapism | 1991 |
Classification of sexual dysfunction for management of intracavernous medication-induced erections.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile | 1990 |
Treatment of male impotence: a new option.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phentolamine | 1990 |
Intracavernous pharmacotherapy in psychogenic impotence.
Topics: Adult; Combined Modality Therapy; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; | 1991 |
An improved vasoactive drug combination for a pharmacological erection program.
Topics: Adult; Aged; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle | 1991 |
Digital subtraction cavernosography: method to detect venous leakage.
Topics: Angiography, Digital Subtraction; Cineradiography; Erectile Dysfunction; Humans; Male; Middle Aged; | 1991 |
Intracorporeal needle breakage: an unusual complication of papaverine injection therapy for impotence.
Topics: Equipment Failure; Erectile Dysfunction; Foreign Bodies; Humans; Injections; Male; Middle Aged; Need | 1992 |
Dual radioisotopic study: a technique for the evaluation of vasculogenic impotence.
Topics: Adult; Arteries; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; P | 1992 |
[Intracavernous self-injection in impotence].
Topics: Adult; Aged; Algorithms; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Se | 1992 |
Twelve-month comparison of two treatments for erectile dysfunction: self-injection versus external vacuum devices.
Topics: Coitus; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male | 1992 |
Evaluation of I-C papaverine in patients with psychogenic and organic impotence.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaver | 1991 |
The role of colour duplex ultrasonography in the diagnosis of vasculogenic impotence.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Induration; Penis; | 1991 |
[Non-surgical treatment of impotence].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle | 1991 |
Nuclear penogram can quantitate and record the effect of pharmacologic treatment of impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Radionuclide Imaging | 1991 |
Dynamic cavernosography in the evaluation of impotence.
Topics: Adult; Angiography, Digital Subtraction; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine | 1991 |
[Acceptance of corpus cavernosum auto-injection therapy in long-term treatment of erectile dysfunction].
Topics: Erectile Dysfunction; Follow-Up Studies; Humans; Injections, Intravenous; Long-Term Care; Male; Midd | 1991 |
[Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papave | 1991 |
Angiodynography (color-coded duplex sonography) in the evaluation of vasculogenic impotence.
Topics: Adult; Angiography; Arteries; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; | 1991 |
[Duplex ultrasound before and after intracavernous papaverine injection in the diagnosis of impotence].
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Ultrasonography | 1991 |
[Psychological factors affect the erectile response to papaverine injection].
Topics: Anxiety; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Priapism | 1991 |
Histopathological change of corpora cavernosa after long-term intracavernous injection.
Topics: Alprostadil; Animals; Dose-Response Relationship, Drug; Erectile Dysfunction; Fibrosis; Injections; | 1991 |
The management of impotence in diabetic men by vacuum tumescence therapy.
Topics: Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Erectile Dysfunction; Human | 1991 |
Color Doppler sonography in the evaluation of erectile dysfunction: patterns of temporal response to papaverine.
Topics: Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penil | 1991 |
Induced priapism and its management.
Topics: Dopamine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Pa | 1991 |
[Prolonged erections after diagnostic injection of papaverine chlorhydrate].
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Priapism | 1991 |
Controlled trial of infusion cavernosometry in impotent and potent men.
Topics: Blood Pressure; Case-Control Studies; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erectio | 1991 |
Purulent corporeal cavernositis secondary to papaverine-induced priapism.
Topics: Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Induration; Priapism | 1991 |
Investigating male sexual dysfunction. Cavernosograms and penile flow studies.
Topics: Alprostadil; Arterial Occlusive Diseases; Erectile Dysfunction; Humans; Male; Papaverine; Penile Ere | 1991 |
Colour duplex sonography in the assessment of impotence.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; M | 1991 |
Cigarette smoking and other vascular risk factors in vasculogenic impotence.
Topics: Diabetes Mellitus; Erectile Dysfunction; Humans; Hypertension; Male; Papaverine; Penile Erection; Pe | 1991 |
Psychologic factors affect erectile response to papaverine.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection | 1991 |
Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
Topics: Adult; Aged; Alprostadil; Calcitonin Gene-Related Peptide; Erectile Dysfunction; Humans; Male; Middl | 1991 |
Changes in penile sensitivity following papaverine-induced erection in sexually functional and dysfunctional men.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Sensatio | 1991 |
Pharmacologically induced erections among geriatric men.
Topics: Adult; Age Factors; Aged; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Injection | 1991 |
Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: a long-term prospective study.
Topics: Adaptation, Psychological; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Marria | 1991 |
Postoperative erectile dysfunction; evaluation and treatment with intracavernous vasoactive injections.
Topics: Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Pe | 1991 |
Significance of the intracavernosal pharmacological injection test, pharmacocavernosography, artificial erection and cavernosometry in the diagnosis of venous leakage.
Topics: Adult; Aged; Contrast Media; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine | 1991 |
Gluteal device for penile injection.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Infusion Pumps, Implantable; Male; Methods; | 1991 |
Correlation between intracavernous papaverine injection, Doppler analysis and cavernosography in impotent patients.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penis; Regional Blood F | 1991 |
Venous leaks: anatomical and physiological observations.
Topics: Adult; Aged; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erect | 1991 |
Comparison of the diagnostic value of pump and gravity cavernosometry in the evaluation of the cavernous veno-occlusive mechanism.
Topics: Adult; Aged; Erectile Dysfunction; Evaluation Studies as Topic; Gravitation; Hemodynamics; Humans; M | 1991 |
Interpretation and quantification of penile blood flow studies using duplex ultrasonography.
Topics: Arteries; Erectile Dysfunction; False Positive Reactions; Humans; Male; Papaverine; Penile Erection; | 1991 |
Intracorporeal injections for the treatment of impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1991 |
Erectile dysfunction following direct vision internal urethrotomy.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Blood Flow Velocity; Endoscopes; Endoscopy; Erectile Dysfu | 1991 |
[Neurotransmitters of penile erection other than vasoactive intestinal polypeptide. Physiologic data and therapeutic consequences].
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Neurotransmitter Agents; Papaverine; Penile Erectio | 1990 |
Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Topics: Adult; Alprostadil; Drug Evaluation; Drug Therapy, Combination; Erectile Dysfunction; Humans; Inject | 1991 |
Penile duplex sonography in the diagnosis of venogenic impotence.
Topics: Adult; Aged; Color; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penis | 1991 |
Vacuum tumescence devices: the role of papaverine in the selection of patients.
Topics: Equipment Design; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Pred | 1991 |
Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Infusions, Parenteral; Male; Middle Aged; Papaverine; Pen | 1991 |
Hypertension and impotence.
Topics: Antihypertensive Agents; Diabetes Complications; Erectile Dysfunction; Humans; Hypertension; Male; M | 1991 |
Comparison of the effects of papaverine versus prostaglandin E1 on penile blood flow by color duplex sonography.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Regional Blood Flow | 1991 |
[Reflectory stimulation of the pudendal nerve in dynamic pharmaco-cavernosometry].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penis; Physical Stimulation; Pressure; Prospective S | 1991 |
[Cavernosography using digital luminescence radiography (DLR) in the diagnosis of venous induced erectile function and of diseases of the corpus cavernosum].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Diseases; Penile Er | 1991 |
[Purulent cavernitis as a complication of self injection into the cavernous body].
Topics: Erectile Dysfunction; Humans; Infections; Injections; Male; Middle Aged; Papaverine; Penile Diseases | 1991 |
[The value of using a facilitating dose of papaverine chlorhydrate during cavernometry].
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Plethysm | 1991 |
[Treatment of erection disorders].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prostaglandins; Prost | 1991 |
[Diabetic impotence].
Topics: Alprostadil; Diabetes Complications; Diabetic Angiopathies; Diabetic Neuropathies; Diagnosis, Differ | 1991 |
Cavernosometry: methodology and reproducibility with and without pharmacological agents in the evaluation of venous impotence.
Topics: Adult; Aged; Blood Pressure; Erectile Dysfunction; False Negative Reactions; False Positive Reaction | 1991 |
Iatrogenic penile foreign body.
Topics: Aged; Erectile Dysfunction; Foreign Bodies; Humans; Injections; Male; Needles; Papaverine; Penis; Ra | 1991 |
[An attempt to classify vascular impotence using penile erection curve patterns].
Topics: Adult; Aged; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; P | 1991 |
Evaluation of penile dorsal arteries and deep arteries in arteriogenic impotence.
Topics: Adult; Aged; Arteries; Blood Flow Velocity; Chronic Disease; Diagnosis, Differential; Erectile Dysfu | 1991 |
[Role of pelvi-perineal rehabilitation in the treatment of cavernous venous leakage].
Topics: Electric Stimulation Therapy; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Pelvis; Pe | 1991 |
Treatment of organic impotence.
Topics: Bacterial Infections; Erectile Dysfunction; Humans; Male; Pain, Postoperative; Papaverine; Penile Pr | 1991 |
The combined use of sex therapy and intrapenile injections in the treatment of impotence.
Topics: Adult; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Female; Humans; Injections; Mal | 1990 |
Penile flow- and blood pressure index and the effective dose of intracavernous papaverine.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; M | 1990 |
[Diagnosis and surgical treatment of impotence caused by venous leakage].
Topics: Adult; Erectile Dysfunction; Humans; Ligation; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1990 |
[Corpus cavernosum injection treatment of erectile impotence].
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections, Intravenous; Male; | 1990 |
Self injection treatment for impotence.
Topics: Erectile Dysfunction; Humans; Male; Medication Errors; Papaverine | 1990 |
Follow up outcome of intracavernous papaverine.
Topics: Adult; Aged; Consumer Behavior; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; M | 1990 |
The diabetes physician and an assessment and treatment programme for male erectile impotence.
Topics: Adult; Aged; Counseling; Diabetes Complications; Diabetes Mellitus; Erectile Dysfunction; Humans; Ma | 1990 |
Diagnostic value of the radioisotope erection penogram for vasculogenic impotence.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Radionuc | 1990 |
[Diagnosis and treatment of impotence of vascular etiology].
Topics: Arterial Occlusive Diseases; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Papaverine | 1990 |
Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence.
Topics: Adult; Aged; Blood Pressure Determination; Chronic Disease; Erectile Dysfunction; Humans; Male; Midd | 1990 |
Comparison of selective internal iliac pharmaco-angiography, penile brachial index and duplex sonography with pulsed Doppler analysis for the evaluation of vasculogenic (arteriogenic) impotence.
Topics: Adult; Aged; Blood Pressure; Blood Pressure Determination; Brachial Artery; Erectile Dysfunction; Ev | 1990 |
[The value of corpus cavernosum sonography following administration of vasoactive substances in the diagnosis of patients with erectile impotence].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Flow Velocity; Diagnosis, Differential; Erectile Dys | 1990 |
High resolution ultrasonography and pulsed wave Doppler for detection of corporovenous incompetence in erectile dysfunction.
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Regiona | 1990 |
Correlation between penile angiography and duplex scanning of cavernous arteries in impotent men.
Topics: Adult; Aged; Angiography; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papa | 1990 |
[Pharmacocavernosometry and pharmacocavernosography in erectile dysfunction].
Topics: Alprostadil; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; P | 1990 |
Papaverine-induced penile blood flow acceleration in impotent men measured by duplex scanning.
Topics: Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penil | 1990 |
[Erectile dysfunction of male spinal cord injury patients].
Topics: Adult; Alprostadil; Ejaculation; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papave | 1990 |
[Intracavernous pharmacotherapy for organic impotence in the elderly].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; | 1990 |
[Intracavernous self-injection for treatment of erectile dysfunction inpatients with spinal cord injuries].
Topics: Administration, Topical; Adolescent; Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Mi | 1990 |
[Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Induration; Priapism | 1990 |
Intracavernous injections for impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Self A | 1990 |
Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
Topics: Animals; Drug Combinations; Erectile Dysfunction; Fibrosis; Infusion Pumps, Implantable; Macaca fasc | 1990 |
Cavernosometry: corroboratory method to surgical treatment of impotence due to venous leakage.
Topics: Erectile Dysfunction; Humans; Male; Manometry; Middle Aged; Papaverine; Penile Erection; Penis; Regi | 1990 |
Pharmacocavernometry in the assessment of erectile impotence.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Infusions, Intravenous; Male; Middle Aged; Papaverine; Pe | 1990 |
Intracavernous papaverine in the management of psychogenic impotence.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penile | 1990 |
Gravity cavernosometry--a simple diagnostic test for cavernosal incompetence.
Topics: Adult; Aged; Blood Pressure; Erectile Dysfunction; Gravitation; Humans; Male; Methods; Middle Aged; | 1990 |
Papaverine hydrochloride in peripheral blood and the degree of penile erection.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Regional Blood Flow; Time Fa | 1990 |
Intracavernous injection therapy: analysis of results and complications.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Fibrosis; Hematoma; Humans; Male; Middle Aged; Papa | 1990 |
Pyogenic granuloma: an unusual complication of papaverine injection therapy for impotence.
Topics: Adult; Erectile Dysfunction; Hemangioma; Humans; Male; Papaverine; Penile Neoplasms | 1990 |
Cavernous vein arterialization for vasculogenic impotence. An animal model.
Topics: Animals; Arteriovenous Shunt, Surgical; Disease Models, Animal; Dogs; Electric Stimulation; Erectile | 1990 |
Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.
Topics: Depressive Disorder; Erectile Dysfunction; Humans; Male; Papaverine; Priapism; Trazodone | 1990 |
Intracavernous papaverine and glaucoma.
Topics: Erectile Dysfunction; Glaucoma; Humans; Injections; Intraocular Pressure; Male; Papaverine; Penile E | 1990 |
The use of vasoactive agents in the treatment of erectile impotence.
Topics: Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1990 |
Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
Topics: American Medical Association; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Ere | 1990 |
Quantitation of pharmacologically-induced penile erections: the value of radionuclide phallography in the objective evaluation of erectile haemodynamics.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Erythrocytes; Hemodynamics; Humans; Male; Middle Age | 1990 |
[Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
Topics: Adult; Aged; Drug Therapy, Combination; Emergencies; Erectile Dysfunction; Humans; Male; Metaraminol | 1990 |
Noninvasive assessment of impotence.
Topics: Blood Pressure Determination; Electromyography; Erectile Dysfunction; Evoked Potentials; Humans; Mal | 1990 |
[Corpus cavernosum autoinjection therapy: initial experiences in erectile dysfunction].
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phento | 1986 |
[Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Papav | 1986 |
[Corpus cavernosum autoinjection therapy--a new concept in the treatment of erectile dysfunction].
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middl | 1986 |
Pharmacologic erection program for the treatment of male impotence.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erecti | 1987 |
Studies on intracavernosal VIP levels during pharmacologically induced penile erections.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Vasoactive Intestinal | 1987 |
Pharmacological erection: diagnosis and treatment applications in 69 patients.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolam | 1987 |
Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
Topics: Aged; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Peni | 1987 |
Intracavernosal injection in the treatment of impotence: a prospective study of sexual, psychological, and marital functioning.
Topics: Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Orgasm; Papaverine; Penile Erection; Ph | 1987 |
[2 years' experiences with cavernosal autoinjection therapy].
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Metaraminol; Papaverine; | 1987 |
Mid-term results of autoinjection therapy for erectile dysfunction.
Topics: Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Erectile Dysfunction; | 1988 |
Utility of Rigiscan and papaverine in diagnosis of erectile impotence.
Topics: Erectile Dysfunction; Evaluation Studies as Topic; Humans; Male; Monitoring, Physiologic; Papaverine | 1988 |
[Intracavernous injection of vasoactive drugs for treating erectile impotence].
Topics: Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile E | 1988 |
Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
Topics: Drug Combinations; Drug Stability; Drug Storage; Erectile Dysfunction; Humans; Male; Papaverine; Pen | 1988 |
[Experience with chemical prosthesis in impotence: report of 138 cases].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentol | 1988 |
Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; | 1989 |
[Diagnosis and treatment of impotence with administration of chemical prosthesis using real-time mechanical sector duplex scanner--with special reference to diabetic patients].
Topics: Adult; Aged; Diabetes Complications; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pe | 1989 |
Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection | 1989 |
Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism.
Topics: Aged; Erectile Dysfunction; Humans; Injections; Male; Ossification, Heterotopic; Papaverine; Penile | 1989 |
[Value of the visual stimulation test (VST) as initial paraclinical test in the study of erectile impotence. Classification of psychogenic impotence using computerized rigidimetry. The value of thymoxamine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Moxisylyte; Papaverine; Penile Erectio | 1989 |
Alpha-adrenoceptor function in isolated penile circumflex veins from potent and impotent men.
Topics: Adult; Aged; Erectile Dysfunction; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contractio | 1989 |
[Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Defense for the use of facilitating drugs. Part I--Pharmacology, classification and complications of active drugs].
Topics: Adrenergic alpha-Antagonists; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phenoxyben | 1989 |
Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
Topics: Aged; Coitus; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; | 1985 |
Radioisotope penile plethysmography: a technique for evaluating corpora cavernosal blood flow during early tumescence.
Topics: Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Erythrocytes; Humans; Male; Middle Aged; Pap | 1989 |
[Impotence due to venous incompetence. Research on reliable diagnostic criteria].
Topics: Adult; Erectile Dysfunction; Evaluation Studies as Topic; Humans; Male; Middle Aged; Papaverine; Pen | 1989 |
Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence.
Topics: Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Penile E | 1989 |
[Possibilities of treatment of erectile disorders by the administration of vasoactive substances into the penis using iontophoresis].
Topics: Adult; Erectile Dysfunction; Humans; Iontophoresis; Male; Middle Aged; Papaverine; Penile Erection | 1989 |
Biweekly intracavernous administration of papaverine for erectile dysfunction.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1989 |
Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
Topics: Adult; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine | 1989 |
Erectile dysfunction posttransplant.
Topics: Erectile Dysfunction; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Papaverine; Pen | 1989 |
Surgical treatment of impotence due to venous outflow.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Regional Blood Flow; | 1989 |
[The intracavernosal administration of papaverine in the diagnosis and treatment of sexual disorders in men].
Topics: Adult; Aged; Chronic Disease; Drug Evaluation; Erectile Dysfunction; Hemodynamics; Humans; Injection | 1989 |
Vascular insufficiency: a significant factor in impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Penis; Phentolamine | 1989 |
Pharmacologically induced prolonged erections produced by papaverine. Follow-up of injection therapy.
Topics: Adult; Aged; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaver | 1989 |
Comparison of penile vascular effect induced by intracavernous injection of papaverine and prostaglandin E1.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Blood Flow Velocity; Erectile Dysfunction; Humans; Male | 1989 |
[Diagnosis of venous insufficiency in erectile dysfunction: comparative studies of cavernosonography and Doppler sonography].
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Phentolamine; Ultrasonog | 1989 |
Determination of erectile penile volume by ultrasonography.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Re | 1989 |
Duplex scanning in suspected vasculogenic impotence: a worthwhile exercise?
Topics: Adult; Aged; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; | 1989 |
[Prostaglandin E1 in erectile dysfunction].
Topics: Alprostadil; Blood Flow Velocity; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injection | 1989 |
[Leakage correction by resection of the deep dorsal penis vein. Assessment of results after 4 years of venous potency surgery].
Topics: Adult; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erec | 1989 |
Intra-individual comparative study of dynamic and pharmacocavernography.
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentol | 1989 |
Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection.
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged | 1989 |
[Pharmaco-cavernosonography and cavernosometry with a new roller pump (AP 300 C)].
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Ultrasonography; Veno | 1989 |
The role of imaging in the diagnostic evaluation of impotence.
Topics: Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phlebography; R | 1989 |
Duplex and color Doppler sonographic evaluation of vasculogenic impotence.
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papav | 1989 |
Sexual impotence caused by vascular disease: diagnosis with duplex sonography.
Topics: Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Regiona | 1989 |
Correlation of altered penile ultrastructure with clinical arterial evaluation.
Topics: Adult; Aged; Arteries; Erectile Dysfunction; Humans; Male; Microscopy, Electron; Middle Aged; Muscle | 1989 |
Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography.
Topics: Adult; Aged; Arteries; Ejaculation; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pen | 1989 |
[Evaluation of impotence: intracorporeal injection of papaverine by color duplex sonography].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Ultrasonography | 1989 |
Autoinjection of corpus cavernosum with papaverine: a practical application device.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Self Administration; Syringes | 1989 |
Chemical prosthesis.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1989 |
Anatomy of penile venous drainage in potent and impotent men during cavernosography.
Topics: Adult; Aged; Contrast Media; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Ere | 1989 |
Treatment of persistent penile erection and priapism using terbutaline.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phenoxybe | 1989 |
The pH analysis of papaverine-phentolamine and prostaglandin E1 for pharmacologic erection.
Topics: Alprostadil; Buffers; Chemical Phenomena; Chemistry; Drug Combinations; Drug Stability; Erectile Dys | 1989 |
[Investigation of intracavernous injection of papaverine for erectile impotence].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1989 |
Pharmacocavernometry: a modified papaverine test.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Methods; Middle Aged; Papaverine; Penile Erection; | 1989 |
Effects of intracavernosal pharmacotherapy on self-esteem, performance anxiety and partnership in patients with chronic erectile dysfunction.
Topics: Anxiety; Coitus; Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; | 1989 |
Papaverine-induced erection.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Self Admi | 1989 |
Diagnosis of vasculogenic impotence: combination of penile xenon-133 washout and papaverine tests.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Radionuclide Imagin | 1989 |
[Intracorporeal injection of papaverine for diagnosis of impotence: clinical evaluation of 120 patients].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1989 |
Experience in diagnosis and treatment of impotence caused by cavernosal leak syndrome.
Topics: Adolescent; Adult; Aged; Contrast Media; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine | 1989 |
[Priapism as a complication following diagnostic papaverine test].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middle Aged; Papaverine; P | 1989 |
Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; | 1989 |
Why do so many people drop out from auto-injection therapy for impotence?
Topics: Erectile Dysfunction; Male; Papaverine; Patient Dropouts; Phentolamine; Retrospective Studies; Self | 1989 |
Intracavernous injections of papaverine and phentolamine: correlation with penile brachial index.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; | 1989 |
Severe arterial insufficiency in impotence confirmed with an improved angiographic technique: the impact of smoking and some other etiologic factors.
Topics: Aged; Angiography; Arteriosclerosis; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pe | 1989 |
[Papaverine and erectile disorders].
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penis | 1989 |
[Current diagnostic-therapeutic trends in vasculogenic impotence].
Topics: Adult; Arteries; Erectile Dysfunction; Humans; Male; Methods; Middle Aged; Papaverine; Penile Erecti | 1989 |
Intracavernous injection therapy in recovery of spontaneous erection (not for self-injection)--its mechanism and indications.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1989 |
[Treatment of impotence with intracavernous papaverin injections].
Topics: Erectile Dysfunction; Humans; Injections, Intravenous; Male; Papaverine; Penile Erection; Penis | 1989 |
[3 years' experience with intracavernous auto-injection therapy].
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; | 1989 |
Quantitative and qualitative analysis of dynamic cavernosographies in erectile dysfunction due to venous leakage.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentola | 1989 |
Enhanced cavernometry: procedure for the diagnosis of venogenic impotence.
Topics: Adolescent; Adult; Aged; Erectile Dysfunction; Humans; Male; Methods; Middle Aged; Papaverine; Penis | 1989 |
[Radionuclide diagnosis of vasculogenic impotence].
Topics: Erectile Dysfunction; Erythrocytes; Humans; Male; Mathematics; Models, Biological; Papaverine; Penis | 1988 |
About pharmacologically induced prolonged erection.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penis | 1985 |
[Hemodynamics of erection: current pharmacological findings].
Topics: Adrenergic alpha-Antagonists; Adult; Cyclic AMP; Erectile Dysfunction; Hemodynamics; Humans; Male; P | 1985 |
[Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
Topics: Adrenergic alpha-Antagonists; Adult; Drug Evaluation; Drug Therapy, Combination; Erectile Dysfunctio | 1986 |
Pharmacological consideration of intracavernous drug injection in the treatment of impotence.
Topics: Adrenergic beta-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine | 1988 |
Papaverine-induced fibrosis of the corpus cavernosum.
Topics: Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Self | 1989 |
Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Liver Function Tes | 1989 |
Use of prostaglandin E1 for papaverine-failed erections.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erecti | 1989 |
[Papaverine-induced priapism. Experiences with a new urologic emergency].
Topics: Adult; Bloodletting; Combined Modality Therapy; Dose-Response Relationship, Drug; Emergencies; Erect | 1989 |
Sexual problems in the elderly, II: Men's vs. women's. A Geriatrics panel discussion.
Topics: Aged; Erectile Dysfunction; Female; Humans; Male; Orgasm; Papaverine; Penis; Prostheses and Implants | 1989 |
Standardized evaluation of erectile dysfunction in 95 consecutive patients.
Topics: Adult; Aged; Blood Pressure Determination; Electromyography; Erectile Dysfunction; Evoked Potentials | 1989 |
Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence.
Topics: Acetylcholine; Diabetes Complications; Diabetes Mellitus; Electric Stimulation; Endothelium, Vascula | 1989 |
[Dynamic cavernosonography and intracavernous drug testing in the diagnosis of erectile dysfunction].
Topics: Adolescent; Adult; Aged; Angiography; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; P | 1987 |
Correlation between intracavernous papaverine injection and Doppler analysis in impotent men.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Regional Blood Flow; Rheolog | 1987 |
[What can be expected of intracavernous injections?].
Topics: Adult; Aged; Apomorphine; Erectile Dysfunction; Humans; Injections; Injections, Subcutaneous; Male; | 1988 |
Diagnostic accuracy of Doppler ultrasound technique of the penile arteries in correlation to selective arteriography.
Topics: Angiography; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; | 1988 |
Prolonged penile erection following papaverine--experiences with prophylaxis and therapy.
Topics: Adult; Aged; Alcoholism; Arteritis; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Pen | 1987 |
[Value of Doppler studies following intracavernous injection of papaverine hydrochloride in the diagnosis of impotence of arterial origin].
Topics: Adult; Angiography; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile | 1988 |
Pudendal arteriography.
Topics: Adolescent; Adult; Aged; Angiography; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; Pap | 1988 |
[Disorders of erectile potency in diabetes mellitus].
Topics: Aged; Alprostadil; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diab | 1988 |
Pharmacoarteriography in the evaluation of impotence.
Topics: Adult; Aged; Angiography; Erectile Dysfunction; Humans; Male; Middle Aged; Nitroglycerin; Papaverine | 1987 |
Penile magnification pharmacoarteriography: details of intrapenile arterial anatomy.
Topics: Arterial Occlusive Diseases; Arteries; Collateral Circulation; Erectile Dysfunction; Humans; Iopamid | 1987 |
Impotence: treatment by autoinjection of vasoactive drugs.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1987 |
Impotence: treatment by autoinjection of vasoactive drugs.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Self Admini | 1987 |
Impotence: treatment by autoinjection of vasoactive drugs.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Male; Papaverine; Phentolamine | 1987 |
Impotence in older men.
Topics: Aged; Aged, 80 and over; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Huma | 1988 |
Therapeutic approaches to sexual impotence.
Topics: Equipment and Supplies; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1988 |
Techniques for performing cavernosometry and cavernosography.
Topics: Adolescent; Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Pen | 1988 |
Pharmacoangiographic assessment of the corpora cavernosa.
Topics: Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; V | 1988 |
Therapeutic roles of intracavernosal papaverine.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Self Admi | 1988 |
[Diagnostic intracorporeal papaverine injection].
Topics: Adult; Aged; Blood Pressure; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine | 1988 |
[Diagnosis of impotence by intracavernous injection of papaverine].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Predictive Value of Tests; Region | 1988 |
Is phentolamine stable in solution with papaverine.
Topics: Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Erectile Dysfunction; Gas C | 1988 |
Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
Topics: Consumer Behavior; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Pain; Papaver | 1988 |
The use of a vacuum constrictor device to augment a partial erection following an intracavernous injection.
Topics: Adult; Aged; Constriction; Drug Combinations; Equipment Design; Erectile Dysfunction; Humans; Male; | 1988 |
[Therapy of erectile dysfunction using papaverine--2 1/2 years' experience].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1988 |
Can an intracavernous papaverine injection be used to diagnose arteriogenic impotence?
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1988 |
Corporeal self-injection for erectile failure.
Topics: Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Self Administration | 1988 |
The intracavernous injection of papaverine as a diagnostic procedure in patients with erectile dysfunction.
Topics: Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Regional Blood | 1988 |
[Surgical therapy of vascular impotence].
Topics: Arterial Occlusive Diseases; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Vascular Disease | 1988 |
Pharmacocavernosography in the evaluation of erectile failure.
Topics: Contrast Media; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; | 1988 |
Erectile responses to intracavernous papaverine and phentolamine: comparison of single and combined delivery.
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papav | 1988 |
Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; | 1988 |
The diagnosis of venogenic impotence: dynamic or pharmacologic cavernosometry?
Topics: Animals; Dogs; Electric Stimulation; Erectile Dysfunction; Male; Methods; Papaverine; Penile Erectio | 1988 |
[Several techniques proposed for the differential diagnosis of diabetic impotence].
Topics: Diabetes Complications; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Papaverine; Pen | 1988 |
Cavernosography and cavernosometry in the evaluation of impotence.
Topics: Erectile Dysfunction; Humans; Male; Methods; Papaverine; Penile Erection; Penis; Phlebography; Veins | 1988 |
Nonprosthetic surgical strategies for impotence.
Topics: Erectile Dysfunction; Humans; Male; Microsurgery; Papaverine; Penile Erection; Penis; Radiography; S | 1988 |
Penile corporeal fibrosis complicating papaverine self-injection therapy for erectile impotence.
Topics: Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penile Induration; Sel | 1988 |
Intracavernous self-injection for erectile failure.
Topics: Adult; Aged; Consumer Behavior; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middl | 1988 |
Diagnosis of male impotence after intracavernous papaverine test.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Pr | 1988 |
Surgery for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Prostheses and Implants | 1988 |
[Study on human penile hemodynamics after the intra-cavernous papaverine HCl injection].
Topics: Adult; Aged; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erect | 1988 |
Diagnosis and treatment of venous leakage: a curable cause of impotence.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentola | 1988 |
[Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Drug Combinations; Erectile Dysfunction; Humans; Male | 1988 |
[Comparison of papaverine-induced Doppler sonography and angiography in the diagnosis of erectile dysfunction].
Topics: Angiography; Blood Flow Velocity; Collateral Circulation; Erectile Dysfunction; Humans; Male; Papave | 1988 |
Arterially originated erectile disturbances: surgical possibilities and their alternatives--some personal thoughts.
Topics: Architecture; Arteriovenous Shunt, Surgical; Erectile Dysfunction; Europe; History, 20th Century; Hi | 1988 |
Papaverine--injection and Doppler-sonographic examination in the diagnosis of vascular erectile dysfunction.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penis; Ultrasonography | 1987 |
Re: Physiology of erection and pharmacological management of impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; United States; United States Food and Drug Administr | 1988 |
Systemic complication of intracavernous papaverine injection in patients with venous leakage.
Topics: Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Veins | 1988 |
Nonselective angiography after intracorporal papaverine injection: an alternative technique for evaluating penile arterial integrity.
Topics: Angiography; Arterial Occlusive Diseases; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; | 1988 |
Functional evaluation of penile hemodynamics.
Topics: Adult; Aged; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erect | 1988 |
Papaverine testing of impotent patients following nerve-sparing radical prostatectomy.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Postoperative Complications; Prosta | 1988 |
Pharmacological treatment of erectile dysfunction after radical prostatectomy.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Po | 1988 |
Intracavernous injection of vasoactive drugs after radical prostatectomy.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prostatectomy | 1988 |
The management of impotence following pelvic surgery.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Postoperative | 1988 |
[Erection resulting from intracavernous injection of papaverine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1988 |
[Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Patient Acceptance of Health Care; Penil | 1988 |
[Long-term experiences with autoinjection therapy of papaverine in erectile dysfunction].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erectio | 1988 |
[Intracavernous injection of vasoactive substances in the treatment of erectile dysfunction].
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injection | 1988 |
[Intracavernous injection of papaverine. Diagnostic value].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection | 1988 |
[Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
Topics: Adult; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentol | 1988 |
Penile-brachial pressure index as a guide for the dosage of intracavernous injection of papaverine.
Topics: Adult; Aged; Blood Pressure; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Ere | 1988 |
Treatment of male impotence--a pharmacologic erection program.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Drug Therapy, Combination; Erectile Dysfunction; Fo | 1988 |
Intracavernosal injection therapy for impotence: preliminary results.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1988 |
Impotence. Assessment in the private-practice office.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Prostheses and Impl | 1988 |
Differential diagnosis in erectile impotence. Intracorporeal papaverine injection and RigiScan tumescence and rigidity monitoring.
Topics: Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Monitoring, Physiologic; Papaverine; Pe | 1988 |
Intracavernous injection of papaverine, phentolamine and phenoxybenzamine.
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phenoxybenzam | 1988 |
[Are intracavernous injections of drugs for impotence harmless?].
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penis; Priapism | 1988 |
Experiences with a standardized diagnostic procedure on out-patient basis in 150 impotent males.
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Prosthes | 1988 |
Nocturnal computed rigidity and tumescence evaluation in the prevention of the iatrogenic priapism.
Topics: Adult; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penil | 1988 |
[Intracavernous papaverine in impotence. Radiographic and manometric studies].
Topics: Adolescent; Adult; Erectile Dysfunction; Humans; Injections; Male; Manometry; Middle Aged; Papaverin | 1988 |
Techniques for performing cavernosometry and cavernosography.
Topics: Erectile Dysfunction; Humans; Male; Manometry; Papaverine; Penis; Phlebography; Regional Blood Flow | 1988 |
Prolonged erections following intracorporeal injection of medications to overcome impotence.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Metaraminol; Middle Aged; Papaverine; Phenoxybenzam | 1988 |
Saline-induced artificial erection without papaverine: a potential source of error in diagnosing cavernosal venous leakage.
Topics: Adult; Erectile Dysfunction; False Positive Reactions; Humans; Male; Middle Aged; Papaverine; Penile | 1988 |
Nocturnal penile tumescence predicting response to intracorporeal pharmacological erection testing.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolam | 1988 |
Development of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents.
Topics: Adult; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1988 |
Erectile dysfunction in multiple sclerosis.
Topics: Adult; Erectile Dysfunction; Evoked Potentials; Humans; Male; Middle Aged; Multiple Sclerosis; Papav | 1988 |
Results of investigation of impotence in patients with overt or probable neuropathy.
Topics: Erectile Dysfunction; Humans; Male; Nervous System Diseases; Papaverine; Penile Erection; Penis; Reg | 1987 |
[Injections into the corpora cavernosa. The pros and cons].
Topics: Dipyridamole; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Patient Dropouts; Penis; P | 1987 |
[Diagnosis of impotence. Report 7: Dynamic cavernography].
Topics: Adult; Aged; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis | 1987 |
[Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases].
Topics: Erectile Dysfunction; Humans; Male; Metaraminol; Papaverine; Penile Erection; Priapism; Vasoconstric | 1987 |
The value of basic investigations in the diagnosis of impotence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Erectile Dysfunction; Humans; Male; Midd | 1987 |
Intracavernous self-injection of papaverine and regitine for the treatment of organic impotence.
Topics: Adult; Aged; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaver | 1986 |
A new alternative in evaluating and treating impotence in men: direct injections of the corpora cavernosa.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phento | 1987 |
Papaverine-induced priapism: case report.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Priapism; Suction | 1987 |
Experience with intracorporeal injection of papaverine and duplex ultrasound scanning for assessment of arteriogenic impotence.
Topics: Adult; Aged; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Ultrasono | 1987 |
Physiology of erection and pharmacological management of impotence.
Topics: Animals; Drug Combinations; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; | 1987 |
[Significance of the penile pressure index and value of the papaverine mini-test (8 mg)].
Topics: Blood Pressure; Erectile Dysfunction; Humans; Male; Papaverine; Penis | 1987 |
Penile pharmacocavernosography and cavernosometry in the evaluation of impotence.
Topics: Adult; Aged; Aged, 80 and over; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; | 1987 |
Information and treatment with intracavernous injections of papaverine and phentolamine.
Topics: Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Self Admini | 1987 |
Treatment of impotence. 1. Nonsurgical methods.
Topics: Bromocriptine; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Psychotherapy; Self Adm | 1987 |
Relevance of dynamic cavernosography to the diagnosis of venous incompetence in erectile dysfunction.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Radiography; Regional | 1987 |
Dynamic corpus cavernosography: effect of papaverine injection.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Cineradiography; Diatrizoate Meglumine; Erectile Dysfu | 1987 |
Cavernosal venocclusive insufficiency in male impotence: evaluation of degree and location.
Topics: Aged; Blood Pressure; Erectile Dysfunction; Humans; Male; Manometry; Middle Aged; Papaverine; Penile | 1987 |
[Ambulatory studies and treatment of erectile impotence. Value of the papaverine test].
Topics: Androgens; Blood Pressure; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Plethysmography; P | 1987 |
Diabetes-related impotence and its treatment in the middle-aged and elderly: Part II.
Topics: Aged; Counseling; Diabetes Complications; Equipment and Supplies; Erectile Dysfunction; Humans; Inje | 1987 |
The effect of papaverine on arterial and venous hemodynamics of erection.
Topics: Adult; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erection; P | 1987 |
The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury.
Topics: Adult; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erecti | 1987 |
Penile self-injection for impotence in patients after radical cystectomy-ileal loop.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Ileum; Male; Papaverine; Penile Erection; Phentolam | 1987 |
Leakage through the crural edge of corpus cavernosum. Diagnosis and treatment.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Pressure; Veins | 1987 |
Quantitation of corporeal venous outflow resistance in man by corporeal pressure flow evaluation.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Re | 1987 |
Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections, Intramuscular; Male; Middle Aged; Papaverine; | 1986 |
The management of erectile impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prostheses and Implan | 1986 |
The erectile angle: objective criterion to evaluate the papaverine test in impotence.
Topics: Adult; Aged; Diagnosis, Differential; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; N | 1987 |
Intracavernous injections for impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine | 1987 |
Priapism--a medical emergency.
Topics: Emergencies; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Priapism | 1987 |
Preliminary report of a new concept in the pharmacological treatment of erectile impotence using an implantable drug delivery system.
Topics: Adult; Erectile Dysfunction; Humans; Infusion Pumps; Male; Papaverine; Penile Erection; Penis | 1987 |
[Spongious autoinjection therapy following implantation of a penis prosthesis--case report].
Topics: Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; | 1987 |
[Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Spinal C | 1987 |
Pharmacocavernometry-cavernography in impotence.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Radiography | 1986 |
[Injection of papaverine in the cavernous body of the penis in the treatment of impotentia erigendi].
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis | 1986 |
Another surgical approach for vasculogenic impotence.
Topics: Adult; Aged; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Re | 1986 |
Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
Topics: Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; | 1986 |
[The treatment of impotence with auto-injections of papaverine].
Topics: Adult; Aged; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Self Ad | 1986 |
[Impotence with venous leakage. An extensive study of 49 cases detected by the artificial erection test].
Topics: Arteries; Blood Pressure Determination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erect | 1986 |
[Preliminary results of the treatment of erectile impotence by intracavernous self administration of vasoactive substances].
Topics: Adult; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; P | 1986 |
Pharmacologic injection therapy.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Self Admi | 1986 |
Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Priapism; | 1986 |
Intracorporal injection of papaverine and phentolamine in the management of impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; | 1986 |
Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.
Topics: Adult; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Injections; Male; Papaverine; Peni | 1987 |
Intracavernous therapy in impotence after pelvic trauma. A preliminary study.
Topics: Adult; Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Pelvis; Penis; Self Administrati | 1986 |
A screening sequence for vasculogenic impotence.
Topics: Adult; Age Factors; Aged; Algorithms; Angiography; Arteries; Blood Pressure; Electric Stimulation; E | 1987 |
Assessment of the immediate and long-term effects of pharmacologically induced penile erections in the treatment of psychogenic and organic impotence.
Topics: Adult; Aged; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; | 1987 |
Intracavernous injections of vasoactive substances for the treatment of impotence.
Topics: Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Vasodilator Agents | 1985 |
Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis.
Topics: Adult; Aged; Arteries; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Regional | 1985 |
Evaluation of arteriogenic impotence with intracorporeal injection of papaverine and the duplex ultrasound scanner.
Topics: Arteries; Erectile Dysfunction; Humans; Male; Papaverine; Penis; Regional Blood Flow; Ultrasonograph | 1985 |
Is intracavernous injection of papaverine a reliable screening test for vascular impotence?
Topics: Adult; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Sexual Dysfunct | 1986 |
Functional evaluation of penile veins by cavernosography in papaverine-induced erection.
Topics: Adult; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Radiography; Veins | 1986 |
Cavernosal alpha blockade: a treatment for erectile impotence.
Topics: Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine | 1986 |
Diagnostic tests for impotence: a comparison of papaverine injection with the penile-brachial index and nocturnal penile tumescence monitoring.
Topics: Adult; Aged; Blood Pressure; Brachial Artery; Erectile Dysfunction; Humans; Injections; Male; Method | 1986 |
[Treatment of organic impotence. Self-administered intracavernous injection of papaverin HCI (a preliminary report)].
Topics: Adult; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Self Administ | 1985 |
Evaluation of treatment of impotence--where are we going?
Topics: Erectile Dysfunction; Humans; Male; Papaverine | 1985 |